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Edwardsiella tarda is an opportunistic gram-negative bacterial pathogen affecting both 
animals and humans. The ability of E. tarda to cause disease is dependent upon multiple 
factors. These include ability to invade epithelial cells, resist phagocytic killing and produce 
hemolysins and catalases.  Recently, a TTSS and an EVP gene cluster related to protein 
secretion have been identified to contribute to the pathogenesis of E. tarda. However, the 
mechanisms about how they secrete proteins and what the relationship between these two 
secretion systems is have not been defined. In this study, we first characterized the 
regulation of the type III secetion system (TTSS) and the E. tarda virulent protein (EVP) 
gene cluster. An in-frame deletion of EsrC, an AraC family protein encoded in the TTSS, 
increased the LD50 value in blue gourami fish, reduced extracellular protein production 
and failed to aggregate. Two-dimensional gel electrophoresis (2D-PAGE) showed that 
EsrC regulated the expression of secreted proteins encoded by the TTSS (such as EseB 
and EseD) and EVP (such as EvpC) gene clusters. Further studies showed that the 
expression of esrC required a functional two-component system of EsrA-EsrB. EsrC in 
turn regulated the expression of selected genes encoded in the TTSS, such as the 
transcriptional unit of orf29 and orf30, but not esaC, while esaC was directly controlled 
by EsrA-EsrB. EsrC was also shown to regulate the EVP gene cluster (evpA-evpH) and a 
promoter was found upstream of evpA. Analysis using RT-PCR and promoterless plasmid 
showed that EsrC regulated the TTSS proteins (EseB, EseD, Orf29 and Orf30) and EVP 
proteins at the transcriptional level. Interestingly, we found that orf29 and orf30 were also 
directly regulated by the EsrA-EsrB two-component secretion system, suggesting that 
 xvi
proteins encoded by these two genes may have different functions from the TTSS secreted 
translocon components (such as EseB and EseD) and apparatus (such as EsaC). 
In our attempt to further characterize the regulation of E. tarda TTSS, we identified a 
chaperone (EscBD) for the TTSS translocon components of EseB and EseD. EscBD has 
the typical characteristics of a TTSS chaperone. An in-frame deletion of escBD abolished 
the secretion of EseB and EseD but not EseC. However, EscBD is not a transcriptional 
regulator as mutation of escBD did not affect the transcription of eseB but reduced the 
amount of a translational fusion protein EseB-LacZ in E. tarda. Co-purification studies 
demonstrated that EscBD formed complexes with EseB and EseD, respectively. However, 
EscBD could not properly bind to EseB and EseD concurrently, indicating the role of 
EscBD is to prevent the premature interaction of EseB and EseD. Collectively, these 
results demonstrate that EscBD functions as a TTSS chaperone for the translocon 
components EseB and EseD in E. tarda. 
Subsequently, we aimed to characterize the EVP gene cluster. A combination of genomics 
walking and phage library screening were carried out to further characterize this gene 
cluster, and seven more genes were found in this cluster. Bioinformatics analysis showed 
that most proteins encoded in this cluster are homologous to proteins in the IAHP clusters 
in other bacterial pathogens.  The IAHP (IcmF associated homologous proteins) cluster in 
many bacterial pathogens has been implicated in the proteins secretion and was named as 
type VI secretion system in Vibio cholerae. However, the individual genes essential for 
the secretion system have not been defined. Thus, we systematically mutagenized all 15 
genes in the EVP gene cluster and analyzed the extracellular protein (ECP) profiles. We 
identified one potential effector (EssA) upstream of the EVP gene cluster and one secreted 
 xvii
secretion apparatus protein (EvpI) inside the EVP cluster which were absent from some of 
the EVP mutants. Our characterization studies showed that the secretion of EssA 
depended on 13 EVP genes including evpC and evpI.  In contrast, a mutation of essA did 
not affect the secretion of EvpC and EvpI.  
To drive protein transfer, all secretion systems have at least one integral inner membrane 
component that can be energized by ATP hydrolysis, which fuels the bioenergetically 
unfavorable secretion process. Of these 13 EVP proteins required for EssA secretion, we 
found two possible ATPases, namely EvpO and EvpH, and we demonstrated that EvpO, 
but not EvpH, interacted with three EVP proteins, namely EvpA, EvpL and EvpN. 
Furthermore, most of EvpO homologs in IAHP clusters from 14 bacterial pathogens 
possessed at least three transmembrane domains and were predicted to be localized on the 
inner membrane, suggesting that EvpO is the scaffold protein for the type VI secretion 
system in E. tarda. 
The present study is an attempt to investigate the virulent factors of E. tarda TTSS and 
EVP gene cluster which are involved in protein secretion. We have successfully 
demonstrated the cross-talk between the TTSS and the EVP gene clusters through a 
regulator of EsrC encoded inside the TTSS, and clearly showed that the EVP gene cluster 
encoded a novel secretion system. Our results will benefit the understanding of E. tarda 
pathogenesis and will provide new targets for the prevention and treatment of infection 
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I.1 E. tarda and its infections 
I.1.1 Taxonomy, identification and distribution  
Edwardsiella tarda is a gram-negative bacillus belonging to the Enterobacteriaceae family 
which includes human pathogens such as Escherichia coli, Salmonella, Shigella, and 
Yersinia species. E. tarda is a relatively new genus, and the first report about the genus of 
Edwardsiella was in Japan by Sakazaki and Murata (1962). This genus includes three 
members, namely E. ictaluri (Hawke, 1979), E. hoshinae (Grimont et al., 1980) and E. 
tarda (Ewing et al., 1965). E. ictaluri can be isolated from catfish and can cause severe 
infections and enteric septicemia (Hawke et al., 1981), while E. hoshinae has been found 
in water, birds, and lizards (Grimont et al., 1980). E. tarda was formerly known as 
Paracolobactrum anguillimortiferum (Hoshina, 1962). In 1965, Ewing and co-workers at 
the Centers for Disease Control and Prevention described and renamed it as E. tarda in 
honor of the American bacteriologist P. R. Edwards.  
E. tarda is small, straight rods (1 μm in diameter × 2-3 µm) and motile bacterium having 
peritrichous flagella. It is oxidase-negative and does not form spores.  This bacterium 
cannot utilize many sugars, and therefore the epithet “tarda” means inactivity. E. tarda 
can grow on tryptic soy agar medium and form small, round, raised and transparent 
colonies at 24-26°C (Meyer and Bullock, 1973). The biochemical characteristics of 
Edwardsiella are similar to Escherichia, Shigella, and Salmonella, but it is easily 
differentiated on the basis of a complete set of biochemical test results (Kelly et al., 1985). 
Rapid identification of E. tarda is also possible through the use of PCR based 
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identification systems. Chen and Lai (1998) have successfully used PCR to identify this 
bacterium in fish and water samples.  
E. tarda is most commonly associated with freshwater environment as well as with 
animals that inhabit these ecosystems, such as fish, toads, snakes, and a variety of 
mammals including humans. E. tarda is more commonly isolated compared to E. ictaluri, 
which is specifically found in catfish and its culture environments, and E. hoshinae, which 
is not so frequently reported.  The presence of E. tarda has been reported in several 
countries (Gilman et al., 1971; Iverson 1973; Onogawa et al., 1976; Desenclos et al., 
1990). However, it is more frequently found in tropical and sub-tropical regions.  
I.1.2 E. tarda infections 
E. tarda is a ubiquitous organism with a broad host range and can cause diseases in both 
humans and animals. 
I.1.2.1 Infections in humans 
E. tarda is the only species of this genus that can infect humans and cause diseases in 
humans. Association of E. tarda with human diseases was first reported in 1969 (Jordan 
and Hadley, 1969). So far, at least 300 clinical cases have been reported. E. tarda 
infections in humans are more common in tropical and subtropical regions (Sakazaki and 
Murata, 1962; Kourany et al., 1977), and in persons with exposure to the aquatic 
environments or exotic animals including amphibians and reptiles, and conditions leading 
to iron overload and dietary habits like ingestion of raw fish (Janda and Abbott, 1993a, 
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Wu et al., 1995). The diseases caused by E. tarda in human infections can generally be 
divided into two categories, namely, gastro- and extra-intestinal infections.  
Gastro-intestinal infections are common compared to extra-intestinal infections. Although 
infections caused by E. tarda in humans are uncommon, gastro-intestinal infections are 
very serious and the mortality rates may reach up to 50% as reported by Janda and Abott 
(1993a).  Some of the clinical symptoms of gastroenteritis caused by this pathogen are 
acute secretory enteritis, and intermittent watery diarrhea with mild fever (38.5-39°C). 
More severe forms of gastroenteritis similar to enterocolitis have also been reported 
(Nagel et al., 1982; Ovartlarnporn et al., 1986; Gilman et al., 1997). 
E. tarda has also been found to cause extra-intestinal diseases such as myonecrosis 
(Slaven et al., 2001), peritonitis with sepsis (Clarridge et al., 1980), septic arthritis (Osiri 
et al., 1997), bacteremia (Yang and Wang, 1999) and wound infections (Vartian and 
Septimus, 1990; Banks, 1992; Ashford et al., 1998). E. tarda was also isolated from 
patients with hepatobiliary diseases and immuno-competence (Janda and Abbott, 1993a). 
I.1.2.2 Infections in animals 
Besides causing diseases in humans, E. tarda is most commonly associated with 
freshwater environments as well as with animals that inhabit these ecosystems, such as 
turtles, water tortoises, fish, toads and snakes (Plumb, 1993), and it can cause 
Edwardsiella septicemia, a mild to severe system disease, in warmed water fish. E. tarda 
is most prevalent in channel catfish (Meyer and Bullock, 1973) and in Japanese eels 
(Egusa, 1976).  The outbreaks of disease caused by E. tarda is typically associated with 
warm summer months, elevated water temperatures, and poor water quality (Meyer and 
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Bullock, 1973; Baya et al. 1997). A high water temperature, coupled with high levels of 
organic matter undoubtedly leads to higher incidences of disease outbreaks. However, 
diseases were also reported to occur at 10-18°C in cultured eels in Taiwan (Liu and Tsai, 
1980). The diseases caused by E. tarda lead to great losses in aquaculture every year in 
the United States and Asia (Janda, 1993a). Therefore, it is important to study the 
pathogenesis of E. tarda and find suitable strategies to either prevent or cure its infection. 
I.1.3 Treatment and prevention 
E. tarda is susceptible to most antibiotics that target Enterobacteriaceae, and its infections 
in humans can normally be treated by any approved drugs, including β-lactam antibiotics, 
cephalosporins, aminoglycosides and quinolones (Clarridge et al. 1980; Wilson et al. 
1989; Janda and Abbott, 1993a). Actually, gastro-intestinal infections often do not 
required treatments and they can be resolved spontaneously (Janda and Abott, 1993a). 
Severe infections have been successfully treated with ampicillin, co-trimoxazole, third 
generation cephalosporins and quinolones (Jordan and Hadley, 1969; Clarridge et al. 1980; 
Ovartlarnporn et al, 1986; Wilson et al. 1989). The extra-intestinal edwadsiellosis can be 
treated with a combination of antibiotics, such as a cephalosporin and an aminoglycoside 
(Janda and Abbott, 1993a). 
E. tarda infection in fish can be administered by oral application of drugs in feeds, such as 
oxytetracycline, sulphadimethoxine-ormetoprim (Plumb, 1999). A potentiated 
sulphonamide, oxalinic acid or miloxacin can be used for treating infections by E. tarda 
strains that are resistant to chloramphenicol, tetracycline and sulphonamide (Aoki et al., 
1985). However, the recovery is slow and those fish survived may exhibit scarred tissues. 
 5
Vaccines against E. tarda infections have been developed in several laboratories. Vaccine 
preparations involved the used of whole cells, disrupted cells, cell extracts, and outer 
membrane proteins as immunogens (Song and Kou, 1979; Salati et al., 1983; Salati, 1985; 
Salati and Kusuda, 1985a and 1985b; Kawai et al., 2004; Liu et al., 2005). However, no 
commercial vaccine has been marketed so far. 
I.2 Virulence factors of E. tarda 
Information regarding E. tarda virulence is rather limited, although several recent studies 
have identified a number of virulence factors associated with the pathogenesis of this 
bacterium. However, the pathogenesis of E. tarda is multi-factorial in nature. Several 
factors contribute to its pathogenesis, including the abilities to resist serum (Janda et al., 
1991b; Ling et al., 2000) and phagocyte-mediated killings (Srinivasa Rao et al., 2001), to 
adhere to,  invade and replicate within epithelial cells (Janda et al., 1991a; Ling et al., 
2000), and to produce toxins and enzymes such as hemolysins (Hirono et al., 1997), 
catalases (Srinivasa Rao et al., 2003b) and dermatotoxins (Ullah and Arai, 1983b) for 
disseminating infection. Recently, two important virulence mechanisms that are related to 
secretion systems, namely, a type III secretion system (TTSS) (Tan et al., 2005) and a 
putative novel secretion system, EVP (E. tarda virulence protein) (Srinivasa Rao et al., 
2004) have also been unraveled.  
I.2.1 Serum and phagocyte resistance 
Serum and phagocyte-mediated killing are the two major defense mechanisms of non-
specific immunity in fish (Blazer, 1991; Dalmo et al., 1997). In order to survive and 
colonize in host cells, bacteria must overcome the primary immune response of the host 
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system. Phagocytic attack is one of the first lines of defenses that the bacterial cells 
encounter after they have gained entry into the host. Opsonized virulent E. tarda strains 
were able to adhere to, survive, and replicate within fish phagocytes (Iida and 
Wakabayashi, 1993; Srinivasa Rao et al., 2001). They had the ability to circumvent the 
anti-bacterial defense by failing to stimulate reactive oxygen intermediates.  
I.2.2 Adherence and invasion of host cell 
E. tarda has the ability to adhere to and invade host cell to establish the successful 
colonization. E. tarda strains that were tested for adherence showed both mannose-
resistant and mannose-sensitive hemagglutination. The hemagglutination activity may be 
mediated by non-fimbrial proteinaceous adhesions, as E. tarda was shown to lack 
fimbriae with electron microscopy studies (Wong et al., 1989). E. tarda cells have been 
observed to be surrounded by a layer of slime (Ullah and Arai, 1983a) and this was 
speculated to help in bacterial adherence to host cells.  
Clinical E. tarda isolates were invasive in a HeLa cell assay (Marques et al., 1984). Janda 
et al. (1991a) reported that E. tarda was able to penetrate and replicate in cultured HEp-2 
cell. Clinical isolates of E. tarda induced plasma membrane ruffles on infection of HEp-2 
cells. However, these membrane ruffles did not coincide with bacteria (Phillips et al., 
1998). Therefore, the bacteria appeared to interact with the host cell and exploit its signal 
transduction pathway via a unique mechanism. The ability of E. tarda to invade epithelial 
cells seems associated with hemolytic activity encoded by the E. tarda hemolysin gene 
(ehl).  Escherichia coli containing the ehl locus invaded HEp-2 cells more efficiently than 
the control, non-hemolytic E. coli strains (Strauss, 1997). Recently, Ling et al. (2000) 
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tested the invasion pathway of E. tarda in vitro and in vivo, they found that both the 
virulent and avirulent E. tarda strains were able to adhere to, invade and replicate within 
the epithelial papillosum of carp, Cyprinus carpio (EPC) cells. The internalization of 
bacteria involved microfilaments and protein tyrosine kinase, and bacteria co-localized 
with polymerized actin. 
I.2.3 Toxins, enzymes and other secreted proteins  
E. tarda could secrete some toxins and enzymes as virulent factors. Ullah and Arai (1983b) 
reported that 19 of the 19 E. tarda isolates produced dermatotoxins and these toxins 
induced erythema in mice. E. tarda also secretes two types of hemolysins, including cell 
associated and iron-regulated hemolysin, and extracellular hole-forming hemolysin (Janda 
and Abbott, 1993b; Chen et al., 1995; Chen et al., 1996; Chen and Huang, 1996; Hirono 
et al., 1997), and the cell-associated hemolysin was an important virulence factor required 
for the invasive activities (Marques et al., 1984; Janda et al., 1991a). 
A number of E. tarda strains produced chondroitinase which may aid in the destruction of 
host tissues and facilitate bacteria dissemination throughout the host body system (Ruoff 
and Ferraro, 1987; Shain et al. 1996). Besides these, E. tarda also produce two 
dermatonecrotic exotoxic substances (Ullah and Arai, 1983b), siderophore (Payne, 1988; 
Kokubo et al., 1990), and a 37 kDA toxin (Suprapto et al., 1996), which contribute to its 
pathogensis.  
Recently, E. tarda strains were found to produce three different types of catalase-
peroxidase (Kat1-3) of which KatB being the major catalase enzyme (Srinivasa Rao et al., 
 8
2003b). KatB was required for E. tarda survival and replication in phagocyte-rich organs 
in gourami fish, indicating its importance in virulence.  
I.2.4 Phosphate specific transport (PST) operon 
Phosphate is an essential nutrient for all the living organisms. The pstSCAB-phoU operon 
is a high-affinity phosphate-specific transport (PST) operon belonging to the family of 
ATP binding cassette (ABC) transporters (Webb et al., 1992). In Salmonella enterica 
serovar Typhimurium, the transposon mutant pstS reduced the expression of the TTSS 
regulator of hilA and the invasion genes, and this repression was due to the negative 
control of the PhoR-PhoB two-component system. The pstS mutation led to the 
accumulation of PhoB~P, and PhoB~P directly or indirectly repressed hilA and the 
invasion genes (Lucas et al. 2000). The transposon mutation of PST operon in E. tarda 
led to more than 3 logs increase of the LD50s in the blue gourami host. 2D-PAGE analysis 
demonstrated that TnphoA insertions in pstB, pstC and pstS abolished the expression of 
TTSS as well as EVP proteins (Srinivasa Rao et al. 2004). 
I.2.5 Type III secretion system in E. tarda 
In an attempt to characterize the virulent factors, both proteomics and genomics 
approaches have been used and several virulence factors have been revealed. Among 
these factors, a TTSS was found in E. tarda to contribute to the virulence. TTSSs are used 
by many bacterial pathogens for the delivery of virulence factors into the host cells (more 
description on TTSSs can be found in I.3.5).  
 9
Tan et al. (2002) compared the ECPs of virulent and avirulent E. tarda strains revealed 
several major, virulent-strain-specific proteins. Proteomics analysis identified two of the 
proteins in the virulent strain PPD130/91. One is homologous to flagellin and the other 
protein spot (EseB) was similar to the translocon protein SseB of Salmonella pathogencity 
island 2 (SPI-2) TTSS (Fig I.1; Tan et al., 2002). The gene sequences were then identified 
using degenerate primers. At the same time, Srinivasa Rao et al. (2003) screened 490 
alkaline phosphatase fusion mutants from a library of 450,000 TnphoA transconjugants 
derived from strain PPD130/91, using blue gourami fish as an infection host. They 
identified 14 virulence genes that were essential for disseminated infection, including 
enzymes, a phosphate transporter, novel protein and a protein similar to SsrB (EsrB), a 
regulator of Salmonella TTSS (Fig I.1; Srinivasa Rao et al., 2003). Based on the 
sequences of EseB and EsrB, the TTSS cluster was identified in the genome of E. tarda. 
The TTSS gene cluster from E. tarda PPD130/91 contained 35 open reading frames, and 
many of the putative genes were similar to those in SPI-2 TTSS of S. enterica serovar 
Typhimurium (Shea et al. 1996; Hensel et al. 1998; Hensel 2000; Tan et al. 2005).  Thus, 
the designation of the E. tarda TTSS genes was based on the sequence homologs in 
Salmonella SPI-2. Similarly to Salmonella SPI-2, the genes of the E. tarda TTSS cluster 
were grouped into four categories:  E. tarda secretion system apparatus (esa), chaperone 
(esc), effectors (ese) and regulators (esr) (Tan et al., 2005). Beside these, the E. tarda 
TTSS also encoded some hypothetical proteins (such as Orf2, Orf29 and Orf30), the 
homologs search of which against NCBI Database did not retrieve any characterized 
proteins.  The virulence of the insertion mutants in genes representing TTSS apparatus, 
translocon, and chaperones were found to have increased at least ten folds in LD50s in 
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comparison with that of the wild type. However, the mutation of the two-component 
system genes esrA and esrB led to near thousand-fold decrease. Furthermore, the 
adherence and invasion rates of esrA and esrB mutants were enhanced while those of the 
apparatus and chaperone mutants remained similar to that of the wild type (Tan et al., 
2005). They proposed that the function of EsrB was possibly similar to the homolog of 
SsrB in Salmonella which was a global regulator and controlled several virulence factors 
encoded both inside and outside of the SPI-2 TTSS (Gray et al., 2002; Feng  et al., 2003).  
With 2D-PAGE analysis, EseB, EseC and EseD were identified as the major components 
in the ECPs and their secretions were TTSS-dependent (Tan et al., 2005). These three 
proteins contributed to the virulence of E. tarda as insertional mutations of them increased 
the LD50 values about 10 times (Tan et al., 2005). Sequence analyses showed that these 
three proteins were homologous to EspA, EspD and EspB of EPEC, respectively (Tan et 
al., 2005). EspA formed a sheath-like structure, and EspB and EspD formed a translocon 
pore in enteropathogenic E. coli (EPEC). EspA, EspB and EspD together constituted a 
molecular syringe and channeled effector proteins into the host cell (Ide et al., 2001). In 
addition, the homologs of EseB, EseC, and EseD in Salmonella (SseB, SseC and SseD, 
respectively) were aslo shown to function as tranlocon components, and they were 
essential for the effectors translocation (Nikolaus et al., 2001). The bioinformatics results 
of EseBCD as translocon components were confirmed by the co-immunoprecipitation, 
which showed that EseBCD formed a complex after secretion (Tan, 2005). 
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I.2.6 EVP gene cluster 
Our laboratory also compared the secreted proteins and total bacterial proteins profiles of 
the wild type E. tarda and those of TnphoA highly attenuated mutants (pstC, pstB, pstS), 
and three proteins that did not belong to the TTSS were found absent from the TnphoA 
highly attenuated mutants (Fig I.1; Srinivasa Rao et al., 2004). Based on the nano 
electrospray ionization (ESI) tandem MS data, EvpA and EvpC were identified and the 
gene sequences were identified with degenerate primers. With genomics walking, an eight 
open-reading-frame gene cluster was sequenced and was named as the EVP gene cluster 
(Srinivasa Rao et al., 2004). Sequence blast search against NCBI GenBank revealed that 
this gene cluster was conserved in many other animal and plant pathogens and symbiont 
such as Salmonella, Vibrio, Yersinia, Escherichia, Rhizobium and Agrobacterium species 
(Srinivasa Rao et al., 2004). EVP proteins contributed to the pathogenesis of E. tarda as 
disruption of the EVP gene cluster resulted in about 2 logs increase of the LD50s in the 
blue gourami host (Srinivasa Rao et al., 2004). The mutation of the EVP genes also led to 
lower replication rates in gourami phagocytes, and reduced protein secretion. In addition, 
evpA and evpC were shown to be regulated by TTSS regulator esrB with the 2D-PAGE 
and the secretion of EvpC was dependent on EvpB (Srinvasa Rao et al., 2004). Mutations 
of the TTSS apparatus did not affect the secretion of EvpC, suggesting that the EVP gene 
cluster encodes a novel secretion system which is different from the TTSS in E. tarda 
(Srinivasa Rao et al., 2004).   
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I.3 Secretion systems in gram-negative bacteria 
Interaction of bacterial pathogens with their host cells is characterized by factors that are 
located on the bacterial surface or are secreted into the extracellular space. Although the 
secreted bacterial proteins are numerous and diverse, only a few pathways by which these 
proteins are transported from the bacterial cytoplasm to the extracellular space or directly 
to the host cell cytoplasm exist.  So far, five distinct mechanisms for extracellular 
secretion of proteins, known as type I though type V, have been descried in gram-negative 
bacteria. Proteins secretion via type II, IV or V secretion systems requires the sec general 
secretion pathway through which the N-terminal signals are removed during secretion. 
However, secretions via type I or type III do not required the sec pathway. 
I.3.1 Type I secretion system 
The type I secretion system was first described in the E. coli alpha-hemolysin (Salmond 
and Reeves, 1993). This secretion system requires three proteins: an inner-membrane 
ATPase (Termed ABC protein for ATP-binding cassette), which provides energy for the 
system (HlyB for E. coli hemolysin), a membrane fusion protein (HlyD) that spans the 
periplasm and the TolC out-membrane protein. Type I secretion is independent of sec 
system and thus does not involve amino terminal processing of the secreted proteins. 
Protein secreted via this pathway occurs in a continuous process without the distinct 
presence of periplasmic intermediates (Fig I. 2).  The secretion signal of proteins via this 
pathway is located within the carboxy-terminal of about 60 amino acides of the secreted 
proteins (for a review, see Binet et al., 1997). 
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I.3.2 Type II secretion system 
The type II secretion system has been studied in many bacteria, such as Klebsiella oxytoca, 
E. coli, Erwinia spp., V. cholerae, Pseudomonas aeruginosa and Aeromonas hydrophila 
(for a review see, Hacker and Kaper, 2000). This system is a sec-dependent protein 
secretion pathway and responsible for secretion of extracellular enzymes and toxins 
(Pugsley et al., 1997; Russel, 1998; Thanassi and Hultgren, 2000). Protein secretion 
through this pathway involved a separate step of transport across the inner membrane 
prior to transport across the cell envelope (Fig. I.2).  Proteins secreted by this system 
possess N-terminal sequences of about 30 amino acids that consist of a basic N-terminal 
domain, a hydrophobic central core segment, and a distal domain that contains a cleavage 
site in which the signal sequence is removed by a periplasmic signal peptidase when the 
exported protein reaches the periplasm (Hueck, 1998). Different from other secretion 
systems, proteins secreted to the extracellular milieu by the type II secretion system 
requires corrected folding (Py et al., 1993). It is believed that recognition and outer 
membrane translocation of the secreted proteins occur once they have folded into a 
secretion-competent conformation (Filloux et al., 1998; Sandkvist, 2001). The specific 
recognition sequence or structure motif for the secretion has yet to be identified. 
The type II secretion system in K. oxytoca is the best characterized, which requires 14 
proteins. Most of proteins encoded in this system are located in the inner membrane while 
PulS and PulD are outer membrane proteins (Pugsley, 1993; Pugsley et al., 1997). PulD 
and its homologs are found as a large oligomer of 12-14 subunits in the outer membrane 
and form the putative pore of the type II secretion system, through which the type II-
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secreted proteins are believed to pass (Kazmierczak et al., 1994; Hardie et al., 1996; 
Lindeberg et al., 1996; Linderoth et al., 1997; Bitter et al., 1998).  
I.3.3 Type IV secretion system 
The type IV secretion system is also a sec-dependant protein secretion system through 
which the amino-terminal signal peptides of the secreted protein were removed (Fig. I.2) 
(Hueck, 1998). The type IV secretion system was firstly described in the plant pathogen 
Agrobacterium tumefaciens wherein it mediates transfer of DNA into plant cells (Kaper 
and Hacker, 1999). The type IV secretion system of A. tumefaciens is located on a 200-kb 
Ti plasmid (Kaper and Hacker, 1999). T-DNA, part of the Ti plasmid is transferred into 
plant cells via this type IV secretion system and integrated into the host genome. Type IV 
secretion system could also mediate protein from a wide range of bacteria into host cells.  
Besides in A. tumefaciens,  the type IV secretion system has also been described in many 
other pathogenic bacteria, such as the Bordetella pertussis Ptl (pertussis toxin) system 
(Farizo et al., 2000), the cytotoxin-associated genes Cag Pathogenecity island (PAI) of 
Helicobacter pylori (Backert et al., 2002), and the Dot/Icm system of Legionella 
pneumophila (Vogel and Isberg, 1999). All these type IV secretion systems are required 
for DNA transfer and contribute to the virulence of pathogens. 
I.3.4 Type V secretion system 
The type V secretion system is possibly the simplest protein secretion system. This 
secretion pathway encompasses the autotransporter proteins, the two-partner secretion 
system, and the recently described type Vc or AT-2 family of proteins (Henderson et al., 
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2004). The secreted protein and the secretion apparatus of type V secretion system are 
encoded in a single open reading frame rather than a cluster of genes encoding a 
multicomponent secretion apparatus in other secretion systems. The protein exported via 
this secretion system from the cytoplasm is sec-dependent, and an amino-terminal signal 
peptides will be cleaved off (Fig. I.2) (Henderson et al., 1998; Henderson et al., 2004). 
I.3.5 Type III secretion system 
The TTSS is a sec-independent secretion system (Fig. I.2) (Hueck, 1998). This secretion 
system has a number of features in common with the flagellum-specific secretion pathway 
(Mecsas and Strauss, 1996). TTSS is generally composed of about 20 proteins, including 
apparatus, effectors, regulators, and chaperones (Hueck, 1998). The tranlocator proteins of 
the apparatus form a needle structure that is 28Å in diameter and deliver effector proteins 
to host cell membranes and cytosols (Marlovits et al., 2004). This needle structure of 
TTSS spans the inner and outer membranes of the bacterial envelope, and translocator 
proteins allow the translocation of effector proteins to the eukarytic cell, probably by 
forming pores in the host cell membrane and/or a connecting channel between the 
bacterium and the eukaryotic membrane (Frankel et al. 1998). Effector molecules of this 
secretion system are secreted without amino-terminus processing (Hueck, 1998; Kubori et 
al.,1998).The recognition and secretion of effector molecules via the TTSS probably have 
different mechanisms. Anderson and Schneewind (1997) found that a 5’ mRNA signal 
was required for the type III secretion of Yop proteins by Yersinia enterocolitica. This 
notion was supported with other investigations from different organisms (Yersinia spp., P. 
syringae, Xanthomonas campestris) showing that their mRNA signal coupled the 
secretion or translocation (Anderson et al., 1999; Anderson and Schneewind, 1999; 
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Fig. I.2. Schematic diagram of bacterial type I to V secretion systems. Recognition 
sequences that target the proteins to the respective secretion complexes are indicated 
either in red (for N-terminal signal sequences) or grey (for C-terminal signal sequences). 
Proteins secreted by the type I and type III pathways traverse the inner membrane (IM) 
and outer membrane (OM) in one step, whereas proteins secreted by the type II and V 
pathways cross the inner membrane and outer membrane in separate steps. The N-
terminal signal sequences of proteins secreted by the type II and V systems are 
enzymatically removed upon crossing the inner membrane, in contrast to proteins secreted 
by the type I and type III systems, which are exported intact. Proteins secreted by the type 
II system are transported across the outer membrane by a multiprotein complex, whereas 
those secreted by the type V system autotransport across the outer membrane by a virtue 
of a C-terminal sequence which is enzymatically removed upon release of the protein 
from the outer membrane. Type IV pathways secrete either polypeptide toxins (directed 
against eukaryotic cells) or protein-DNA complexes between either two bacterial cells or 
between a bacterial and eukaryotic cell. (Adopted from Type III secretion systems in 
animal- and plant-interacting bacteria. Schesser, et al., 2000, with permission). 
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Mudgett et al., 2000; Ramamurthi and Schneewind, 2003). However, the 5’ mRNA 
signal was not found in some other effector proteins (Lloyd et al., 2001; Karavolos et al., 
2005).  Most effector proteins are believed to have no conserved amino acid sequence as 
signals. However, Miao and Miller (2000) found that a conserved amino acid sequence in 
several effectors directed the translocation by type III secretion in S. enterica serovar 
Typhimurium.  Taken together, these investigations indicate that the effector traslocation 
may have different mechanisms. 
I.3.5.1 Regulation of type III secretion system 
TTSSs are complex protein secretion and delivery machines utilized by many animal- and 
plant-interacting bacteria that occupys diverse niches. Although the structural components 
of the type III secretion and translocation apparatus are well conserved across species, the 
regulatory mechanisms are diverse, and multifaceted regulatory systems are required to 
impart spatial and temporal controls of type III gene expression (Hueck, 1998; Francis et 
al., 2002). 
Most bacterial pathogens normally reside in the environments surrounding their hosts. 
Upon contact with the hosts, these bacteria sense the changes via a sensor-response 
regulatory system (a two-component system) to induce the expression of TTSS proteins. 
The sensor kinase is usually phosphorylated upon the signal stimulation, transfers the 
phosphoryl group to the response regulator, and thus increases the regulator’s affinity for 
targeted DNA binding (Stock et al., 2000). 
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I.3.5.1.1 Regulation of Salmonella pathogenecity island 1 (SPI-1) 
S. enterica serovar Typhimurium causes a variety of diseases ranging from mild 
gasteroenteritis to life threatening systemic infections. To ensure successful colonization 
and dissemination, this bacterium possesses a number of virulence genes, of which the 
TTSS is of particular importance.  Two independent TTSSs are encoded by Salmonella 
SPI-1 and SPI-2, respectively (Hueck, 1998). 
Expression of the SPI-1 TTSS is controlled in response to a specific combination of 
environmental signals that presumably act as cues that the bacteria are in the appropriate 
anatomic location. SPI-1 TTSS encodes many transcriptional regulators, including HilA, 
HilD, HilC (also called SprA/SirC), InvF and SprB (Kaniga et al., 1994; Bajaj et al., 1995; 
Eichelberg et al., 1999; Rakeman et al., 1999; Schechter et al., 1999; Lostroh et al., 2000), 
among which HilA belongs to the OmpR/ToxR family, whereas HilD, HilC and InvF 
belong to the AraC/XylS family of transcriptional regulators (Kaniga et al., 1994; Bajaj et 
al., 1995; Schechter et al., 1999; Lostroh et al., 2000). In SPI-1, HilA plays a key role in 
coordinating expression of the SPI-1 TTSS. By binding upstream of the -35 sequences of 
PinvF and Pprg, HilA directly activates the expression of the inv/spa and prg/org operons 
that encode the components of the TTSS apparatus (Lostroh et al., 2000; Lostroh and Lee, 
2001). Activation of PinvF leads to the production of InvF. In an apparent complex with the 
chaperone protein SicA, InvF then induces the expression of several effector genes 
encoded on SPI-1 and elsewhere in the S. enterica serovar Typhimurium genome (Darwin 
and Miller, 1999; Eichelberg et al., 1999; Darwin and Miller, 2001).  
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The expression of HilA is subject to complicated regulation and the regulators of RtsA, 
HilC and HilD have been implicated in this regulation. A mutation in HilD results in an 
approximately 10-fold decrease in hilA expression and 53-fold decrease in invasion of 
cultured epithelial cells (Schechter et al., 1999). However, a mutation in hilC or rtsA 
results in a modest 50% decrease in hilA expression, and only a slight (20% to ~3-fold) 
decrease in invasion (Eichelberg et al., 1999; Rakeman et al., 1999; Schechter et al., 1999; 
Lucas and Lee, 2001, Ellermeier and Slauch, 2003). Besides activating the expression of 
hilA, RtsA, HilC and HilD could also act independently of HilA to activate transcription 
of invF (Akbar et al., 2003; Ellermeier and Slauch, 2003).  These three regulators, RtsA in 
particular, also induce the effector gene slrP independent of HilA and InvF (Ellermeier 
and Slauch, 2003). 
Some other proteins which encoded outside the SPI-1 are also involved in the modulation 
of SPI-1 TTSS. These include several two-component regulatory systems. Two-
component regulatory system SirA-BarA is required for the maximal expression of hilA 
(Lucas and Lee, 2001), and this regulation appears through the CsrA-CsrB system (Altier 
et al., 2000a). The CsrA and CsrB have been implicated in controlling levels of hilA 
expression through modulation of hilD and hilC transcriptional levels. Deletion of csrA 
resulted in a ~10-fold defect in hilA expression and ~100-fold defect in invasion of 
epithelial cells (Altier et al., 2000a and 2000b). Subsequent experiments demonstrated 
that hilC and hilD transcriptions were undetectable in strains that had a deletion in csrA or 
overexpressed csrA from an arabinose-inducible promoter. Thus, the CsrA-CsrB 
regulatory system appears to play a role in maintaining appropriate levels of hilD and hilC 
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transcripts for subsequent activation of hilA expression (Altier et al., 2000a; Altier et al., 
2000b).  
PhoP-PhoQ, which regulates virulent and physiological genes in a variety of gram-
negative bacteria, represses expression of the SPI-1 TTSS in response to low magnesium 
concentrations and low pH (Behlau and Miller, 1993; Pegues et al., 1995; Chamnongpol 
et al., 2003). While the PhoB-PhoR two-component regulatory system represses the 
expression of hilA in response to low extracellular Pi (Lucas et al., 2000; Lucas and Lee, 
2001). 
I.3.5.1.2 Regulation of Salmonella SPI-2 
Genes encoded in Salmonella SPI-2 TTSS are specifically induced inside both phagocytes 
and epithelial cells. Low concentration of Mg2+ or Ca2+, as well as starvation of phosphate 
induce the expression of SPI-2 genes. These signals are probably perceived through two 
two-component systems, namely, EnvZ-OmpR, and SsrA-SsrB. The two-component 
regulatory system SsrA-SsrB, encoded within SPI-2, controls the expression of 
components of the SPI-2 TTSS apparatus as well as its translocated effectors. The 
expression of SsrA-SsrB is in turn regulated by the OmpR-EnvZ two-component system, 
in which OmpR binds directly to the ssrA promoter region and activates the transcription 
of ssrA (Lee et al., 2000, Feng et al., 2003).  SsrA-SsrB was found to be essential for the 
induction of SPI-2 gene expression in response to low osmolarity, acidic pH or the 
absence of Ca2+, while OmpR-EnvZ seems to play a minor role in sensing these signals 
(Garmendia et al., 2003). The global regulator PhoP-PhoQ has also been shown to 
modulate SPI-2 gene expression (Miller 1991; Deiwick et al., 1999; Hensel, 2000). The 
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regulation of PhoP-PhoQ on SPI-2 may be through modulation events upstream of OmpR 
as the PhoP-PhoQ regulatory system is not required for SPI-2 expression in the presence 
of OmpR~P (Kim and Falkow, 2004).   
The SPI-2 TTSS was negatively regulated. The negative modulator YdgT was shown to 
repress the transcription of SPI-2 genes. However, a mutation of ydgT also led to the 
attenuation of virulence (Coombes et al., 2005). 
I.3.5.1.3. Regulation of EPEC LEE TTSS 
EPEC causes severe diarrhea in young children. It causes a lesion on the intestinal 
epithelial cells and was named as the attaching and effacing (AE) lesion. The genes 
involved in the formation of the AE lesions are encoded within a 35.6 kb chromosomal 
pathogenicity island named the locus of enterocyte effacement (LEE) (McDaniel et al., 
1995). LEE encodes a TTSS and some of its effectors. It consists of 41 genes, organized 
in five major operons (LEE1 to LEE5) and several additional transcriptional units (Elliott 
et al., 1998; Mellies et al., 1999). The key regulator of LEE is Ler, an H-NS paralog, 
encoded by the first gene of the LEE1 operon, and it positively regulates expression of 
LEE2, LEE3, LEE4, LEE5, espG, and map (Friedberg et al., 1999, Mellies et al.,1999; 
Sperandio et al., 2000; Sanchez-SanMartin et al., 2001) by competing for binding with H-
NS, which represses their expression in the absence of Ler (Sanchez-SanMartin  et al., 
2001; Haack et al., 2003). 
The expression of ler is regulated by per loci, which comprises the products of the three 
orfs of perA, perB, and perC (Mellies et alu., 1999). Per acts directly only on LEE1, 
activating the LEE-encoded regulator of Ler, which in turn activates the expression of 
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other LEE operons (Mellies et al., 1999). It was also reported that another level of control 
of the TTSS genes via quorum sensing existed in EPEC (Sperandio et al., 1999). Quorum 
sensing activated the transcription of a LysR-like regulator QseA, which in turn activated 
the transcription of Ler (Sperandio et al., 2002). 
I.3.5.1.4. Regulation of P. aeruginosa TTSS 
P. aeruginosa is an opportunistic pathogen of humans responsible for several infections of 
clinical importance. It also utilizes a chromosomally encoded TTSS to deliver effector 
molecules into the host cytosol to interfere with the physiological signaling pathways 
(Yahr et al., 1996). The expression of P. aeruginosa TTSS can be triggered by contacting 
with eukaryotic host cells, calcium chelation or the presence of serum (Frank, 1997; Vallis 
et al., 1999). At least four regulators, namely ExsA, ExsC, ExsD, and ExsE, are involved 
in the expression of the P. aeruginosa TTSS (McCaw et al., 2002; Dasgupta et al., 2004; 
Rietsch et al., 2005; Urbanowski et al., 2005). ExsA is an AraC family positive 
transcriptional activator and is required for the expression of all the TTSS genes (Yahr 
and Frank, 1994; Frank, 1997). ExsD is an anti-activator (negative regulator) of ExsA and 
inhibits the transcription of the TTSS by binding to ExsA (McCaw et al., 2002). Under 
low-Ca2+ conditions, the negative regulatory activity of ExsD is suppressed through an 
unknown mechanism (McCaw et al., 2002).  The activity of ExsD can be repressed by 
ExsC, which functions as an anti-anti-activator by binding to ExsD (Dasgupta et al., 
2004). Recently, a new regulator of ExsE, an inhibitor of ExsC, was found to be a 
secreted regulator of the P. aeruginosa TTSS (Rietsch et al., 2005; Urbanowski et al., 
2005). The reduced intracellular pool of ExsE increases the levels of ExsC available to 
bind ExsD and frees ExsA to activate the transcription of the TTSS (Urbanowski et al., 
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2005). ExsC is also positively regulated by another regulator, PsrA, which could bind to 
the exsCEBA promoter region and enhance the expression of ExsC (Shen et al.,  2006). 
I.3.5.2 Chaperones of TTSS 
The major function of TTSSs used by many gram-negative bacteria is to secrete proteins 
into the bacteria milieu or inject virulence factors into host cells. Under most conditions, 
the production and secretion of secreted proteins or effectors are not coupled and their 
storage inside the bacteria cytosol involves their association with specific chaperones. 
TTSS chaperones rarely share sequence similarities, but they have common physical 
characteristics, including a low molecular weight, acidic pI, and a predicted amphipathic 
helix near their C-terminal ends (Parsot et al., 2003). TTSS chaperones have been divided 
into three classes: Class I, chaperones (~130 residues) which associate with one (Class IA) 
or several (Class IB) effectors, typified by the Yersinia SycE chaperone that served a 
single substrate of YopE, and Shigella flexneri Spa15 protein, which interacted with four 
secreted proteins, IpaA, IpgB1, OspC3 and OspB; Class II, chaperones (~160 residues) 
which are associated with translocators, typified by the Yersinia SycD protein, which was 
required for the proper secretion of two proteins of YopB and YopD; and Class III, 
chaperones of the flagellar export system, which was speculated to be the ancestor of the 
TTSS secretion system (Page and Parsot, 2002; Parsot et al., 2003).  All these chaperones 
are involved in the stabilization of their substrate(s), the prevention of their premature 
interactions with other partners during storage and the secretion of their substrate(s). In 
addition, some of the chaperones are also required for the regulation of particular genes in 
TTSS. 
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I.3.5.2.1 Chaperones of effectors 
Most chaperones identified so far associate with only one effector protein, such as  SycE 
(Wattiau  and  Cornelis, 1993) and SycT (Iriarte and Cornelis, 1998) of Yersinia subsp, 
and CesF of EPEC (Elliott et al., 2002).  Chaperones in this class have multi-functions for 
their effectors. They can either prevent complete folding of the effector proteins or 
promote secondary structure formation of an otherwise unstructured domain.  In Yersinia, 
the SptP35-139 and YopE17-85 polypeptides associating with their respective chaperones 
adopted secondary but not tertiary structures (Stebbins and Galan, 2001; Birtalan et al., 
2002). In most cases, the absence of Class I chaperone reduced the amount of its substrate, 
as exemplified by YopE, SptP, and IpgD (Frithz-Lindsten et al., 1995; Fu and Galan, 
1998; Niebuhr et al., 2000). However, SycH, chaperone of YopH, is not required for the 
stability of its substrate, as YopH accumulates in the bacterial cytoplasm with its 
enzymatic properties in the absence of SycH (Wattia et al., 1994; Persson et al., 1995). 
The secretion of most effectors is reduced but not abolished in the absence of their 
chaperones (Parsot et al., 2003). However, YopH and YopN are produced but not secreted 
in the absence of their chaperones, which suggests that chaperones do play a role in 
secretion (Day and Plano, 1998; Cambronne et al., 2000). 
Besides the use of chaperone for a single effector, Spa15 in S. flexneri has been shown to 
associate with several effectors, including IpaA, IpgB1, IpgB, and OspC3 (Page et al., 
2002). Spa15 is necessary for the stability of IpgB1 and probably also for OspC3 and 
OspB, but not for IpaA (Page et al., 2002). 
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1.3.5.2.2 Chaperones of translocators 
Similar to chaperones for effectors, Class II chaperones are also essential for the stability 
of translocators. They may be independently associated with each of the two translocators 
and prevent their premature interaction inside cytoplasm. This notion was supported with 
the immunoprecipitation experiments showing that IpgC interacted with IpaB or IpaC 
independently in S. flexneri (Menard et al., 1994). In the absence of IpgC, IpaB associated 
with IpaC and led to its degradation (Menard et al., 1994).   
The role of Class II chaperone in the secretion of translocators has not yet been shown.  
Recombinant translocators without the chaperone binding sites were found to be secreted 
by a constitutively secreting strain (Page et al., 2001), suggesting that the secretion of 
translocator may not need its chaperone.  
Some of chaperones in this class play important roles in the regulation of TTSS genes. In 
Salmonella, SicA was shown to be required for activation of the sicAsipBCDsicPsptP, 
sigDE, and sopE operons (Darwin and Miller, 2000; Tucker and Galan, 2000). While in S. 
flexneri, IpgC, homolog of SicA, was also involved in activation of genes, such as ipaH 
(Mavris et al., 2002).  
1.3.5.2.3 Chaperones of the flagellar system 
Flagella are long surface appendages that are necessary for bacterial motility and have 
been considered as the ancestor of TTSSs. Components of the hook and the filament of 
flagella secreted via flagella required some proteins which share physical characteristics 
with TTSS chaperones, and thus these proteins were classified as the chaperones of the 
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flagellar system (Page and Parsot, 2002). Chaperones of this class bind to the C-terminal 
of their substrates which are supposed to form amphipathic helices that mediate 
interactions between the subunits in the flagellum (Fraser et al. 1999; Auvray et al., 2001). 
Similar to class II chaperones, the binding of flagellar chaperones with their substrates 
could prevent premature interactions between the subunits in the bacterial cytoplasm 
(Auvray et al., 2001). 
1.3.6 A putative novel secretion system 
Beside these five well characterized secretion systems (type I to type V), a highly 
conserved gene cluster has been found in several gram-negative bacteria, such as 
Salmonella, Vibrio, Yersinia, Escherichia, Pseudomonas, Rhizobium, and Agrobacterium 
species (Folkesson et al., 2002; Moore et al., 2002; Bladergroen et al., 2003;  Das and 
Chaudhuri, 2003; Pukatzki et al., 2006; Mougous et al., 2006).  Bioinformatics analysis 
showed that one protein encoded in each of these clusters had homology to the Legionella 
pneumophila IcmF (Vogel and Isberg, 1999), and thus these clusters were designated as 
IcmF-associated homologous protein (IAHP) clusters (Das and Chaudhuri 2003).  
Proteins encoded in the IAHP cluster of R. leguminosarum was reported to share limited 
homology with proteins encoded in the type III and type IV secretion systems, and the 
impairment of this cluster affected the secretion of at least one protein (Bladergroen et al., 
2003).  Folkesson and co-workers (2002) analyzed this cluster in S. enterica serovar 
Typhimurium and found that this gene cluster encoded putative cytoplasmic, periplasmic 
and outer membrane proteins. In E. tarda, an EVP gene cluster (evpA-H) homologous to 
IHAP gene clusters was found to contribute to the pathogenesis, and at least one secreted 
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protein (EvpC) was encoded in this cluster. Deletion of evpB abolished the secretion of 
EvpC and led to lower intracellular replication rate of the mutant inside fish macrophage 
(Srinivasa Rao et al., 2004). Recently, Pukatzki et al. (2006) found that the vas gene 
cluster, IAHP cluster homolog in V. cholerae, contributed to the pathogenesis in 
Dictyostelium as a model host.  Their characterization studies showed that this cluster was 
involved in extracellular secretion of proteins lacking N-terminal hydrophobic leader 
sequences. Four proteins were found to be secretion dependent on the full functional vas 
cluster. They proposed that this cluster was encoding a novel secretion system-type VI 
secretion system (Pukatzki et al., 2006). The role of HSI-I, one of three IHAP clusters in 
P. aeruginosa, was also investigated and was found to be essential for the secretion of 
Hcp1 (Mougous et al., 2006).  ClpV, the ClpB homolog in this cluster, was found to form 
discrete foci in the bacterial cell. The mutation of icmF homolog and hcp1 reduced the 
number of cells with these foci (Mougous et al., 2006). In addition, the ClpV proteins in 
EPEC and S. enterica servor Typhimurium IAHP clusters formed hexameric structures 
that had ATPase activity, but lacked protein disaggregase activity (Schlieker et al., 2005). 
Thus, a role of ChpV as a core component of protein secretion apparatus to provide the 
energy for protein translocation was speculated (Mougous JD et al., 2006).  They further 
characterized the structure of hexameric protein Hcp1 and found that they formed rings 
with a 40 Å internal diameter (Mougous et al., 2006). Thus, they reported that the IAHP 
cluster of P. aeruginosa encoded the apparatus of the new secretion system.  
Interestingly, this secretion system was shown to cross-talk with type III secretion system 
in some bacteria. In S. enterica serovar Typhimurium and P. aeruginosa, the positive 
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regultors of their TTSS repressed the gene expression in the EVP-like clusters (Parsons 
and Heffron, 2005; Mougous et al., 2006).  
I.4 Objectives 
The purpose of this PhD thesis, firstly, was to study the regulation of esrC on the TTSS 
and EVP gene clusters, and the relationship between the two-component system EsrA-
EsrB and EsrC. The TTSS and EVP gene clusters were regulated by EsrA-EsrB two-
component system. However, the relationship of TTSS and EVP is not clear, and how the 
two-component system regulates TTSS and EVP gene clusters is needed to be defined.  
Thus, deletion mutagenesis and reporter gene analysis were used to study these genetic 
relationship. The information from this study should supplement the understanding of 
TTSS regulation and is important to understand the regulation of the EVP secretion 
system. 
To further characterize the regulation of E. tarda TTSS, we mutated orf2 and found that it 
was not required for the expression of the TTSS genes but was required for the secretion 
of EseB and EseD. Thus the second objective was to characterize the function of Orf2.  
The information from this study should be important for the understanding of the 
secretion mechanism of the TTSS in E. tarda.   
The third objective was to complete the EVP gene cluster via DNA sequencing, leading to 
the characterization of its structure organization, and to define genes essential for the 
novel secretion system in E. tarda. The EVP gene cluster has been proposed to encode a 
novel secretion system. However, the sequence of this EVP gene cluster in E. tarda was 
not complete. To this end, a phage library was constructed, and clones containing the 
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complete EVP gene cluster were screened and the EVP gene cluster was sequenced. Then 
the combination of gene knockout and 1D-PAGE were used to identify proteins that were 
essential for the secretion of EvpC. Such investigation will facilitate the understanding of 
the relationship of EVP with its homologs in other pathogens 
The fourth objective was to identify the proteins secreted by EVP and define the secretion 
signal of these secreted proteins. Secretion systems are used by bacteria to secrete proteins 
into the culture milieu or translocate proteins into host cells.  In this study, mass 
spectrometry was used to identify proteins secreted by the TTSS and EVP. Deletion 
method was used to truncate the secreted proteins and the secretions of these truncated 
proteins were investigated. The investigation of effector proteins would eventually 
contribute to the understanding of the infection mechanism of E. tarda. Information from 
this investigation could benefit the understanding of the mechanism of how this novel 
secretion system secretes its substrates. 
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Chapter II. Common materials and methods 
II.1 Bacterial strains, plasmids and buffers 
The bacterial strains used and their sources are as given in Table II.1. Routine E. tarda 
cultures were grown in tryptic soy broth (TSB) (BD Biosciences, Sparks, Md.) or on 
tryptic soy agar (TSA) (BD Biosciences, Sparks, Md.). E. coli were grown in Luria 
Bertani broth (LB) (BD Biosciences, Sparks, Md.) or on LB agar (LBA) (BD Biosciences, 
Sparks, Md.). Cultures of E. tarda and E. coli were incubated at 25°C and 37°C, 
respectively. Stock cultures of E. tarda and E. coli strains were maintained in a 
suspension of TSB and LB respectively with 25% (v/v) glycerol at -86°C. When required, 
the culture media were supplemented with antibiotics (St Louis, MO, USA) at the 
following final concentrations unless otherwise stated: ampicillin (Amp, 100 μg/ml), 
chloramphenicol (Cm, 30 μg/ml), colistin (Col, 12.5 μg/ml), kanamycin (Km, 100 μg/ml), 
and tetracycline (Tc, 12.5 μg/ml).  
Phosphate buffered saline (PBS, pH 7.2), which consists of 123.2 mM NaCl, 10.4 mM 
Na2HPO4 and 3.2 mM KH2PO4, was used for all bacterial washings and re-suspensions. 
II.2 Preparation of E. tarda cultures 
A single colony of each E. tarda strain used was first inoculated into 5 ml of TSB and 
incubated statically overnight at 30°C. A fresh culture was prepared the next day by 
transferring 0.5 ml of the overnight culture into a fresh tube of 5 ml TSB. The sub-
cultured bacteria were then incubated for 2-3 h at 25°C until an optical density (OD) at 
540 nm approximately reached 0.5 (OD540 0.5 is predetermined as approximately 1 ×108  
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Table II.1. Bacterial strains and plasmids used for this study 
 
Strain or plasmid Origin/Genotype and/or relevant propertiy Source/Reference 
E. tarda   
AL 93/79 Channel catfish Department of Fishery, Auburn University 
ATCC15947T Human serotype O1483:H1 American Type Culture Collection, Rockville, MD, USA 
E381 Tilapia Niigata, Japan 
NE8003 Japanese flounder Nagasaki, Japan 
NUF251 Japanese flounder Nagasaki, Japan 
PPD125/87 Guppy AVA*, Singapore 
PPD129/91 Tilapia AVA, Singapore 
PPD130/91 Serpae tetra AVA, Singapore 
PPD453/86 Arowana AVA, Singapore 
PPD499/84 Diseased fish AVA, Singapore 
PPD76/87 Sword tail AVA, Singapore 
SU226 Eel culture pond water Shizuoka, Japan 
   
E. coli   
DH5α SupE44 Δlac U169 (ø80lacZΔM15)hsdR17 recA1 endA1 gyrA96 thi-1relA1; Amps Hanahan, 1983 
JM109 Kms, Cols, Cms Promega 
MC1061 (λpir) (λpir), thi thr-1 leu6 proA2 his-4 argE2lacY1 galK2 ara14 xyl5 supE44, λpir Rubires et al., 1997 
SM10 (λpir) thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu Kmr pir Rubires et al., 1997 
S17-1 (λpir) thi pro hsdR hsdM
+ recA[RP42-Tc::Mu-Km::Tn7 
(Tpr Smr)Tra+] Simon et al., 1983 
XL1-blue MRA (P2) Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 gyrA96 relA1 lac (P2 lysogen) Stragene 
   
Plasmid   
pGEM-T Easy  Cloning vector; Ampr Promega 
pRE112 Suicide vector; R6K ori sacB Chlr Edwards et al., 1989 
*AVA, Agri-Veterinary Authority of Singapore 
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CFU/ml). The cells were harvested by centrifuging at 4, 000 × g for 5 min at 4°C. The 
supernatant was discarded and the cells were washed twice with PBS. The bacterial cells 
were re-suspended in PBS and adjusted to OD540=0.5 using a spectrophotometer 
(Shimadzu, UV1601, Japan).  
II.3 Molecular biology techniques 
II.3.1 Genomic DNA isolation  
E. tarda strains were grown in 5 ml TSB at 25°C overnight. Bacterial genomic DNA was 
extracted as described in the manuals of the Genomic DNA isolation/purification kits 
(Promega, USA). The purified genomic DNA obtained was dissolved in 50 μl of TE 
buffer (10 mM Tris-HCl and 1 mM EDTA, pH 7.5) and stored at -30°C. 
II.3.2 Genome walking and cloning 
Genome-walking libraries (EcoRV, PvuII, SmaI and StuI) were constructed according to 
the Universal Genome WalkerTM kit (BD Biosciences Clontech, Palo Alto, CA, USA) 
user manual. Briefly, 2.5 μg of genomic DNA was digested with different restriction 
enzymes, and the digested DNA was purified and ligated to Genome Walker adaptors by 
mixing the followings: 4.0 μl purified genomic DNA (approximately 0.5 μg), 1.9 μl 
Genome Walker adaptor (25 μM), 1.6 μl 5 × ligation buffer and 0.5 μl T4 DNA ligase (1 
U/μl). The ligations were incubated at 16ºC overnight and then seated at 70ºC for 5 min 
to stop the reaction.  Seventy-two μl of TE (pH 7.4) was added and the genome-walking 
library was stored at –20ºC in aliquots. 
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PCR amplification was performed in an Applied Biosystems (ABI) PCR system 2400 or 
2700 PCR machine with the Advantage 2 polymerase mix (BD Biosciences Clontech, 
Palo Alto, CA, USA). The PCR conditions were: 1 min at 94ºC, 7 cycles of 15 s at 94ºC, 
4 min at 72ºC, 32 cycles of 15 s at 94ºC, 3 min at 67 º C. The PCR products were subject 
to electrophoresis for analysis.  
 II.3.3 Cloning and transformation into E. coli cells 
PCR products were cloned into the pGEM-T Easy vector system (Promega, Madison, WI, 
USA) according to the manufacturer’s instructions and transformed into E.coli JM109. E. 
coli competent cells were prepared and transformed according to the procedure provided 
by Sambrook and co-workers (1989). Transformants were plated on LBA containing 
ampicillin, isopropylthiogalactoside (IPTG, Bio-Rad), and 5-bromo-4-chloro-3-indolyl-β-
D-galactopyranoside (X-gal, Bio-Rad), for blue-white colony selection.  
II.3.4 Analysis of plasmid DNA  
The boiling lysis procedure described by Holmes and Quigley (1981) was used for the 
mini-preparation of plasmid DNA. Briefly, 30 μl of overnight bacterial culture was 
obtained and spun at 13, 000 × g for 1 min. The bacterial pellet was resuspended in 11 μl 
of STET solution [0.1 M NaCl, 10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0), 5% 
Triton X-100, 0.8 μg/μl lysozyme and 10 μg/μl RNase A]. Subsequently, the tubes were 
placed on boiling water bath for 30 seconds and cooled down to room temperature. One 
μl of 10 × buffer of appropriate restriction enzyme and 0.1-0.2 units of restriction enzyme 
was added and the tubes were incubated at appropriate temperature for 30 min. The 
digested samples were analyzed by gel electrophoresis using 1% (w/v) agarose gel 
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(Seakem®, BioWhittaker Molecular Applications, USA), followed by staining in 
ethidium bromide. Clones containing the right insert in the plasmid were selected for the 
purification. 
II.3.5 Purification of plasmid DNA 
QIAGEN Plasmid Mini (for high copy plasmid) or Midi (for low copy plasmid) 
(QIAGEN GmbH, Germany) were used for the plasmid DNA isolation. Bacterial strains 
containing plasmids were cultured in LB broth (with appropriate antibiotics) and 
incubated in a shaker (Forma scientific, USA) with 225 rpm shaking at 37°C. After the 
bacteria were cultured for 16 to 18 h, the plasmid DNA was extracted according to 
manufacturer’s protocol. The quality and concentration of DNA was determined using 
spectrophotometer. 
II.3.6 Phage Library  
II.3.6.1 Phage Library construction 
Lambda FIX®II/XhoI partial fill-in vector kit and Gigapack® III Plus-11 packaging 
extract kit (Stratagene, La Jolla, CA, USA) were used for the library construction 
according to the manufacturer's instructions. Briefly, 50 μg genomic DNA was partial 
digested with BamHI to get 9 to 23 kb fragments. The DNA fragment was extracted with 
phenol-chloroform and resuspended in 25 μl Tris-EDTA. A ligation was set up as 
followings: 1.0 μg of the Lambda FIX II predigested with XhoI, 0.4 μg of BamHI 
digested insert, 0.5 μl of the 10 × ligase buffer, 0.5 μl of 10 mM rATP, 2U of T4 DNA 
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ligase, and milli-Q water up to a final volume of 5 μl. The ligation was incubated at 4°C 
overnight and packaged with Gigapack III packaging extract. 
The packaged phage was diluted appropriately and mixed with E. coli XL1-blue MRA 
(P2). The mixture was incubated at 37°C for 15 min, followed by adding 3 ml of LB top 
agar (LB with 0.7% agarose) (48°C) and plated immediately on pre-warmed LB agar 
plates. 
II.3.6.2 Plaque screening  
The plate was put at 4°C for 2 h after the plaque grown into 1 mm in diameter, and a 
nitrocellulose membrane (GeneScreenTM) was placed on the plaque surface for 2 min to 
let the plaques transfer to the membrane. A needle was used to pick though the agar for 
orientation. The membrane was then denatured by 1.5 M NaCl and 0.5 M NaOH (pH 8.0) 
for 2 min, followed by neutralization with 1.5 M NaCl and 0.5 M Tris-HCl (pH 8.0) for 5 
min. The membrane was blotted briefly on Whatman paper and the DNA was crosslinked 
to the membrane by a UV-transilluminator (SPS-TF, Vilber Lourmat, France) for 5 min. 
The probe preparation and the hybridizing were performed as described in Southern 
hybridization section. 
II.3.6.3 Purification of phage DNA 
QIAGEN Lambda Midi (QIAGEN GmbH, Germany) was used for the plasmid DNA 
isolation. Lambda phage containing the right insert was propagated on agarose plates and 
5 ml SM buffer was overlaid on each plate at 4°C overnight. The liquid was transferred to 
a clean tube and chloroform (2% v/v) was added. The mixture was vortexed vigorously, 
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followed by centrifuging at 10, 000 × g for 10 min. The lambda DNA from the 
supernatant was extracted according to manufacturer’s protocol.  
II.3.7 DNA sequencing 
 DNA sequencing was carried out on an ABI PRISM® 3100 genetic analyzer with 
BigDye Terminator version 3.1 Cycle Sequencing Kit. Sequencing PCR reaction was set 
up as following: 1 μl of autoclaved water, 100 to 200 ng of the plasmid DNA  or lambda 
phage DNA or 40 to 50 ng of PCR product, 0.2 μl of  5 μM primer and 1 μl of BigDye. 
PCR was carried out in an ABI PCR system 2400 or 2700 using the conditions: 1 min at 
96°C, followed by 25 cycles of denaturation 96°C, 10 s, annealing 50°C, 5 s, extension 
60°C, 1 min 30 s. The final holding temperature was 16°C. The PCR product was 
purified by ethanol and sodium acetate precipitation prior to automated sequencing. In 
brief, the PCR product was transferred to a 1.5 ml microcentrifuge tube, and 20 μl of 95% 
ethanol and 0.5 μl of 3 M sodium acetate (pH 4.6) were added. The mixture was vortexed 
for about 10 s and centrifuged for 15 min at 13, 000 × g in a conventional benchtop 
centrifuge (Eppendorf, Germany). The supernatant was carefully removed and the pellet 
was washed with 500 μl 70% ethanol followed by centrifugation for 5 min at 13, 000 × g. 
The wash step was repeated once and the supernatant was carefully decanted. Residual 
ethanol was removed after pulse-spinning of the tube. The pellet was air-dried at room 
temperature and stored at -20°C until automated sequencing. 
Eleven μl of Hi-DiTM formamide (ABI) was added to dissolve the pellet prior to loading 
to the 96-well plate (ABI) for sequencing. 
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II.3.8 Sequence analysis  
Vector NTI DNA analysis software (InforMax, Bethesda, MD, USA) was used for the 
sequence assembly and further editing. DNA and protein sequences obtained were 
submitted to the National Center for Biological Information (NCBI) 
(http://www.ncbi.nlm.nih.gov/BLAST) for analysis using the Basic Local Alignment 
Search Tool (BLAST) network service (Altschul et al., 1990). DNA and protein 
homology were compared against a nucleotide and protein sequence database, 
respectively, using the corresponding BLASTN and BLASTP or PSI-BLAST program.  
II.3.9 Southern hybridization  
II.3.9.1 DNA preparation 
Genomic DNA of E. tarda strains was digested with proper restriction enzymes prior to 
the Southern hybridization analysis. Approximately, 1.5 μg digested DNA was analyzed 
with 1% (w/v) Seakem® LE agarose gel (BMW, USA). Electrophoresis was carried out 
in 1 x Tris-acetate-EDTA (TAE) buffer at 100 V for 1 h. Gel was stained with ethidium 
bromide to ensure that digestion of genomic DNA was proper. Subsequently, the gel was 
washed with solution I (0.25 M HCl) for 15 min, solution II (0.4 M NaOH, 0.6 M NaCl) 
for 45 min, and solution III (0.6 M NaCl and 0.5 M Tris-HCl, pH 7.5) for 45 min. The 
washing was carried out in a plastic container with gentle shaking on a BioDancer (New 
Brunswick Scientific, USA). The gel was then transferred to a glass plate, and a piece of 
nylon-based membrane (GeneScreenTM, PerkinElmer, USA) presoaked in solution III 
was placed on its top. Air bubbles between the gel and membrane was removed 
thoroughly. Three to four pieces of Whatman paper presoaked in 10 x SSC buffer were 
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placed on the membrane. Paper towels and a heavy object were placed on top of the 
Whatman paper and the blotting process was performed overnight at room temperature. 
Finally, the membrane was air-dried and the transferred DNA was cross-linked to the 
membrane by a UV-transilluminator (SPS-TF, Vilber Lourmat, France) for 5 min. 
II.3.9.2 Probe preparation 
The probes for Southern analysis used in this study were labeled with the DIG 
(Digoxigenin) DNA labeling and detection kit (Roche Molecular Biochemicals, 
Germany). To label the DNA probe, 15 μl purified DNA (1-3 μg PCR product) was 
denatured by boiling for 10 min and immediately kept on ice. The following reagents: 2 
μl 10 × hexanucleotide mix, 2 μl dNTP labeling mix, and 1 μl Klenow enzyme labeling 
grade were added to the freshly denatured probe. The labeling reaction was incubated 
overnight at 37°C.  
 II.3.9.3 Hybridization analysis  
The nylon membrane cross-linked with DNA was incubated in an appropriate volume (20 
ml/100 cm2 membrane) of pre-warmed (37°C) DIG Easy Hyb solution in a hybridization 
bag (Kirkegaard & Perry Laboratories, USA) with gentle shaking for 30 min to 2 h. The 
DIG-labeled DNA probe was denatured by boiling for 10 min and rapidly cooled on ice. 
After brief spin, the probe DNA was then added to the hybridization bag and mix well 
with the DIG Easy Hyb solution. The membrane was incubated with the hybridization 
solution containing the probe overnight at 42°C with gentle shaking. 
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II.3.9.4 Washing and visualization  
After hybridization, the membrane was washed twice with 2 × SSC, 0.1% (w/v) sodium-
dodecyl-sulfate (SDS) for 5 min each at room temperature with constant shaking. The 
membrane was then washed twice more with 0.5 × SSC, 0.1% (w/v) SDS (pre-warmed to 
65°C) at 65°C with constant shaking (15 min each). The subsequent steps were carried 
out at room temperature. The membrane was rinsed briefly in washing buffer [0.1 M 
Maleic acid, 0.15 M NaCl; pH 7.5; 0.3% (v/v) Tween 20] and incubated with freshly 
prepared 1 × blocking solution (in Maleic acid buffer) for 30 min. The appropriate 
volume of anti-DIG-AP was carefully diluted 1:5, 000 in blocking solution. The 
membrane was then incubated with the antibody solution for 30 min and followed by two 
washes (15 min each) in washing buffer. The membrane was equilibrated for 2-5 min in 
detection buffer (0.1 M Tris-HCl, 0.1 M NaCl, pH 9.5). For detection, the membrane was 
incubated in freshly prepared substrate solution (40 μl of NBT/BCIP to every 2 ml of 
detection buffer) in the dark. The reaction was stopped by washing the membrane for 5 
min with TE-buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) when the desired band 
intensities were observed. 
II.4 Protein techniques 
II.4.1 Preparation of extracellular proteins from E. tarda 
E. tarda strains were grown in DMEM at 25°C without shaking for 24 h [supplied with 
5% (v/v) CO2 atmosphere]. The bacteria were adjusted to an OD value of 0.8 at 550 nm 
and inoculated into fresh DMEM at a 1:200 dilution. The ECPs fraction was isolated after 
24 h by TCA–acetone precipitation (Shimizu et al., 2002). Briefly, the bacterial cultures 
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were centrifuged at 4, 000 × g for 20 min at 4°C. The culture supernatant was then passed 
through a 0.22 μm, low-protein-binding Millex filter (Millipore Corp., Bedford, MA, 
USA). The flow-through was precipitated with 10% (w/v) TCA for at least 1 h at 4°C. 
The protein pellet was washed with -20°C acetone thrice and then air dried. The protein 
pellet was dissolved in an appropriated volume of ReadyPrep reagent 3 [5 M urea, 2 M 
thiourea, 2% (w/v) CHAPS, 2% (w/v) SB 3-10, 40 mM Tris, and 0.2% (w/v) Bio-Lyte 
3/10 ampholyte (Bio-Rad, Richmond, CA, USA)]. Insoluble materials were removed by 
centrifugation at 14, 000 × g for 20 min at room temperature. Protein sample were stored 
at -86°C until analysis. 
 The concentration of protein in the ECP samples was determined with the Bio-Rad 
Protein Assay. Briefly, 200 μl of dye reagent concentrate (Bio-Rad) were added to each 
tube (799 μl H2O + 1 μl protein) and the tubes were vortexed thoroughly and incubated at 
room temperature for 10 min. The mixtures were then subject to the reading at OD595. 
The protein concentration of each ECP sample was obtained based on the standard curve 
plotted for the BSA protein of known concentrations. 
II.4.2 One-dimensional polyacrlamide gel electophoresis (1D-PAGE) 
1D-PAGE was performed according to a standard protocol (Sambrook et al., 1989) and 
12% polyacrylamide gels were used for protein separation. Briefly, the resolving gel 
solution was poured into the gap between two glass plates and isopropanol was layered 
on top. The isopropanol overlay was poured off and the gel was washed several times 
with milli-Q water after the resolving gel was polymerized completely. The 5% stacking 
gel was poured on top of the resolving gel and a clean Teflon comb was immediately 
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inserted. The Teflon comb was carefully removed after the stacking gel polymerized 
completely and the wells were washed with milli-Q water to remove any traces of 
unpolymerized acrylamide. 
 Prior to loading, protein samples were mixed with the SDS gel-loading buffer [50 mM 
Tris-HCl, 100 mM DTT (Bio-Rad Laboratories, Hercules, CA,, USA), 2% (w/v) SDS, 
0.1% (w/v) bromophenol blue, 10% glycerol] and were boiled for 5 min. The samples 
were loaded to the gel well, and a constant current of 5 mA per gel was applied. After the 
dye front has moved into the resolving gel, the current was increased to 15 mA per gel. 
Tris-glycine electrophoresis buffer [25 mM Tris, 250 mM glycine (pH 8.3), 0.1% (w/v) 
SDS] was used for the electrophoresis.  
II.4.3 Two-dimensional polyacrylamide gel electophoresis  
II.4.3.1 Iso-electric focusing (IEF) 
Ettan™ IPGphor™ Isoelectric Focusing System (Amersham, USA) was used for the 
first-dimension isoelectric focusing according to the manufacturer's instructions. Briefly, 
the 18 cm Immobiline Drystrips with a linear or nonlinear gradient from pH range of 3 to 
10 (Amersham, USA) were passively rehydrated for overnight (12 to 16 h) at room 
temperature with 340 μl rehydration buffer [8 M urea, 2% (w/v) CHAPS, 0.5% 
immobilized pH gradient (IPG) buffer, 50 mM dithiothreitol, and a trace amount of 
bromophenol blue]. Fifty μl of rehydration buffer was added to the desired amount of 
protein sample (Total volume < 30 μl) after rehydration, and cup loading was employed 
to load the protein sample just prior to IEF. IEF was performed using the following 
conditions: 150 V for 1:30 h, 500 V for 1.5 h, 4000 V for 1.5 h, 8, 000 V for 40, 000 Vh. 
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II.4.3.2 Second-dimensional PAGE 
After IEF, the 18 cm IPG strips were equilibrated in equilibration buffer I [6 M urea, 2% 
(w/v) SDS, 50 mM Tris-HCl pH 8.8, 30% (v/v) glycerol and 130 mM DTT, trace 
amounts of bromophenol blue] for 10 min, followed by equilibration buffer II [6 M urea, 
2% (w/v) SDS, 50 mM Tris-HCl (pH 8.8), 30% (v/v) glycerol and 135 mM 
iodoacetamide (Sigma, USA), trace amounts of bromophenol blue] for another 10 min. 
For second dimension SDS-PAGE, 12% polyacrylamide gels (20 × 20 cm, 1.0 mm thick) 
were used. The equilibrated-gel strips were placed on top of the 12% polyacrylamide gel. 
The gels were mounted in a PROTEAN II XL Cell (Bio-Rad, USA) and the Tris-glycine 
electrophoresis buffer [25 mM Tris, 250 mM glycine (pH 8.3), 0.1% (w/v) SDS] was 
used. The proteins were then resolved with a constant current of 25 mA per gel.  
II.4.4 Silver staining of protein gels 
Silver staining (Blum et al., 1987) was used for more sensitive detection of proteins in 
the gel. The gel was first fixed in 50% (v/v) methanol and 10% (v/v) acetic acid for at 
least 30 min, followed by 15 min in 50% (v/v) methanol. The gel was then washed 5 
times (5 min each) with milli-Q water, followed by fresh 0.02% (w/v) sodium thiosulfate 
(Sigma, USA) for 1 to 2 min, and washed twice (1 min each) with milli-Q water. Freshly 
prepared, 0.2% (w/v) silver nitrate (Merck, Germany) solution was then added and the 
gel was stained for 25 min. The gel was then washed twice (1 min each time) with milli-
Q water and developed [3% (w/v) sodium carbonate, 0.025% (v/v) formaldehyde (Sigma, 
USA)] until appropriate. The developing was stopped by adding 1.4% (w/v) EDTA for 
10 min. 
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II.5 Western blot  
Protein samples were subject to 1D-PAGE and transferred onto Immun-BlotTM PVDF 
membrane [0.2 μm] (Bio-Rad, USA) with Semi-Dry transfer system (Bio-Rad, Hercules, 
CA, USA) using transfer buffer consisting of 100 mM Tris (pH 7.4), 200 mM glycine, 
20% (v/v) methanol. The membrane was then blocked using 5% (w/v) skim milk in 
phosphate buffered saline with 0.05% Tween 20 (TPBS) for overnight at room 
temperature. The next day, the membrane was incubated with primary antibody in 1% 
(w/v) skim milk in TPBS for 1 h and 20 min. The membrane was washed five times in 
TPBS and incubated with secondary antibody in TPBS for 1 h, followed by another five 
times wash in TPBS. Signal detection was performed using the SuperSignal WestPico 
Chemiluminescent substrate (Pierce, Rockford, IL, USA) and the Lumi-Film 
Chemiluminescent Detection film (Roche Diagnostic, Mannheim, Germany). 
II.6 Animal studies 
II.6.1 Animal model and maintenance 
The animal model used in this research was the three-spotted blue gourami, Trichogaster 
trichopterus (Pallas). Fish were purchased from Mainland Tropical Fish Farm in 
Singapore. Average weight of 12 g and length of 10.0 cm were selected for the following 
experiments. Fish were allowed to acclimatize before the start of an experiment for at 
least two weeks. Briefly, fish were placed in water containing 0.5% (w/v) sodium 
chloride and 5 ppm acriflavine for one week upon arrival, followed by one more week in 
clean water. The fish were maintained in clean, de-chlorinated water at 25-28°C and fed 
with commercial fish pellets at 1% of their body weight daily.  
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II.6.2 Fifty percent median lethal dose (LD50) studies 
All the fish were anaesthetized prior to injection. Fish was put in water containing 0.02% 
(v/v) 2-phenoxyethanol (Sigma, USA) for ease of handling and reduction of pain during 
injection. Three groups of ten fish each were injected intramuscularly with 0.1 ml of 
PBS-washed bacterial cells adjusted to the required concentrations. The number of 
bacterial cells for each injected dose was confirmed by appropriate dilutions and CFU 
(colony forming unit) counting on TSA plate. Fish mortality was then observed for 7 
days and the LD50 values were calculated according to the method of Reed and Muench 
(1938). 
II.7 Statistical Analysis 
All data were expressed as mean ± SD. The data were analyzed using Student's t test. 
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E. tarda is a gram-negative enteric pathogen that causes hemorrhagic septicemia in 
fish and gastro- and extra-intestinal infections in humans. A TTSS and a EVP gene 
cluster have been found to play important roles in E. tarda pathogenesis. The previous 
studies suggested that the TTSS and EVP gene clusters were regulated by a two-
component system of EsrA-EsrB. In this study, we have characterized another 
regulator, EsrC, which showed significant sequence similarity to the AraC family of 
transcriptional regulators. Mutants with in-frame deletions of esrC increased the LD50s 
in blue gourami fish, reduced ECP production and failed to aggregate. 
Complementation of ΔesrC restored these three phenotypes. 2D-PAGE showed that 
EsrC regulated the expression of secreted proteins encoded by the TTSS (such as EseB 
and EseD) and EVP (EvpC) gene clusters. The expression of esrC required a 
functional two-component system of EsrA-EsrB. EsrC in turn regulated the expression 
of selected genes encoded in TTSS (such as the transcriptional unit of orf29 and orf30, 
but not esaC) and genes encoded in the EVP gene cluster. The present study sheds 
light on the regulation of these two key virulence-associated secretion systems and will 





E. tarda is an important cause of hemorrhagic septicemia. It infects many commercially 
important farmed fish species and has led to extensive losses in both freshwater and 
marine aquaculture (Thune et al., 1993). The organism has a broad host range, and is also 
known to cause infections in higher animals, including humans (Janda and Abbot, 1993a). 
In humans, it causes gastro- and extra-intestinal infections such as myonecrosis (Slaven 
et al., 2001), bacteremia (Yang and Wang, 1999), septic arthritis (Osiri et al., 1997), and 
wound infections (Banks, 1992). Pathogenesis of E. tarda is multi-factorial. Several 
potential virulence factors have been reported, including the abilities to invade epithelial 
cells (Janda et al., 1991b; Ling et al., 2000), to resist serum (Janda et al., 1991b; Ling et 
al., 2000) and phagocyte-mediated killings (Srinivasa Rao et al., 2001), and to produce 
toxins and enzymes such as hemolysins (Hirono et al., 1997), catalases (Srinivasa Rao et 
al., 2003b) and dermatotoxins (Ullah and Arai, 1983b) for disseminating infection.  
Using a combination of comparative proteomics of secreted proteins and TnphoA 
mutagenesis, we identified a TTSS (Tan et al., 2002; Srinivasa Rao et al., 2003a) and a 
putative secretion system EVP (Srinivasa Rao et al., 2004) that contributed to E. tarda 
PPD130/91 pathogenesis. TTSSs are generally used by bacterial pathogens to deliver 
virulence factors into host cells to subvert normal cell functions (Hueck, 1998). The 
TTSS gene cluster of E. tarda PPD130/91 contains 35 open reading frames  (Tan et al., 
2005). The gene members of E. tarda TTSS are composed of apparatus, chaperones, 
effectors and regulators. Some of the gene members of the E. tarda TTSS are 
homologous to other TTSSs encoded by pathogens such as EPEC, S. enterica serovar 
 49
Typhimurium and Y.  enterocolitica. The designation of the E. tarda TTSS genes is based 
on the sequence homologs in Salmonella SPI-2 (Hensel, et al., 1998). The inactivation of 
the TTSS in E. tarda led to the increase of LD50s in blue gourami fish (Srinivasa Rao et 
al., 2003a, Srinivasa Rao et al., 2004). 
The other gene cluster (EVP) is not unique to E. tarda but is widely distributed in 
many other animal and plant pathogens and symbionts such as Salmonella, Vibrio, 
Yersinia, Escherichia, Rhizobium and Agrobacterium species with putative secretion 
functions (Srinivasa Rao et al., 2004). In R. leguminosarum, the impairment of EVP-
like cluster affected the secretion of at least one protein based on 2D-PAGE analysis 
(Bladergroen et al., 2003). Some proteins encoded in this EVP-like locus of Rhizobium 
shared homology with proteins encoded by the type III or type IV secretion systems 
(Bladergroen et al., 2003). Folkesson and co-workers (Folkesson et al., 2002) also 
analyzed the EVP homolog in S. enterica serovar Typhimurium and found that this 
gene cluster encoded putative cytoplasmic, periplasmic and outer membrane localizing 
proteins. In E. tarda, eight genes (evpA-H) have been found in the EVP cluster 
(Srinivasa Rao et al., 2004). evpA and evpC are under the control of a TTSS regulator 
esrB while the secretion of EvpC is dependent on EvpB instead of on a functional 
TTSS. The deletion of evpB or evpC led to lower replication rates in gourami 
phagocytes, and reduced protein secretion and virulence in blue gourami fish 
(Srinivasa Rao et al., 2004). Complementation of evpB and evpC deletion mutants 
restored the secretion of EvpC, partially increased the replication rates in gourami 
phagocytes and lowered the LD50s in gourami fish, indicating that these EVP genes are 
vital for E. tarda pathogenesis (Srinivasa Rao et al., 2004). 
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The expressions of type III secretion apparatus and effectors are usually subject to 
complicated regulation (Francis et al, 2002). The previous studies suggested that EsrB 
regulated both the TTSS (such as eseB and eseD) and the EVP gene cluster (such as 
evpA and evpC) (Srinivasa Rao et al., 2004). In addition, the regulation of these two 
gene clusters is controlled by other factors such as temperature and the pstSCAB-phoU 
operon (Srinivasa Rao et al., 2004). This pstSCAB-phoU operon is a high-affinity 
phosphate-specific transport (PST) operon belonging to the family of ATP binding 
cassette (ABC) transporters (Webb et al., 1992). The previous studies demonstrated 
that TnphoA insertions in pstB, pstC and pstS abolished the expression of TTSS as well 
as EVP proteins and the resulting PST mutants were highly attenuated in blue gourami 
fish (Srinivasa Rao et al., 2004). However, it is not clear how the two-component 
system and these factors regulate the TTSS and EVP locus.  
 A common mechanism of gene regulation in bacteria is via regulatory proteins of the 
AraC family. To date, this family contains more than 100 members as identified by 
sequence homology to the AraC protein of E. coli (Gallegos et al, 1997). With a few 
exceptions, AraC homologs are transcriptional activators. In this study, we describe the 
identification of EsrC, an AraC homolog encoded inside the TTSS. The markerless in-
frame deletion mutation of esrC disrupted the expressions of the secreted proteins of the 
TTSS and EVP locus. The phenotype of the ΔesrC mutant is similar to the phenotypes of 
the esrA and esrB mutants. Our studies showed that EsrA-EsrB regulates the expression of 
the secreted proteins of TTSS and EVP proteins through EsrC.  
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III.2 Materials and Methods 
III.2.1 Bacterial strains and plasmids  
The bacterial strains and plasmids used in this study are shown in Table II.1 and Table 
III.1. E. tarda stains were grown in TSB or DMEM at 25°C without shaking, while E. 
coli strains were cultured in LB at 37°C. Appropriate antibiotics were added when 
necessary as described in chapter II. 
III.2.2 Construction of deletion mutants and plasmids 
Overlap extension PCR (Ho et al, 1989) was used to generate in-frame deletion of esrC 
on the E. tarda PPD130/91 chromosome. For the construction of ΔesrC, two PCR 
fragments were generated from PPD130/91 genomic DNA with the primer pairs of 
MutC-for plus MutC-int-rev, and MutC-rev plus Mut-int-for (Table III.2). The resulting 
products generated a 754-bp fragment containing the upstream of esrC and a 751-bp 
fragment containing the downstream of the esrC, respectively. A 16-bp overlap in the 
sequences (underlined) permitted amplification of a 1505-bp product during a second 
PCR with primers of MutC-for and MutC-rev, both of which were introduced a KpnI 
restriction site (bold), respectively. The resulting PCR product contained a deletion from 
nucleotides 34 to 660 of esrC. The PCR product was cloned into pGEM-T Easy vector, 
and DNA sequencing was performed to confirm that the construct was correct. The 
ΔesrC fragment was excised with KpnI, ligated into suicide vector pRE112 (Chlr) 
(Edwards et al, 1998) and the resulting plasmid then transformed into SM10 λpir. The 
single cross-over mutants were obtained by conjugal transfer into E. tarda PPD130/91. 
Double cross-over mutants were obtained by plating onto 10% sucrose TSA plates. The 
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deletion mutants were confirmed by PCR and sequencing. The construction of other esrC 
deletion mutants followed a similar protocol. The primers used for the construction of 
ΔesrCN1 are MutC-N-for plus N-rev, and MutC-N-rev plus N-for. The primers used for 
the construction of ΔesrCN2 are MutC-N-for plus N2-rev, and MutC-N-rev plus N2-for. 
The primers used for ΔesrC163 are MutC-HTH-for plus HTH-rev, and MutC-HTH-rev 
plus HTH-for. The primers used for ΔesrC263 are MutC-HTH2-for plus HTH2-rev, and 
MutC-HTH2-rev plus HTH2-for. The corresponding restriction sites (KpnI or SacI) are 
labeled in bold print. 
For the construction of pACYC + esrC, the complete esrC gene was obtained by PCR 
using Pfu Turbo polymerase (Stratagene) with E. tarda PPD130/91 as the template DNA. 
The PCR products were digested and ligated into ScaI and EcoRI digested pACYC184 
plasmid. For the construction of pQEesrB and pQEesrC, the complete esrB and esrC 
genes were amplified using the forward primer esrB-com-for or esrC-com-for containing 
the ribosome binding site (underlined) and EcoRI site (bold), and the reverse primer esrB-
com-rev or esrC-com-rev which supplied the BamHI site (bold) (Table III.2). The PCR 
products were digested with BamHI and EcoRI, and cloned into EcoRI and BamHI 
digested PQE60lacI (Tu et al, 2003). 
For the construction of LacZ reporter plasmids, the putative promoter regions were 
amplified from E. tarda PPD130/91 genomic DNA and the PCR products were cloned 
into pGEM-T Easy vector. The resulting plasmids were sequenced and the inserts were 
cut with BamHI and EcoRI (or MfeI) and subcloned into BamHI and EcoRI digested 
pRW50 plasmid (Lodge et al., 1992).  
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Table III.1. Strains and plasmids for this study 
 
Strain or plasmid Description Reference or 
source 
E. tarda   
PPD130/91 Wild type, Kms, Colr, Amps, LD50=105.0 Ling, et al., 
2000  
ΔesrC PPD130/91, in-frame deletion of esrC (missing amino acids 12 to 220) This study 
ΔesrCN1 PPD130/91, in-frame deletion of esrC (missing amino acids 2 to 72)  This study 
ΔesrCN2 PPD130/91, in-frame deletion of esrC (missing amino acids 2  to 124)  This study 
ΔesrC163 PPD130/91, in-frame deletion of esrC (missing amino acids 139 to 159)  This study 
ΔesrC263 PPD130/91, in-frame deletion of esrC (missing amino acids 190 to 213)  This study 
esrA esrA::pFS-esrA (Kmr) Unpublished 
data 
esrB esrB::TnphoA (Kmr), LD50 >108.0 Srinivasa Rao, 
et al., 2003a 
pstC pstC::TnphoA (Kmr), LD50 >108.0 Srinivasa Rao, 
et al., 2003a 
306 TnphoA  mutant 306, Kmr, LD50 >108.0 Unpublished 
data 
ΔesrC + esrC ΔesrC with pACYC + esrC This study 
   
E. coli   
JM109 Kms, Cols, Cms  Promega 
MC1061 (λpir ) thi thr1 leu6 proA2 his4 argE2 lacY1 galK2 ara14 xyl5 supE44 pir Rubirés et al., 
1997 
SM10 (λpir ) thi thr leu tonA lacY supE recA-RP4-2-Tc-Mu Kmr pir Rubirés et al., 
1997 
   
Plasmid   
pGEM-T Easy  Ampr  Promega 
pRE112 pGP704 suicide plasmid, pir dependent, Chlr, oriT, oriV, sacB Edwards et al., 
1998 
pREΔesrC pRE112 with esrC fragment deleted  12  to 220 amino acids This study 
pREΔesrCN1 pRE112 with esrC fragment deleted 2  to 72 amino acids This study 
pREΔesrCN2 pRE112 with esrC fragment deleted 2  to 124 amino acids This study 
pREΔesrC163 pRE112 with esrC fragment deleted 139 to159 amino acids This study 
pREΔesrC263 pRE112 with esrC fragment deleted 190  to 213 amino acids This study 
pACYC184 Tetr, Chlr Amersham 
pACYC + esrC pACYC184 with wild type esrC gene This study 
pRW50 lacZ reporter vector, Tetr Lodge, et al., 
1992 
pRWesrA pRW50 containing -711 to +89 of esrA relative to putative translational 
start site 
This study 
pRWesrB pRW50 containing -879 to +89 of esrB relative to putative translational 
start site 
This study 





Table III.1. Strains and plasmids for this study (continued) 
 
pRWesaC 
pRW50 containing -876 to +110 of esaC relative to putative translational 
start site This study 
pRWorf29 
pRW50 containing -667 to +101 of orf29 relative to putative translational 
start site This study 
pRWevpA 
pRW50 containing -711 to +89 of evpA relative to putative translational 
start site This study 
pRWevpC 
pRW50 containing -822 to +92 of evpC relative to putative translational 
start site This study 
pRWevpD 
pRW50 containing -562 to +92 of evpD relative to putative translational 
start site This study 
pRWevpH 
pRW50 containing -746 to +89 of evpH relative to putative translational 
start site This study 
pQE60lacI Derivative of pQE60, IPTG inducible, Ampr Tu, et al., 2003 
pQEesrB pQE60lacI with wild type esrB gene This study 




Table III.2. Oligonucleotides used in this study 
 
Name  Sequence (5' to 3') 
MutC-for ATGGTACCCTGTCCAGGCTGA TCA ATGCC 
MutC-int-rev GAAGGCTGGCCCGACGACCGGTGACGAGCAGTAGATGCAA 






















 III.2.3 LD50 determinations  
Healthy naïve blue gourami (T. trichopterus Pallas) of approximately 14 g were infected 
with E. tarda as described in the Chapter II and previously (Ling et al., 2000). The LD50s 
were calculated by the method of Reed and Muench (Reed and Muench, 1938). 
III.2.4 Phagocyte isolation 
Phagocytes were isolated from the head kidney of naïve gourami and purified following 
the procedure of Secombs (Secombs, 1990) and as described by Srinivasa Rao and co-
workers (Srinivasa Rao et al., 2001). Purified phagocytic cells (4 x 106 to 5 x 106 
cells/well) were allowed to adhere to 48-well tissue culture plates (Falcon) in an L-15 
medium (Sigma, USA) that was supplemented with 5% fetal bovine serum (FBS). After 3 
h of incubation at 25°C in a 5% (v/v) CO2 atmosphere, the cells were washed twice with 
Hanks’ balanced salt solution (HBSS) (Sigma, USA) and infected with E. tarda at a 
multiplicity of infection of 1:1 and incubated at 25°C for 30 min. The cells then were 
washed twice with HBSS and incubated with 100 μg/ml gentamicin to kill all the 
extracellular bacteria for 90 min. Then, the monolayers were washed twice with HBSS 
and lysed with 1% Triton X-100, and viable bacterial counts were enumerated by plate 
count. Phagocyte replication ratios were calculated by dividing the viable bacterial count 
after 5 h by the 2 h bacterial count. 
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III.2.5 2D-PAGE and protein identification 
Protein isolation and 2D-PAGE were performed as described in Chapter II.  Protein spots 
were identified with matrix-assisted laser desorption ionization-time of flight mass 
spectrometry (MALDI-TOF MS) as described earlier (Li et al., 2004).  
III.2.6 RNA isolation and RT-PCR analysis 
RNA was isolated from E. tarda PPD130/91 using Trizol reagent (Invitrogen, USA) 
following manufacturer’s protocol. One-step RT-PCR kit (Qiagen, USA) was used to 
carry out the reverse transcription polymerase chain reaction.  The RT-PCR reaction 
involved one hold at 50ºC for 30 min, one hold at 95ºC for 15 min,  followed by 32 cycles 
of 94ºC for 1 min, 60ºC for 1 min, 72ºC  for 1 min. The sequences of the primers used 
were eseDF (5’-TGA GCT GAT GGT TCA GCT TG-3’) and eseDR (5’-TTG AGC GCC 
TTT TCC AGC GT-3’).  
III.2.7 β-galactosidase assays 
Bacteria were grown in DMEM (for E. tarda) or LB (for E. coli) overnight at 25°C or 
37°C. β-galactosidase activities were determined with cells permeabilized with SDS 
and chloroform as described by Miller (Miller, 1972). Briefly, 1 ml bacterial overnight 
culture was transferred to 1.5 ml tubes and spun down. After removal of the 
supernatant, the cell pellet was resuspended in 600 µl Z-buffered (60 mM Na2HPO4; 
40 mM NaH2PO4; 10 mM KCl; 1 mM MgSO4; pH 7.0) by vortexing. 0.05% SDS (25 
µl) and 25 µl of chloroform were added to each tube to permeabilize the bacteria. 
Samples of 100 µl of 4 mg/ml ONPG were added to start the reaction. When the 
suspension started to show a yellow color, the reaction was terminated by adding 250 
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µl of 1 M NaCO3. The tube was centrifuged at 1, 3000 × g for 5 min to pellet the 
bacteria. Supernatant was transferred to cuvette for determination of absorbance at 420 
nm.  Culture density was assessed at OD600, and unites of activity were calculated as 
OD420/[reaction time (min) × OD600].  
III.3 Results  
III.3.1 Sequence analysis of regulators 
The TTSS of E. tarda is subject to the regulation of a two-component regulator EsrA-
EsrB (Fig. III.1A; Tan et al., 2005). The deduced amino acid sequence of EsrA has a high 
homology to a number of two-component system sensors including SpiR (SsrA) of S. 
enterica serovar Typhimurium (31% in identity and 45% in similarity from residues 29 to 
834 of EsrA) which controls the TTSS of SPI-2 (Ochman et al., 1996), and MmoS of 
Methylococcus capsulatus (31% in identity and 48% in similarity from residues 411 to 
905 of EsrA) which is involved in the copper-dependent regulation of a soluble methane 
monooxygenase (Csaki et al., 2003). The response regulator EsrB has a CheY-like 
receiver domain at the N-terminal half and a helix-turn-helix domain at the C-terminal 
half. The homologs of EsrB include the response regulator SsrB of the two-component 
system SsrA-SsrB of S. enterica serovar Typhimurium (42% in identity and 57% in 
similarity from residues 25 to 214 of EsrB) (Cirillo et al., 1998) and the response 
regulator YvqC of the two-component system YvqE-YvqC of Bacillus subtilis (30% in 
identity and 50% in similarity from residues 8 to 208 of EsrB) (Wipat et al., 1998). 
Our ongoing effort is to characterize the regulation of the TTSS of E. tarda, and we found 



























Fig. III.1. Schematic presentation of TTSS and EVP gene clusters of E. tarda PPD130/91. (A) TTSS gene cluster and (B) EVP gene 
cluster.  The arrows indicate confirmed promoters and the stars denote the corresponding lacZ fusions constructed but no promoter 
activities were detected.  
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Fig. III.2. Amino acid sequence alignments of the EsrC and other members of the AraC 
family of transcription regulatory proteins of TTSSs, including VirF (Y. enterocolitica) 
and ExsA (P. aeruginosa). Black boxes denote identical residues, and shaded boxes 
indicate conserved substitutions. The underlining indicates the putative helix-turn-helix 
domains. 
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direction as esaG, esaH, esaI, esaJ, orf19, esaK and esaL (Fig. III.1A) and are 
presumably in the same transcriptional unit as no obvious transcription termination 
sequences have been found between them. The putative ribosome binding site 
(AGGAGC) was identified 6 bp upstream of the postulated translational initiation codon 
of esrC. A homology search of EsrC retrieved a large number of bacterial transcriptional 
regulators of the AraC family. Some of them are regulators of TTSSs including ExsA of 
P. aeruginosa (30% in identity and 59% in similarity from residues 133 to 229 of EsrC) 
(Frank et al., 1991) and VirF of Y. enterocolitica (32% in identity and 63% in similarity 
from residues 136 to 221 of EsrC) (Cornelis et al., 1989) (Fig. III.2). Members of this 
protein family, as exemplified by AraC, contain the dimerization and effector binding 
domains in the N- terminal half, and two potential helix-turn-helices (HTHs) DNA 
binding and transcriptional activation domains at the C-terminal half. The similarity 
among these proteins is higher at the C-terminal half which is supposed to be a DNA 
binding domain (Fig. III.2). However, no homology was found within the 126 N-terminal 
amino acids of EsrC in a search of the databases. 
III.3.2 Role of EsrC in E. tarda virulence and protein secretion 
  The homology of EsrC to the TTSS transcriptional activators suggests that EsrC may be 
required for the virulence of E. tarda. A deletion mutant, ΔesrC, was constructed to 
remove an internal fragment of 627 bp and the resulting mutant contained the first 33 bp 
and the last 30 bp of the esrC gene. The ΔesrC mutant increased its LD50 (2.6 logs higher 
than that of the wild type) in blue gourami fish and showed a lower replication rate in blue 
gourami phagocytes (Table III.3). ΔesrC was also found to secrete less than 10% of the 
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Table III.3. Characterization of TTSS regulator mutants derived from E. tarda 
PPD130/91 
 
Strain ECP concentration (μg/ml) Aggregation† Macrophage replication* LD50 
PPD130/91 4.50 ± 0.23 Y ++ 105.0 
esrA 0.25 ± 0.08 Na +a 107.6a 
esrB 0.53 ± 0.08b Nb ND 108.0b 
ΔesrC 0.19 ± 0.05 N + 107.6 
ΔesrCN1 0.18 ± 0.07 N ND 107.8 
ΔesrCN2 0.21 ± 0.08 N ND 107.5 
ΔesrC163 0.17 ± 0.08 N ND 107.6 
ΔesrC263 0.19 ± 0.06 N ND 107.6 
ΔesrC + esrC 4.30 ± 018 Y ++ 105.4 
 
ECP, extracellular protein.  
†For the aggregation phenotype in DMEM, ‘Y’ denotes aggregation and ‘N’ denotes no aggregation. 
*For the macrophage replication assay, ‘++’ denotes bacterial normal replication and ‘+’ denotes bacterial 
reduced replication.  
ND, not determined. 
a Tan et al., 2005 
b  Srinivasa Rao et al., 2004. 
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Fig. III.3. Proteome analysis of E. tarda PPD130/91 and the ΔesrC mutant. Total protein 
(A and B) and ECP (C and D) fractions in DMEM were separated on Immobiline 
DryStrips (pH 3-10) combined with 2D-PAGE analysis (12.5% polyacrylamide). A and C, 
wild type; B and D, ΔesrC. 30 µg of samples were loaded for the total protein fractions. 
ECP fractions were adjusted according to the relative secreted protein amount of each 









Fig. III.4. Transcription of eseD was reduced by the mutation of esrC. The E. tarda wild 
type and ΔesrC mutant were grown in DMEM. Total RNA was isolated and treated with 
DNase I to remove contaminated DNA. Equal amounts of RNA were used to perform RT-
PCR, and PCR products were analyzed by agarose gel electrophoresis. A. Transcriptions 
of eseD were analyzed in wild type and ΔesrC by RT-PCR. (B) Transcriptions of 




extracellular proteins (ECPs) and did not show any aggregation in DMEM after 24 h of 
culturing (Table III.3). In general, the phenotypes of the ΔesrC mutant are similar to those 
of esrA and esrB insertional mutants (Table III.3). Complementation of the ΔesrC deletion 
mutant in trans with a plasmid-borne wild type copy of esrC (ΔesrC + esrC) restored the 
wild type phenotypes, including lower LD50s, an increase in the replication rate inside the 
blue gourami phagocytes, autoaggregation and the production of a normal amount of 
ECPs (Table III.3).  
To show the importance of the N-terminal sequence and the two HTHs on the function of 
EsrC, four additional in-frame deletion mutants were constructed: ΔesrCN1 (deleted 71 
amino acids from the N-terminal), ΔesrCN2 (deleted 123 amino acids from the N- 
terminal), ΔesrC163 (deleted the first HTH domain), and ΔesrC263 (deleted the second 
HTH domain) (Table III.1). All these mutants significantly reduced the LD50s and the 
values were comparable to those of the ΔesrC deletion mutant (Table III.3). All these four 
ΔesrC mutants also had low ECP production and failed to aggregate in DMEM culture 
(Table III.3). Our results demonstrate that EsrC plays an important role in E. tarda 
pathogenesis and an intact and complete protein is required for it to function. 
To find out which genes are regulated by EsrC, the total bacterial proteins and the ECPs 
of the wild type and the ΔesrC mutant were compared using 2D-PAGE (Fig. III.3A and 
3B). Four protein spots (spots 1-4) were absent in the ΔesrC mutant. Spots 1 and 2 were 
confirmed with MALDI-TOF MS as the TTSS secreted proteins EseB and EseD, 
respectively. Spots 3 and 4 were identified as EvpA and EvpC of the EVP proteins, 
respectively. The two secreted proteins EseC (spot 5) and E2 (spot 6) reported previously 
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(Srinivasa Rao et al., 2004) were also absent in the ECP profile of the ΔesrC mutant (Fig. 
III.3C and 3D).  
To investigate whether the effect of esrC on EseB and EseD was on the transcriptional 
level, mRNA from E. tarda PPD130/91 and the ΔesrC mutant was isolated and subject to 
RT-PCR to check the transcription message of eseD.  The results showed that the 
expression level of eseD decrease significantly in the ΔesrC mutant compared to that in 
the wild type (Fig. III.4). However, no difference was observed for the16S rRNA product 
in both the wild type and the mutant (Fig. III.4), suggesting that EsrC affects the eseD 
expression at the transcriptional level. 
III.3.3 Functional relationship between two-component system EsrA-EsrB and EsrC 
The observation that esrA, esrB and esrC mutants had similar low ECP productions 
(which were less than 10% of the wild type strain) in DMEM (Table III.3) led us to 
examine their interactions in regulating the TTSS of E. tarda.  EsrA-EsrB is a putative 
two-component system that regulates the expressions of the TTSS and EVP gene clusters. 
However, the opposite orientation of esrA and esrB in the chromosome makes their 
transcriptional relationship elusive. To investigate the relationship of esrA, esrB and esrC, 
we examined the effect of loss-of-function mutations in each of them on the expression of 
esrA, esrB and esrC. Plasmids pRWesrA, pRWesrB and pRWesrC carrying the lacZ 
transcriptional fusions to the upstream (putative promoter) regions of esrA, esrB and esrC, 
respectively, were constructed (Fig. III.1A), and introduced into the wild type, esrA, esrB 
and ΔesrC mutants. High β-galactosidase activities were detected in all the wild type 
































Fig. III.5. Effect of loss-of-function mutants in regulatory proteins on the expression of 
esrA, esrB and esrC. Levels of transcription of the different reporter gene fusions in 
different E. tarda genetic backgrounds were measured by assaying β-galactosidase 
activities in bacterial cell lysates. The values represent the mean ± SD from one 
representative experiment performed with triplicate samples. Equivalent results were 
obtained at least in triplicates. 
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in front of esrA, esrB and esrC (Fig. III.5). The inactivation of esrA did not reduce the β-
galactosidase expression of esrB-lacZ, and the inactivation of esrB also did not decrease 
the expression of the lacZ of esrA-lacZ (Fig. III.5). When the plasmid pRWesrC was 
introduced into esrA and esrB mutants, the expression of β-galactosidase were reduced 
about 100-fold to that of the wild type and was comparable to the vector control pRW50. 
Our results therefore suggest that EsrA and EsrB exert their regulatory effect upstream on 
esrC. The inactivation of esrA, esrB, and esrC in the chromosome did not affect the 
expression of esrA-lacZ, esrB-lacZ and esrC-lacZ, respectively, indicating that they may 
not be self-regulated (Fig. III.5). To determine whether EsrB directly activates esrC 
expression, the effect of providing esrB in trans under the control of lacI on the 
expression of esrC-lacZ from pRWesrC was tested in E. coli. Upon the induction of IPTG, 
pQEesrB was able to activate esrC-lacZ expression in E. coli. Very low LacZ activity was 
detected without the IPTG induction (Table III.4). Therefore, esrB may directly activate 
the expression of esrC.  
III.3.4 Regulation of TTSS apparatus genes and orf29 and orf30 
To find out whether esrC regulates TTSS apparatus genes, we examined the expression of 
esaC in the ΔesrC mutant. EsaC is homologous to SsaC of Salmonella SPI-2, which is a 
TTSS apparatus protein. The inactivation of esaC abolished the secretion of EseB, EseC, and 
EseD (Tan, 2005). Plasmid pRWesaC carrying the lacZ fusion with the promoter region 
of esaC (Fig. III.1A) was introduced into the E. tarda wild type and esrA, esrB, and 
ΔesrC mutants. High β-galactosidase activities were detected in the wild type, confirming 
the presence of a promoter. However, expression of the lacZ fusion was reduced over 20-
fold in the esrA and esrB mutants, but not in the ΔesrC mutant (Fig. III.6). Our results 
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suggest that the EsrA-EsrB two-component system regulates the expression of esaC, and 
esrC is not required for an esaC expression.   
Plasmid pRWorf29 carrying the lacZ fusion with the promoter region of orf29 was also 
constructed (Fig. III.1A) and introduced into esrA, esrB, and ΔesrC mutants. As shown in 
Fig. III.6, expression of lacZ of orf29-lacZ in the ΔesrC mutant was found to be four 
times lower than that in the wild type, demonstrating regulation by EsrC on the 
transcriptional unit of orf29 and orf30. Expression of lacZ of orf29-lacZ was also 
examined in the background of esrA or esrB, and the β-galactosidase activities in these 
two mutants were also reduced (Fig. III.6), indicating that EsrA-EsrB also can regulate the 
transcriptional unit of orf29 and orf30 independent of EsrC. Therefore, it is likely that 
there are two promoters upstream of orf29: one is esrC dependent, and the other is EsrB 
dependent. Expressions of orf29 and orf30 were regulated by both EsrB and EsrC and 
could be activated from either of these promoters.  
III.3.5 EsrC regulates the EVP gene cluster 
EvpA and EvpC were shown to be regulated by EsrC earlier in the 2D-PAGE studies (Fig. 
III.3). The next question is how EsrC regulates the expression of EVP genes and whether 
EsrC also regulates the other genes encoded in the EVP gene cluster. Plasmid pRWevpA 
containing the putative promoter region of evpA (Fig. III.1B) was introduced into the E. 
tarda wild type and the ΔesrC mutant. As shown in Fig. III.7, high β-galactosidase 
activities were detected in the wild type, which confirmed the presence of a promoter. 
Expression of the LacZ reporter decreased over 30 times in the ΔesrC mutant when 
compared to the wild type (Fig. III.7). The data further confirmed the regulation of EsrC  
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Table III.4. Expression of reporter fusions with esrB or esrC in E. coli 
 
β-galactosidase activitiesa Plasmids No IPTG IPTG 
                 pRWesrC 11 ± 2 13 ± 3 
pQEesrB + pRWesrC 19 ± 3 4475 ± 1075 
                  pRWevpA 24 ± 4 15 ± 3 




a β-galactosidase activities (in Miller units) present in E. coli JM109 

































Fig. III.6. Effect of loss-of-function mutants in regulatory proteins on the expression of 
esaC and orf29.  Levels of transcription of the different reporter gene fusions in different 
E. tarda genetic backgrounds were measured by assaying β-galactosidase activities in 
bacterial cell lysates. The values represent the mean ± SD from one representative 
experiment performed with triplicate samples. Equivalent results were obtained at least in 
triplicates. 
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on the evpA-lacZ, and indicate that the regulation is at the transcriptional level. To find 
out whether there were other possible promoters in this EVP gene cluster, we constructed 
three more reporter fusions in pRW50 plasmids with the upstream sequences of evpC, 
evpD and evpH (Fig. III.1B). These constructs were introduced into the E. tarda wild type 
and the lacZ expression was monitored. The results showed that the expressions of 
reporters in all the E. tarda wild type with these three constructs had low β-galactosidase 
activities which were comparable to the vector control (pRW50) (data not shown). The 
results indicate that there may not be other promoters in the regions examined. It is 
possible that the EVP gene cluster transcript in one single unit and EsrC is required for the 
expression of all the genes in this EVP gene cluster. To determine if EsrC directly 
activates evpA expression, the effect of providing esrC in trans under the control of lacI 
on the expression of evpA-lacZ was tested in E. coli. Under the induction of IPTG, 
pQEesrC was able to activate evpA-lacZ in E. coli while very low LacZ activity was 
detected without the IPTG induction (Table III.4). Therefore, EsrC may directly activate 
the expression of evpA. 
III.3.6 Regulation of esrA-esrB and esrC   
The expression of TTSS secreted proteins and EVP proteins was temperature dependent 
(Srinivasa Rao et al., 2004), and EsrC was speculated to contribute to the receiving of 
temperature change signals due to the similarity to thermo-induced regulator VirF in 
yersiniae (Fig. III.2). However, there is no evidence to support this hypothesis. To clarify 
this, plasmids pRWesaC and pRWesrC were transformed into the E. tarda wild type, and 




























Fig. III.7. Effect of ΔesrC on the expression of evpA. Levels of transcription of the 
reporter gene fusion in different E. tarda genetic backgrounds were measured by assaying 
β-galactosidase activities in bacterial cell lysates. The values represent the mean ± SD 
from one representative experiment performed with triplicate samples. Equivalent results 
were obtained at least in triplicates. 
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expression of lacZ of esrC-lacZ and esaC-lacZ at 37°C decreased approximately two 
times compared to that in 25°C, respectively. These data indicate that the expression of 
esrC itself is affected by temperature. As we had shown earlier that esrC was under the 
control of esrA and esrB, we were interested to find out whether the effect of temperature 
on the esrC transcription was the result of the decrease of esrA and esrB expressions. The 
expression of lacZ in the E. tarda wild type carrying pRWesrA or pRWesrB at 37°C and 
25°C was examined. We found that the expression of lacZ of the E. tarda wild type 
carrying esrA-lacZ was similar at either 37°C or 25°C. However, the expression of lacZ 
by the wild type carrying esrB-lacZ was two times lower at 37°C than that at 25°C, 
demonstrating that the expression of esrB, but not esrA, was regulated by temperature. 
These results suggest that the effect of temperature on the expressions of eseB, eseD and 
EVP genes is through regulating the expression of esrB. The insertion of TnphoA in pst 
genes has been reported to affect the expression of the TTSS and EVP genes (Srinivasa 
Rao et al., 2004). On the other hand, a TnphoA mutant (306) was found to be highly 
attenuated when injected into blue gourami fish and it failed to produce TTSS (EseB and 
EseD) and EVP proteins (EvpA and EvpC) (Tan et al., 2005). Sequencing data at the 
point of transposon insertion of this mutant showed similarity to a putative membrane 
protein of Y. pestis.  Therefore, we were very interested in exploring how these mutants 
affected this regulatory hierarchy. To this end, the plasmids of pRWesrA, pRWesrB and 
pRWesrC were transformed into pstC and mutant 306. As shown in Fig. III.8, in both 
pstC and mutant 306, the expressions of lacZ of esrA-lacZ and esrB-lacZ did not decrease 
although eseB, eseD, evpA, and evpC failed to express in these mutants (data not shown) 
(Srinivasa Rao et al., 2004). In sharp contrast, the expression of esrC-lacZ was reduced 
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significantly. These results indicate that the effect of pstC and mutant 306 on the 
expression of TTSS and EVP genes might not be through regulating the transcription of 
esrA and esrB. We further examined the expression of the TTSS apparatus gene esaC in 
pstC and mutant 306. Interestingly, in both of these mutants, the expression of lacZ of 
esaC-lacZ decreased significantly. Such observation indicates that the insertion of 
TnphoA in pstC and the putative membrane protein also affects TTSS apparatus gene 
expression. 
III.4 Discussion 
III.4.1 EsrC is a positive regulator 
We report here the characterization of another novel regulatory protein, EsrC, which is 
encoded within the TTSS of E. tarda. EsrC has a significant sequence similarity to 
members of the AraC family of the transcriptional regulatory proteins. A non-polar 
deletion mutation in esrC rendered the mutant less virulent. The wild type phenotypes 
could be restored by the complementation of esrC provided by a plasmid with a 
constitutive promoter. Our results suggest that esrC is an essential virulence gene for E. 
tarda pathogenesis and its role is comparable to esrA and esrB (Table III.3). The LacZ 
reporter fusion analysis indicated that EsrC was downstream of the EsrA-EsrB regulatory 
pathway (Fig. III.9). The regulation of EsrB on esrC was possibly direct since EsrB could 
regulate the expression of the reporter fusion (esrC-lacZ) in E. coli (Table III.4). esrC was 
possibly in the same transcriptional unit and under the same mode of regulation with the 
apparatus genes (Fig. III.9). esrC was also shown to be not self-regulated (Fig. III.5). The 































Fig. III.8. Effect of temperature, pstC and mutant 306 on the expression of esrA, esrB, 
esrC and esaC. E. tarda strains with different reporter fusions were cultured at 25°C or 
37°C in DMEM. Levels of transcription of the different reporter gene fusions were 
measured by assaying β-galactosidase activities in bacterial cell lysates. The values 
represent the mean ± SD from one representative experiment performed with triplicate 
samples. Equivalent results were obtained at least in triplicates. 
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hypothesis was further confirmed by the reporter esaC-lacZ which was expressed in the 
ΔesrC mutant but not in the esrA or esrB insertional mutants (Fig. III.6). Although both 
EsrC and the two-component system EsrA-EsrB control the TTSS, EsrA-EsrB may 
directly regulate the expression of TTSS apparatus genes while it is EsrC that regulates 
the expression of some specific transcriptional units such as the secreted proteins of TTSS 
(e.g. EseB and EseD). The regulation of EsrA-EsrB on TTSSs is, therefore, different from 
SsrA-SsrB in Salmonella species, in which SsrA-SsrB controls the expression of genes 
encoding both secreted proteins and the TTSS apparatus. The difference may be due to the 
lack of another regulatory protein encoded within TTSS of SPI-2.  
III.4.2 EsrC regulates orf29 and orf30 and EVP 
 The expression of orf29 and orf30, the two novel genes identified at the end of the TTSS, 
was controlled by both EsrA-EsrB and EsrC, which might indicate that they were part of 
the TTSS gene cluster (Fig. III.1A and 9). The regulation of these two ORFs is different 
from that of other TTSS apparatus genes (e.g. esaC), which are directly regulated only by 
the EsrA-EsrB two-component system. orf29 and orf30 may have a special function for 
TTSSs. The analysis with COILs (http://www.ch.embnet.org/software/coils_form.html) 
showed that the predicted proteins had a high degree of coils. Pallen and co-workers 
(Pallen et al., 1997) reported that many of the secreted proteins of the TTSS shared a 
common coiled-coil structure feature. Orf29 and Orf30 share no homology with known 
structure proteins of the TTSS which are believed to be conserved in different bacterial 
species. Therefore, it is likely that orf29 and orf30 do not encode for apparatus but instead 
are effector proteins of E. tarda. This possibility will be examined in our future study. 
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The EVP gene cluster is encoded outside of the TTSS and mutation in esrB has been 
reported to affect the expression of EvpA and EvpC (Srinivasa Rao et al., 2004). However, 
the secretion of EVP proteins is independent of the TTSS. Mutations in the putative 
translocon proteins of the TTSS did not affect the secretion of EvpC (Srinivasa Rao et al., 
2004). The EsrA-EsrB two-component system regulates EVP via EsrC (Fig. III.9). The 
LacZ reporter study suggests that EsrC regulated the transcription of the evpA-H 
transcriptional unit and only one promoter sequence was found (Fig. III.1 and 7), and the 
regulation of EsrC on evpA is possibly direct (Table III.4). The homologs of the EVP gene 
cluster are widely distributed in other pathogens such as Escherichia, Salmonella, Vibrio 
and Yersinia species with unknown functions (Srinivasa Rao et al., 2004), and it is 
possible that these homologs may also be regulated by the regulators encoded in the 
respective TTSSs. The direct regulation of the EVP gene cluster by the regulators encoded 
within the TTSS of E. tarda suggests the functional relationship between the TTSS and 
the EVP gene cluster. The EVP gene cluster and its homologs encode several conserved 
core proteins and possibly encode a novel secretion system (Bladergroen et al., 2003; 
Folkesson et al., 2002; Srinivasa Rao et al., 2004). This is the first report to suggest a 
communication between the TTSS and the EVP in E. tarda. In Salmonella species, SPI-5 
encodes at least five effectors (Wood et al., 1998), among which SigD/SopB is 
coordinately regulated with SPI-1 genes (Darwin et al., 2000) and is secreted by the SPI-1 
TTSS (Hong et al., 1998). However, PipB, another effector in SPI-5, is part of the SPI-2 
regulon and is translocated by the SPI-2 TTSS to the Salmonella-containing vacuole 
(Knodler et al., 2002). These studies demonstrate a functional and regulatory cross-talk 
between different secretion systems. E. tarda might use EsrC to coordinate the EVP 
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secretion system with the TTSS in infection or survival in host cells.  
III.4.3 Involvements of other regulators  
 The regulators encoded within the TTSS usually respond to regulation by environmental 
factors or other global regulators. In Salmonella species, the SsrA-SsrB two-component 
system was regulated by another two-component system OmpR-EnvZ, of which the 
response regulator OmpR binds directly to the ssrA and ssrB promoter (Feng et al., 2003; 
Lee et al., 2000). In E. tarda, a transposon mutant (306) which has an insertion in a 
putative membrane protein was also shown to affect the expression of the TTSS. Unlike 
OmpR-EnvZ in Salmonella species, this mutant did not affect the expressions of esrA or 
esrB but suppressed the expression of esrC and the TTSS apparatus genes (e.g. esaC) (Fig. 
III.8). Interestingly, transposon insertion in pstC also has a similar effect on the 
expressions of TTSS and EVP (Fig. III.8), suggesting that the PST operon has some 
control over the expressions of TTSS and EVP. The PST operon is required for phosphate 
transport (Webb et al., 1992). In S. enterica serovar Typhimurium, the transposon mutant 
pstS reduced the expression of the TTSS regulator of hilA and the invasion genes, and this 
repression was due to the negative control of the PhoR-PhoB two-component system. The 
pstS mutation led to the accumulation of PhoB~P, and PhoB~P directly or indirectly 
repressed hilA and the invasion genes (Lucas et al., 2000).  E. tarda might have a similar 
mechanism: the insertion inactivation of the PST system may lead to the accumulation of 
some negative regulators of the TTSS which have not been identified and thus repressing 
the expression of TTSS genes.  If this is the case, this negative regulation would not 
modulate the expressions of esrA and esrB as both of their expressions were not affected 
in the pstC mutant background (Fig. III.8). This negative regulator might directly interact 
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with EsrB and interrupt its function. Another hypothesis is that some proteins encoded in 
the PST operon function as positive regulators and coordinate with EsrB in regulating the 
TTSS. However, we have shown that in E. coli, under the induction of IPTG, pQEesrB 
could activate lacZ expression of esrC-lacZ because of large amounts of EsrB 
accumulation. In E. tarda, as a regulator gene, the expression of esrB was low and EsrB 
could not activate the expression of the TTSS without the help of the positive regulator 
encoded in the PST operon. Future studies will attempt to distinguish between these 
possibilities.  
III.4.4 Effect of high temperature   
The expression of the esrB-lacZ fusion decreased substantially at 37°C when compared to 
25°C, but there was no change for the esrA-lacZ fusion at different temperatures. Our 
results suggest that the regulation of temperature on the TTSS is through the modulation 
of esrB expressions (Fig. III.9). It is possible that the primary regulatory event is at the 
esrB transcription and the accumulation of EsrB increases the transcription of esrC. This 
results in the increased production of EsrC activator proteins which bind to sites upstream 
of the target genes and activate transcription. If so, the mechanism response for 
temperature sensing is independent of EsrB and EsrC. EsrA functions as a sensor in EsrA-
EsrB two-component system, and it is possible that EsrA is the one that responds to 
temperature changes. However, the expression of esrB-lacZ in ersA mutant background 
did not decrease compared to that in the wild type background at 25°C (Fig. III.5). From 
these data, we hypothesize that there must be proteins other than EsrA responding to 
temperature changes.  Alternatively, temperature changes may affect DNA conformation 
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Fig. III.9. A model for the regulation of TTSS and EVP gene clusters by EsrA, EsrB and 
EsrC in E. tarda PPD130/91. Growing in DMEM at 25 °C favors the expressions of esrA 
and esrB. EsrA is speculated to phosphorylate EsrB, and the accumulation of activated 
EsrB leads to the expressions of esrC and downstream TTSS apparatus genes as well as 
orf29 and orf30. EsrC then activates the expressions of TTSS secreted proteins, orf29 and 
orf30 and the EVP gene cluster. The regulation of EsrB on the TTSS apparatus genes or 
esrC transcription was subject to the modulation of other factors such as the PST operon. 
Other possible unknown environmental factors are indicated in the diagram. 
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expressions of a variety of genes (Dorman, 1996; Dorman et al., 1988; Galan and Curtiss 
III, 1990; Higgins et al., 1988). In E. tarda, the topology of the DNA promoter region of 
esrB may vary at different temperatures and result in altered esrB expressions. Further 
experiments need to be done to confirm these two hypotheses. 
In conclusion, we report that the EsrA-EsrB/EsrC regulatory cascade is the key regulon 
controlling the expressions of TTSS and EVP gene clusters and plays a vital role in E. 
tarda pathogenesis. EsrA-EsrB controls most of the transcriptional units of the TTSS to 
ensure that the TTSS is functional. EsrA-EsrB also controls EsrC which regulates a subset 
of transcriptional units. They may be effector proteins or proteins for special functions 
such as the transcriptional units of orf29 and orf30. Another main role of EsrC is to 
control the EVP gene cluster, possibly another secretion system that is different from the 
TTSS. The EsrA-EsrB/EsrC regulatory cascade, therefore, can coordinate the expressions 
of these two secretion systems during infection and host-bacteria interactions. The 
sequencing of the TTSS and EVP gene clusters is ongoing. More transcriptional units will 
be identified and this will help to dissect the precise roles of this EsrA-EsrB/EsrC 
regulatory cascade. Future work will also be carried out to identify and characterize the 
factors affected by the insertional disruptions of pstC and the putative membrane protein, 
and to identify factors which communicate temperature changes with the TTSS and EVP 
gene clusters. The above information will be useful at understanding the functions of 
TTSS and EVP gene clusters and thus the pathogenesis of E. tarda.  
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Chapter IV.  EscBD is a chaperone for the TTSS translocon components 








The results of this chapter are included in the following manscript: 
 
Zheng, J.,  Y. P. Tan, J. Sivaraman, Y. K. Mok, and K. Y. Leung. EscBD is a chaperone 







E. tarda is a gram-negative enteric pathogen that causes diseases in both humans and 
animals. Recently, a TTSS has been found to contribute to E. tarda pathogenesis. EseB, 
EseC and EseD were shown to be secreted by the TTSS and they were the major 
components in the ECPs. Co-immunoprecipitation experiment showed that these three 
proteins formed a complex after secretion. In this study, we investigated the function of 
EscBD (previously named as Orf2), a hypothetical protein encoded upstream of eseB. 
EscBD has the characteristics of a chaperone, which is a 13 KDa small protein, located 
next to the tranlocators in the TTSS gene cluster, and has a coiled-coil structure at the N-
terminal region predicted by COILs. An in-frame deletion of escBD abolished the 
secretion of EseB and EseD and complementation of ΔescBD restored the export of EseB 
and EseD into the culture supernatant. Further studies showed that EscBD was not a 
secreted protein and it was located on the membrane and inside the cytoplasm. A 
mutation of escBD did not affect the transcription of eseB but reduced the amount of 
translational fusion protein EseB-LacZ in E. tarda. Co-purification studies demonstrated 
that EscBD formed complexes with EseB and EseD, respectively but not concurrently. 
Our results demonstrate that EscBD functions as a TTSS chaperone for the translocon 




E. tarda is a gram-negative bacillus of the family Enterobacteriaceae. It is a ubiquitous 
organism with a broad host range and wide geographical distribution. E. tarda is found in 
freshwater and marine environments and is known to colonize in animals residing in 
these ecosystems (Plumb et al., 1993). In humans, gastro- and extra-intestinal infections 
can be caused by E. tarda, including myonecrosis (Slaven et al., 2001), septic arthritis 
(Osiri et al., 1997), bacteremia (Yang and Wang et al., 1999), wound infections (Banks, 
1992) and bacterial peritonitis (Janda et al., 1991b). E. tarda also causes hemorrhagic 
septicemia in many farmed and feral fish and other aquatic animals, and leads to great 
losses in aquaculture industries (Thune et al., 1993). Therefore, it is important to study 
the pathogenesis of E. tarda and find suitable strategies to prevent this disease.  
Many factors are reported to contribute to the pathogenesis of E. tarda. These include the 
abilities to adhere to, invade and replicate within epithelial cells (Janda et al., 1991b; 
Ling et al., 2000) and fish tissues (Ling et al., 2001), to resist serum- (Janda et al., 1991b; 
Ling et al., 2000) as well as phagocyte-mediated killings (Srinivasa Rao et al., 2001). E. 
tarda also produces toxins and exoenzymes such as hemolysins (Hirono et al., 1997), 
catalases (Srinivasa Rao et al., 2003b) and dermatotoxins (Ullah and Arai, 1983b) for 
disseminating infection. Recently, we have identified two important virulence 
mechanisms that are related to secretion systems, namely, a TTSS (Tan et al., 2005) and 
a novel secretion system, encoded by EVP gene cluster  (Srinivasa Rao et al., 2004). 
These two secretion systems cross-talk through a two-component system EsrA-EsrB and 
a regulator EsrC (see Chapter III). Disruption of the TTSS or EVP gene cluster resulted 
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in about 1 to 2 logs increase of the LD50s in our blue gourami host (Srinivasa Rao et al., 
2004; Tan et al., 2005). 
The TTSS is a contact-dependant protein secretion system and it is generally composed 
of about 20 proteins, including apparatus, effectors, regulators, and chaperones (Hueck, 
1998). The tranlocator proteins of the apparatus form a needle structure that is 28Å in 
diameter to inject effector proteins directly into eukaryotic cells (Marlovits et al., 2004) 
where the normal cellular functions are subverted for the benefit of the bacteria. In E. 
tarda, a TTSS was identified with the combination of genomics and proteomics 
approaches (Tan et al., 2002; Srinivasa Rao et al., 2003a; Tan et al., 2005). The TTSS of 
E. tarda PPD130/91 contained 35 open reading frames, which include E. tarda secretion 
system apparatus, chaperone, effectors, regulators, and some unknown genes (orf) (Tan et 
al., 2005). With 2D-PAGE analysis, EseB, EseC and EseD were identified as the major 
components in the ECPs and their secretion was TTSS-dependent. These three Ese 
proteins contributed to E. tarda pathogenesis as the mutation of eseB, eseC or eseD led to 
the decrease of virulence about ten-fold in comparison to that of the wild type (Tan et al., 
2005). Sequence analyses showed that these three proteins were homologous to EspA, 
EspD and EspB of EPEC, respectively (Tan et al., 2005). EspA formed a sheath-like 
structure, and EspB and EspD formed a translocon pore in EPEC. EspA, EspB and EspD 
together constituted a molecular syringe and channeled effector proteins into the host cell 
(Ide, 2001). In addition, the homologs of EseB, EseC, and EseD in Salmonella (SseB, 
SseC and SseD, respectively) had also been shown to function as translocon components, 
and they were essential for the effectors translocation (Nikolaus et al., 2001). The 
sequence similarities of EseB, EseC and EseD with their homologs in EPEC and 
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Salmonella suggest that these three Ese proteins may have similar functions to form a 
translocon complex to facilitate the tanslocation of effectors. This notion was supported 
with the immoprecipitation showing that EseB, EseC and EseD formed a complex after 
secretion (Tan, 2005). 
Many of the TTSS secreted proteins are dependent on specific chaperones for secretion 
as well as stabilization in the bacterial cytosol prior to secretion. The binding of a 
chaperone with the secreted protein can prevent the premature interactions of a secreted 
protein with other secreted protein(s) and/or with parts of the secretion and translocation 
machinery (Wattiau et al., 1996; Bennett and Hughes, 2000). In addition, chaperones 
were shown to be required for the genes regulation (Darwin et al., 2000 and 2001) and 
conferred secretion-pathway specificity to their cognate secreted proteins (Lee and Galan, 
2004). In E. tarda, EscA and EscB have been proposed to be the chaperones for TTSS 
proteins (Tan et al., 2005). However, the chaperones for the secreted proteins EseB, EseC 
and EseD have not been characterized. In the present study, we found that Orf2 was 
essential for the secretion of EseB and EseD. Further characterization showed that Orf2 
bond to EseB and EseD, respectively. These results indicate that Orf2 is a chaperone of 
EseB and EseD, and thus it was renamed as EscBD. 
IV.2 Materials and Methods 
IV.2.1 Bacterial strains and plasmids 
 The bacterial strains and plasmids used in this study are described in Table IV.1. E. 
tarda stains were grown in TSB or DMEM at 25°C without shaking, while E. coli strains 
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were cultured in LB at 37°C. Appropriate antibiotics were added when necessary as 
described in chapter II.  
IV.2.2 Construction of deletion mutants and plasmid 
 Overlap extension PCR (Ho et al., 1989) was used to generate in-frame deletion of orf2 
(escBD) and eseE on the E. tarda wild type PPD130/91 chromosome as described in 
chapter II. For the construction of ΔescBD, two PCR fragments were generated from 
PPD130/91 genomic DNA with the primer pairs of escBD-for plus escBD-int-rev and 
escBD-int-for plus escBD-rev (Table IV.2). The resulting product generated a 760-bp 
fragment containing the upstream of escBD and a 784-bp fragment containing the 
downstream of the escBD, respectively. A 17-bp overlap in the sequences (underlined) 
permitted amplification of a 1556-bp product during a second PCR with primers of 
escBD-for and escBD-rev, both of which were introduced a KpnI restriction site (bold), 
respectively. The resulting PCR product, contained a deletion from nucleotides 22 to 339 
of escBD, was ligated into suicide vector pRE112 (Chlr) (Edwards et al., 1998) and 
transformed into SM10 λpir. The single cross-over mutants were obtained by conjugal 
transfer into E. tarda PPD130/91. Deletion mutants were screened on 10% sucrose TSA 
plates. The construction of eseE deletion mutant followed the same protocol. The primers 
used for ΔeseE were eseE-for plus eseE-int-rev and eseE-int-for plus eseE-rev (Table 
IV.2). For the construction of LacZ transcriptional or translational strains, the eseB 
internal fragment was amplified with the forward primer eseB-int-for and the reverse 
primer eseB-int-rev (Table IV.2) from PPD130/91 genomic DNA. The PCR product was 
digested with XbaI and EcoRI and ligated into the same sites within pVIK112 or 
pVIK111. The resulting plasmids were transformed into S17-1 λpir. The plasmids were
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Table IV.1. Strains and plasmids used for this study 
 
Strain or plasmid Description Reference or source 
E. tarda   
PPD130/91 Wild type, Kms, Colr, Amps, LD50=105.0 Ling et al., 2000 
ΔeseE PPD130/91, in frame deletion of eseE This study 
ΔescBD PPD130/91, in frame deletion of escBD This study 
ΔescBD+escBD ΔescBD with pSAescBD This study 
ΔesrC PPD130/91, in frame deletion of esrC  This study 
eseB eseB::pFS-eseB (Kmr) Tan et al., 2005 
eseC eseC::pFS-eseC (Kmr) Tan et al., 2005 
eseD eseD::pFS-eseD (Kmr) Tan et al., 2005 
eseB::pVIK212 PPD130/91; in-frame eseB-lacZ transcriptional fusion This study 
ΔescBD eseB::pVIK212 ΔescBD; in-frame eseB-lacZ transcriptional fusion This study 
ΔesrC eseB::pVIK212 ΔesrC; in-frame eseB-lacZ transcriptional fusion This study 
eseB:: pVIK211 PPD130/91; in-frame eseB-lacZ translational fusion This study 
ΔescBD eseB::pVIK211 ΔescBD; in-frame eseB-lacZ translational fusion This study 
ΔesrC eseB::pVIK211 ΔesrC; in-frame eseB-lacZ translational fusion This study 
   
E. coli   
JM109 Kms, Cols, Cms  Promega 
MC1061 (λpir ) 
thi thr1 leu6 proA2 his4 argE2 lacY1 galK2 ara14 xyl5 supE44 
pir Rubirés et al., 1997 
SM10 (λpir ) thi thr leu tonA lacY supE recA-RP4-2-Tc-Mu Kmr pir Rubirés et al., 1997 
S17-1 (λpir) Tpr Smr recA, thi, pro, hsdR-M+RP4: 2-Tc:Mu: Km Tn7 λpir Simon et al., 1983 
BL21(DE3)/pLysS F-, ompT, hsdSβ(rβ-mβ-), dcm, gal, (DE3) tonA, pLysS  Stratagene 
   
Plasmids   
pGEM-T Easy  Ampr  Promega 
pRE112 pGP704 suicide plasmid, pir dependent, Chlr, oriT, oriV, sacB Edwards et al., 1998 
pSA10 pKK177-3 derivative, lacI, Ampr Silverman et al., 2000 
pSAescBD-FLAG pSA10 with wild type escBD plus FLAG tag This study 
pVIK111 lacZY  for translation fusions; Kmr Kalogeraki et al., 1997 
pVIK112 lacZY  for transcription fusions; Kmr Kalogeraki et al., 1997 
pVIK211 pVIK111, eseB internal fragment; in-frame translational fusion  This study 
pVIK212 
pVIK112, eseB internal fragment; in-frame transcriptional 
fusion This study 
pETduet-1 Ampr Novagen 
pETB-D 
pETDuet-1with full length eseB fused to 6His at the N-terminal 
and escBD This study 
pETD-D 
pETDuet-1with full length eseD fused to 6fHis at the N-terminal 
and escBD  This study 
pETescBD pETDuet-1 with escBD This study 
pACYCDuet-1 Chlr Novagen 
pACYC-eseB pACYCDuet-1 with full length eseB This study 
pACYC-eseD pACYCDuet-1 with full length eseD This study 
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eseB-exp-for T GGATCC GATGACTGTCAATACAGACTA  




escBD-exp-rev  TCTCGAGTTAGATGAAGTCATGCCCGA 
Table IV.2. Oligonucleotides used in this study 
 
 
then transferred from S17-1 λpir into E. tarda by conjugation and the LacZ 
transcriptional or translational strains were selected for kanamycin and colistin resistance. 
For the construction of pSAescBD-FLAG, the complete escBD gene was amplified 
with escBD-com-for and escBD-com-rev, which supplied a FLAG tag in frame with 
EscBD at its terminal (Underline, Table IV.2) and SalI site. The PCR product was 
digested with SalI and EcoRI and ligated into the same sites within the pSA10 plasmid. 
To generate co-expression plasmids pETB-D and pETD-D, eseB and eseD were 
amplified from E. tarda PPD130/91 chromosome with the primer pairs (Table IV.2) of 
eseB-exp-for and eseB-exp-rev (for eseB), eseD-exp-for and eseD-exp-rev (for eseD) 
escBD-exp-for and escBD-exp-rev (for escBD). The PCR product was digested with 
BamHI and HindIII (eseB) or BamHI and EcoRI (eseD) and cloned into corresponding 
sites in pETDuet-1 (Novagen, USA). The resulting plasmids were then digested with 
NdeI and XhoI and were introduced with NdeI and XhoI digested escBD PCR product 
that was amplified from the E. tarda wild type chromosome. 
To construct pACYCD-eseB and pACYC-eseD, EseB and EseD were removed from 
pETC-D and pETC-B (unpublished data) with NdeI and XhoI and cloned into 
corresponding site of pACYCDuet-1. 
IV.2.3 1D-PAGE, 2D-PAGE and Western analysis of proteins 
Protein samples were dissolved in the appropriate volume of protein denature buffer 
and boiled for 5 min. Proteins were separated immediately on 12% 1D-PAGE. For 
Western analysis, proteins were transferred to PVDF membrane with semi-dry system 
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and examined using the SuperSignal WestPico Chemiluminescent substrate as 
described in chapter II. EseB, EseC and EseD were detected by the addition of diluted 
anti-EseB (1:10, 000), anti-EseC (1:10, 000) and anti-EseD (1:5, 000) polyclonal 
antisera, respectively, followed by 1:5000 dilution of mouse anti-rabbit IgG HRP 
(Santa Cruz Biotechnology, USA). For detection of EscBD-FLAG, the anti-FLAG M2 
monoclonal antibody (Sigma, USA) was used at 1:2, 500. Protein isolation and 2D-
PAGE were performed as previously described (Srinivasa Rao et al., 2004). Proteins 
were identified with MALDI-TOF MS as described elsewhere (Li  et al., 2004). 
IV.2.4 Fractionation of bacterial cells 
Bacteria were fractionated as described by Neyt and Cornelis (1999) with slight 
modification. E. tarda cultured in DMEM was harvested by 10 min centrifugation at 5, 
000 × g at 4°C.  The ECPs were prepared by precipitation of the supernatant with TCA as 
described previously (chapter II). The bacterial pellet was resuspended in cold 10 mM 
Tris-HCl, pH 8.0 with 5 mM MgCl2, followed by sonication. The intact cells were 
pelleted by centrifugation at 10, 000 × g for 5 min. The supernatant was then centrifuged 
for 30 min at 100, 000 × g to separate the membrane fraction (insoluble fraction, pellet) 
from the cytosolic fraction (soluble fraction). The membrane fraction (pellet) was washed 
once with cold 10 mM Tris-HCl, pH 8.0 with 5 mM MgCl2 and dissolved in an 
appropriate volume of ReadyPrep reagent 3 for 1D-PAGE. 
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IV.2.5 β-galactosidase assays 
 E. tarda strains were grown in DMEM for 24 h at 25°C with 5% (v/v) CO2. β-
galactosidase activities were determined with cells permeabilized with SDS and 
chloroform as described by Miller (1972) and in chapter III. 
IV.2.6 Co-purification assay 
The ability of Ni2+-NTA column to bind 6His-EseB-EscBD and 6His-EseD-EscBD 
complex was determined following the product manual with slight modification (Qiagen, 
USA). Briefly, 6His-EseB and EscBD, and 6His-EseD and EscBD were expressed from 
plasmids pETB-D and pETD-D, respectively, with 0.5 mM IPTG. The bacterial pellets 
were resuspended in buffer containing 300 mM NaCl, 50 mM Tris (pH 8.0) and 10 mM 
β-mercaptoethanol supplemented with 20 mM imidazole, and lysed by sonication. The 
lysates were cleared by centrifugation and incubated at 4°C for 1 h with 50 μl Ni2+-NTA 
resin (Qiagen, USA) with gentle mixing. The suspensions were then poured into a 
column followed by 5 washes with buffer containing 300 mM NaCl, 50 mM Tris (pH 8.0) 
and 10 mM β-mercaptoethanol supplemented with 30 mM imidazole. Binded proteins 
were eluted with 50 μl buffer containing 300 mM NaCl, 50 mM Tris (pH 8.0) and 10 mM 
β-mercaptoethanol supplemented with 200 mM imidazole. The association study of 6His-
EseB, EseD and EscBD or 6His-EseD, EseB and EscBD was performed by transforming 
pACYC-eseD or pACYC-eseB into E. coli harboring pETD-D or pETD-B, respectively, 
followed by similar protocol for co-purification. 
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IV.3 Results 
IV.3.1 Orf2 is necessary for the secretion of EseB and EseD 
 Chaperones of TTSSs are usually located near their target proteins, and they are 
generally needed for the stabilization and secretion of effectors and translocon 
components. In an effort to characterize the chaperone for the translocon proteins EseB 
and EseD, we examined several candidate genes that are encoded in their vicinity and are 
inside the TTSS gene cluster of E. tarda PPD130/91. These include EscA, EscB, and 
EseE (Fig. IV. 1A). Three deletion mutants were constructed and autoaggregation of 
overnight E. tarda culture in DMEM was used as a quick assay to confirm the secretion 
of EseB. The previous results suggested that secreted EseB was required for the 
autoaggregation phenotype (Tan et al., 2005). Autoaggregation was not found for 
mutants ∆escA and ∆escB (Mo Z. L., and K. Y. Leung. unpublished data) as well as 
∆eseE, which suggest that these genes are not necessary for the secretion of EseB. We 
also analyzed Orf2, which was located immediately upstream of eseB (Fig. IV.1A). The 
homology search of Orf2 against NCBI Database did not retrieve any characterized 
homologs. However, the close proximity of orf2 with eseB suggests that Orf2 may be the 
chaperone for EseB. To investigate the role of orf2, an in-frame deletion mutant Δorf2 
was constructed. The resulting mutant removed an internal fragment of 318 bp, and 
contained the first 21 bp and the last 6 bp of the orf2 gene. The Δorf2 mutant did not 
show any autoaggregation phenotype after 24 h of culturing in DMEM. The results of 
2D-PAGE analysis revealed that EseB and EseD were absent in the ECPs of the Δorf2 
mutant (Fig. IV.1B and 1D). The secretion of EseC in the Δorf2 mutant was not affected, 
suggesting that Orf2 is specific for EseB and EseD but not EseC, and the TTSS-
 95
 96
dependent secretion is not blocked. Complementation of the Δorf2 mutant in trans with 
pSAorf2-FLAG restored the secretion of EseB and EseD in the supernatant and the 
autoagregation phenotype. We also investigated the secretion of EseB and EseD with the 
anti-EseB and anti-EseD. However, we could not detect these two proteins in the 
bacterial culture supernatant. These results suggest that Orf2 is essential for the secretion 
of EseB and EseD. On the other hand, the deletion mutant of ∆eseE led to the absence of 
EseC but not EseB and EseD in the ECPs (Fig. IV.1C), indicating that EseE is essential 
for the secretion of EseC instead of EseB or EseD. 
IV.3.2 Orf2 has chaperone features and is not secreted into culture 
 The typical features of TTSS chaperones include small in molecular weight and rich in 
alpha-helix structure (Bennett and Hughes, 2000; Cornelis and Van Gijsegem, 2000), and 
these characteristics were observed in Orf2. The predicted molecular weight of Orf2 was 
13 kDa, which was within the 10-15 kDa range of most known type III chaperones. It has 
an alpha-helical structure, and a stretch of N-terminal sequence has strong coiled-coils 
motif (Fig. IV.2). Thus, we renamed orf2 as escBD (chaperone for E. tarda secreted 
protein EseB and EseD). However, the predicted pI of EscBD was 7.3, which was near 
neutral and different from the predicted acidic pI of nearly all identified type III cytosolic 
chaperones and was also different from the basic pI of chaperone SseA from Salmonella 
SPI-2 TTSS (Zurawski and Stein, 2003). 
To localize EscBD in E. tarda, the ΔescBD mutant was complemented with pSAescBD-
FLAG and the secreted proteins were collected. After sonication, the soluble and 









     
 
Fig. IV.1.  (A). Schematic representation of eseBCD region of E. tarda.  Arrows represent each of the open reading frames. ese genes 
encoding secreted proteins or putative effectors of the TTSS are indicated by hatched arrows. Genes encoded apparatus (esa), 
chaperones (esc), and hypothetical protein (orf) are represented by checkered, black, and open arrows, respectively. orf2 was renamed 
as escBD. (B-D). Proteome analysis of E. tarda PPD130/91, ΔeseE and  ΔescBD mutants. ECPs fractions in DMEM were separated 
on Immobiline DryStrips (pH 3-10) combined with 2D-PAGE analysis (12.5% polyacrylamide). B. wild type; C. ΔeseE; D. Δorf2. 
ECPs were adjusted according to the relative secreted protein amount of each strain: wild type (10 µg), ΔeseE (5 µg), Δorf2 (5 µg). 
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Fig. IV.2.  Coiled-coil domains prediction of Orf2. The presence of coiled-coil domains 
in E. tarda EscBD was predicted by the COILS software and the prediction outputs are 
presented graphically. Predictions were made using three scanning windows, 14 (green), 
21 (blue) and 28 (red) residue windows. Scan ouputs shown were performed using a 









Fig. IV.3. Localization of EscBD. Western analysis with anti-FLAG M2 monoclonal 
antibody of the bacteria secreted proteins, bacterial insoluble fraction, and bacterial 
soluble fraction of ΔescBD and its complemented strain.   
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then analyzed by Western blotting with anti-FLAG antibody. As shown in Fig. IV.3, 
EscBD-FLAG was found in both the soluble (bacterial cytoplasm) and the insoluble 
fractions (bacterial membranes) but not in the ECPs. In contrast, no EscBD-FLAG was 
detected in the ΔescBD background (Fig. IV.3). These results suggest that EscBD is not a 
secreted protein but a protein localizes in the cytoplasm or on the bacterial membranes. 
IV.3.3 EscBD is required for the stability of both EseB and EseD in the cytoplasm  
To investigate if EscBD is required for the stability of EseB and EseD in the cytoplasm of 
E. tarda, the whole bacterial proteins of the wild type, ΔescBD mutant and its 
complemented strain were separated with 1D-PAGE and immunoblotted with either anti-
EseB, anti-EseC or anti-EseD antibody. Samples were loaded to represent the same 
number of bacteria for each strain. As shown in Fig. IV.4A, the amount of EseB and 
EseD were reduced in the ΔescBD background, while no difference was observed for 
EseC when comparing the wild type with the ΔescBD mutant. When complementation of 
pSAescBD-FLAG was introduced into the ΔescBD mutant, EseB and EseD were restored 
to nearly the same level as that of the wild type. Taken together, these results suggest that 
EscBD is required for the stability of EseB and EseD but not for EseC. We also used 2D-
PAGE to analyze the total bacterial proteins of the ΔescBD mutant and the wild type, and 
the results further confirmed the reduction of EseB and EseD in ΔescBD (Fig. IV.4B). 




















Fig. IV.4. EscBD affected the stability of EseB and EseD. 
A. Western analysis of total bacterial proteins from the same number of E. tarda wild 
type PPD130/91 and its mutants (3.3×106 CFU).  The Western blot was probed with anti-
EseB, anti-EseC or anti-EseD rabbit polyclonal antibody, and the last lane in each blot 
was the total proteins from eseB, eseC or eseD mutant, respectively, as a negative control. 
B. proteome analysis of  the total proteins from the E. tarda wild type PPD130/91 (a) and 
the ΔescBD mutant (b) grown in DMEM culture at 25°C. The total protein fraction was 
separated on an Immobiline DryStrip (pH 3-10) combined with 2D-PAGE analysis 
(12.5% polyacrylamide). Gels were silver stained. Identical amounts of protein were 






IV.3.4 EscBD is not required for the transcription of eseB and eseD  
Chaperone is generally for the stabilization of its target proteins. However, some 
chaperones also have regulation functions, such as SicA of S. enterica typhimurium 
(Darwin, 2000 and 2001). The influence of ΔescBD on EseB and EseD accumulation 
could also be explained if ΔescBD affected their transcription. To address whether the 
decrease of EseB and EseD accumulation was due to the transcription or not, we 
examined the effect of deletion mutation in escBD on EseB at the transcription and 
translation levels. pVIK112 is a transcriptional fusion suicide plasmid carrying lacZY and 
has been used to study the regulation of genes at the transcriptional level (Kalogeraki, 
1997). We cloned a 462-bp fragment of eseB and generated the plasmid pVIK212 in 
which eseB was in transcriptional fusion with lacZY. The plasmid was integrated by 
conjugation onto the chromosome of E. tarda wild type PPD130/91, ΔescBD and ΔesrC 
mutants, and created the strains of eseB::pVIK212, ΔescBD eseB::pVIK212 and ΔesrC 
eseB::pVIK212, respectively. The β-galactosidase activities were then examined. As 
shown in Fig. IV.5, strong β-galactosidase activities were detected in eseB::pVIK212, 
and nearly the same β-galactosidase activities were found in ΔescBD eseB::pVIK212. 
However, the β-galactosidase activities decreased significantly in ΔesrC eseB::pVIK212. 
These results further confirm the role of esrC as a transcriptional regulator (see Chapter 
III) and suggest that the deletion of escBD does not affect the transcription of eseB.  Thus, 
EscBD is not a transcriptional regulator as EsrC. In order to further address the role of 
escBD in the stabilization of EseB and EseD, pVIK111, which is a translational fusion 
suicide plasmid carrying lacZY (Kalogeraki, 1997) was used to construct the translational 












































Fig. IV.5. EscBD is not required for the transcription of eseB. Levels of the 
transcriptional and translational reporter fusions in different E. tarda genetic backgrounds 
were measured by assaying β-galactosidase activities in the bacterial cell lysates. The 
values represent the mean ± SD from one representative experiment performed with 
triplicate samples. Equivalent results were obtained at least in triplicates. 
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generated the plasmid pVIK211. The resulting plasmid was integrated by conjugation 
onto the chromosome of E. tarda wild type PPD130/91, ΔescBD and ΔesrC mutants, and 
created the strains of eseB::pVIK211, ΔescBD eseB::pVIK211 and ΔesrC eseB::pVIK211. 
The β-galactosidase activities in these strains were examined. As expected, the mutation 
of transcriptional regulator esrC decreased the level of EseB-LacZ fusion proteins in the 
bacteria, as the β-galactosidase in ΔesrC eseB::pVIK211 was reduced more than 6 times 
compared to that in eseB::pVIK211 (Fig. IV.4B). The decrease level of β-galactosidase in 
ΔescBD eseB::pVIK211 was also observed, demonstrating that a mutation of escBD 
affected the EseB-LacZ level in the bacteria. These results could be explained by that the 
deletion of escBD affected the stability of EseB in the cytoplasm, as ΔescBD did not 
affect the transcription of eseB. Together, these results suggest that EscBD is not required 
for the transcription of eseB and eseD, but enhances their stability in the cytoplasm. 
However, we still can not rule out the possibility that EscBD has a role in EseB 
translation. 
IV.3.5 EscBD interacts with both EseB and EseD 
To determine the interaction of EscBD with EseB, we co-expressed EseB and EscBD in 
pETDuet-1 plasmid. The resulting plasmid produced EseB with 6His-tag at the N-
terminal (6His-EseB) and EscBD in E. coli.  Lysates of E. coli expressing 6His-EseB and 
EscBD were incubated with Ni2+-NTA resins in column. The binding substrates were 
eluted and examined in Coomassie blue stained 1D-PAGE gel. As shown in Fig. IV.6A, 
co-expression of 6His-EseB with EscBD in E. coli led to two proteins retained on the 
column and they could be eluted together by using a high concentration (200 mM) of 
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Fig. IV.6. Association between 6His-EseB or 6His-EseD and EscBD. A. 1D-PAGE 
analysis (Coomassie blue staining) of the proteins bound to Ni2+-NTA resins incubated 
with the cleared extracts from E. coli  BL21(DE3) /pLysS expressing 6His-EseB plus 
EscBD, 6His-EseB, and EscBD, respectively.  B. 1D-PAGE analysis (Coomassie blue 
staining) of the proteins bound to Ni2+-NTA resin incubated with the cleared extracts 
from E. coli  BL21(DE3)/pLysS expressing 6His-EseD plus EscBD, 6His-EseD, and 
EscBD, respectively.  
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imidazole. The molecular weights of these two proteins on the 1D-PAGE were 
corresponding to 6His-EseB and EscBD, respectively, and the protein corresponding to 
EscBD was further confirmed with the MALDI-TOF MS. However, when lysates of E. 
coli expressing 6His-EseB alone were applied to the column, the band corresponding to 
EscBD was not observed from the eluted sample (Fig. IV.6A). In another control 
experiment, EscBD was not retained on a Ni2+-NTA column when lysates of E. coli 
expressing EscBD only was used (Fig. IV.6A). Thus, our results suggested that the 
EscBD specifically interact with EseB. 
The interaction of EseD and EscBD was also examined with similar assay. As shown in 
Fig. IV.6B, EscBD was co-purified with 6His-EseD when lysates of E. coli expressing 
6His-EseD together with EscBD were incubated with a Ni2+-NTA resins column (Fig. 
IV.6B). As a control, EscBD could not bind to Ni-NTA resins and flowed through the 
column (Fig. IV.6B), suggesting that EseD specifically interacts with EscBD. 
Collectively, the co-purification of EseB or EseD with EscBD, respectively, strongly 
supports the direct association of EseB or EseD with EscBD, which is consistent with the 
chaperone function of EseBD. 
IV.3.6 EscBD does not bind to EseB and EseD concurrently 
To investigate whether EscBD forms a complex with EseB and EseD concurrently, we 
transformed pACYC-eseD or pACYC-eseB into E. coli harboring pETB-D or pETD-D, 
respectively. The resulting E. coli produced either 6His-EseB, EseD and EscBD or 6His-
EseD, EseB and EscBD.  Proteins lysates from the E. coli were purified with Ni2+-NTA 
resins in column. Our results showed that although all the three protein expressed 
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Fig. IV.7. Association of EseB, EseD and EscBD. A. 1D-PAGE analysis (Coomassie 
blue staining) of the proteins bound to Ni2+-NTA resins incubated with the cleared 
extracts from E. coli  BL21(DE3)/pLysS overproducing 6His-EseB plus EseD and 
EscBD, 6His-EseD plus EseB and EscBD, respectively.  B. Western blot analysis of the 
proteins bound to Ni2+-NTA resin incubated with the cleared extracts from E. coli  
BL21(DE3)/pLysS expressing 6His-EseB plus EseD and EscBD, EseD alone, 6His-EseD 
plus EseB and EscBD, and EseB alone, respectively. 
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well in E. coli, only two of them could be co-purified with the Ni2+-NTA column.Two 
major protein bands corresponding to EscBD and 6His-EseB or 6His-EseD were visible 
in 1D-PAGE (Fig. IV.7A). Trace of EseD was detected with Western blot analysis from 
the elution binding substrates of 6His-EseB, EseD and EscBD (Fig. IV.7B). However, 
EseB was undetectable in the elution binding substrates when lysates containing 6His-
EseD, EseB and EscBD were applied to the column (Fig. IV.7B). As a control, EseB or 
EseD was not detected from the eluted binding substrates when lysates of E. coli 
expressing EseB or EseD alone were applied to the column (Fig IV.7B). These results 
suggest that EscBD could not properly bind to EseB and EseD concurrently and indicate 
that the function of EscBD is possibly to prevent the pre-mature interaction of EseB and 
EseD. 
IV.4 Discussion 
Like many other gram-negative pathogens, E. tarda appears to rely on a TTSS for their 
pathogenesis (Tan et al., 2005). Three major Ese proteins are secreted by this E. tarda 
TTSS. Of the three Ese protein, EseB was predicted to be a major component of the E. 
tarda TTSS translocon based on its similarity to EspA, and formed a translocon complex 
together with EseC and EseD on the bacterial cell surface (Tan et al. 2005). Supporting 
this hypothesis, co-immunoprecipitation experiment showed that EseB, EseC and EseD 
formed a complex after secretion (Tan, 2005). 
The secretion of TTSS translocon components is generally chaperone dependant. Up to 
now, various chaperones involved in the translocon component have been reported in 
EPEC, Salmonella and Shigella species. However, the secretion of EseB and EseD in E. 
 108
tarda is still unclear. We reported here the identification and further characterization of 
EscBD, a specific chaperone for EseB and EseD. EscBD shares most of the 
characteristics of typical TTSS chaperones, such as alpha-helical propensity, small size 
(< 20 kDa), and a carboxy-terminal amphipathic alpha-helical segment (Wattiau et al., 
1996; Bennett and Hughes, 2000). However, the predicted pI of EscBD is near neutral, 
which is different from most characterized acidic or basic type III chaperones (Wattiau et 
al., 1996; Bennett and Hughes, 2000; Page and Parsot, 2002). Chaperones with near 
neutral pI are not unprecedented. CesD in EPEC had a predict pI of 7.4 (Wainwright and 
Kaper, 1998). However, the association of neutral pI chaperones with their cognate 
proteins remains uncharacterized. Crystallization of the EscBD complex is needed to 
provide insights into the mechanism. Another atypical feature of EscBD is its location 
both on the membrane and inside the cytoplasm. Most of the characterized type III 
chaperones are found in the cytosol, and only a small number of chaperones have 
membrane associations. For example, CesD from EPEC and SseA from Salmonella were 
localized to both the cytoplasmic membrane and cytoplasm (Wainwright and Kaper, 1998; 
Zurawski and Stein, 2003). The mechanism of membrane localization of chaperones is 
unclear. However, cycles of chaperone membrane insertion and deinsertion may be a 
possible explanation for the dual location. The cytoplasmic chaperone CesT was 
demonstrated to recruit Tir and was co-localized to the EPEC inner membrane (Elliott et 
al., 1999; Thomas et al, 2005), and the ATPase of TTSS played critical roles in the 
chaperone release from and unfolding of the cognate secreted protein in an ATP-
dependent manner (Akeda and Galan, 2005). Thus, the membrane insertion may be the 
initial step for the reorganization of effector-chaperone complex with the TTSS ATPase. 
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TTSS chaperones have been divided into three classes: Class I, chaperones which 
associate with one or several effectors, typified by the Yersinia SycE chaperone that 
served a single substrate of YopE; Class II, chaperones which associated with 
translocators, typified by the Yersinia SycD protein, which was required for the proper 
secretion of two proteins of YopB and YopD; and Class III, chaperones of the flagellar 
export system, which was supposed to be the ancestor of the TTSS secretion system (for 
review, see Page and Parsot, 2002; Parsot et al., 2003). Chaperones from flagellar system 
participated in flagellar assembly and recognized the C-terminal domain of their 
substrates, and these C-terminal domains were proposed to form amphipathic helices that 
mediated interactions between the subunits in the flagellum (Fraser et al., 1999; Auvray 
et al., 2001). Despite the evidence of EscBD as a chaperone, this protein seems to possess 
features different from most of other chaperones. For example, the EscBD substrate of 
EseB is neither an effector nor a translocon pore, and EscBD could also be detected on 
the bacterial membrane. The characteristics of EscBD are reminiscent of SseA of 
Salmonella SPI-2. SseA interacted with C-terminal coiled-coils domain of SseB and was 
classified as Class III flagella chaperones (Zurawski and Stein, 2004).  Similarly, Coiled-
coils domains were predicted with COILS at the C-terminal of EseB and EseD (Tan, 
2005). EscBD may interact with EseB and EseD at their coiled-coils domains. Thus, 
EscBD seems more similar to SseA as for the classification. However, EscBD does not 
share sequence similarity with SseA. Its predicted coiled-coils domain is at the N-
terminal while that of SseA is at the C-terminal. Thus, the future study to delineate how 
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Bacterial pathogens use different protein secretion systems to delivery virulent factors to 
the culture milieu or into host cells. So far, five secretion systems have been 
characterized in gram-negative bacteria. Recently, a putative secretion system encoded by 
an IAHP cluster has been uncovered in several gram-negative bacterial pathogens and 
was defined as type VI secretion system in V. cholerae.  In E. tarda, a partial EVP gene 
cluster has also been implicated in the protein secretion. Here, we completed the EVP 
gene cluster sequencing and found that it was homologous to the IAHP clusters in other 
bacterial pathogens. We systematically mutagenized all the 15 EVP genes and identified 
one potential effector (EssA) and one secreted secretion apparatus protein (EvpI). The 
secretion of EssA was dependent on 13 EVP genes including evpC and evpI which 
encoded secreted proteins. In contrast, a mutation of essA did not affect the secretion of 
EvpC and EvpI. Thus, we proposed that the 13 proteins encoded by the EVP gene cluster 
function as apparatus components of the type VI secretion system of E. tarda. Of these 
13 apparatus component, we demonstrated that EvpO, a possible ATPase, interacted with 
three EVP proteins. Since the IAHP clusters are conserved among bacterial pathogens, 
our findings will shed significant insights into the secretion mechanism of type VI 
secretion systems in other bacteria, and provide an additional class of targets for vaccine 
and antimicrobial therapies. 
 112
V.1 Introduction 
E. tarda, a wide-host-range gram-negative bacterium, is the most commonly isolated 
member of the genus Edwardsiella.  This species has a broad host range including fresh 
mussels, fish, reptiles, seals, swines, and other vertebrates (Owens et al., 1974; Van 
Damme and Vandepitte, 1980; Goldstein, et al., 1981; Vandepitte et al., 1983; Cook and 
Tappe, 1985). It is the only species currently recognized to be pathogenic for humans in 
the genus Edwardsiella (Jordan and Hadley, 1969). In humans, E. tarda has been most 
often associated with sporadic cases of gastroenteritis (Jordan and Hadley, 1969; 
Bockemuhl et al., 1971). In some instances, it also causes extra-intestinal diseases, most 
commonly involving in cases of septicemia or bacteremia (Wilson et al., 1989). 
Pathogenesis of E. tarda is multi-factorial. Several potential virulence factors (Ullah and 
Arai, 1983; Janda et al., 1991b; Hirono et al., 1997; Ling et al., 2000; Srinivasa Rao et al., 
2001; Srinivasa Rao et al., 2003b) have been reported, including the proteins secreted by 
the TTSS and EVP gene clusters (Srinivasa Rao et al., 2005; Tan et al., 2005). 
ECPs or bacterial surface proteins play key roles in the interaction of bacteria with their 
environments or with other organisms.  Gram-negative bacteria often secrete ECPs for 
various functions, such as proteolysis, hemolysin, and cytotoxicity. They are often 
primary factors in the virulence of the bacteria in animals or plants. Protein secretion by 
gram-negative bacteria is a remarkably complicated biological process. Proteins must be 
transversed through the two membrane barriers, the inner membrane and the outer 
bacterial envelope, in order to be released into the extracellular environment. To 
accomplish this feat, the bacteria have evolved a variety of specialized multi-protein 
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secretion systems that can deliver polypeptides across both membranes. Although the 
secreted bacterial proteins are numerous and diverse, only a few pathways exist by which 
these proteins are transported from the bacterial cytoplasm to the extracellular space. 
Currently, there are five general types of secretion systems used by gram-negative 
bacteria for protein secretion (Hueck, 1998).  To secrete protein, all these systems have at 
least one integral inner membrane component that can be energized by ATP hydrolysis, 
which fuels the bioenergetically unfavorable secretion process. 
Using a comparative proteomics of secreted proteins from E. tarda wild type and TnphoA 
mutants, we found a partial EVP gene cluster in which some of the genes contributed to E. 
tarda PPD130/91 pathogenesis (Srinivasa Rao et al., 2004). The homologs of EVP 
proteins are widely distributed in many other animal and plant pathogens and symbiont 
such as Salmonella, Vibrio, Yersinia, Escherichia, Rhizobium, Edwardesiella, 
Agrobacterium, and Pseudomonas species with putative secretion functions (Folkesson et 
al., 2002; Moore et al., 2002; Srinivasa Rao et al., 2004; Pukatzki et al., 2006; Mougous 
et al., 2006). Mutation of EVP genes in E. tarda resulted in about 1 to 2 logs increase of 
the LD50s in our blue gourami host. Deletion of evpB led to the abolishment of EvpC 
secretion to the culture supernatant (Srinivasa Rao et al., 2004). In addition, the EVP-
related gene cluster in V. cholerae mediated cytotoxicity in phagocytic cells and was 
required for the secretion of at least four proteins lacking canonical hydrophobic amino-
terminal signal sequences (Pukatzki et al., 2006). In P. aeruginosa, the EVP-like cluster 
was required to secrete Hcp1 and contributed to the pathogenesis in cystic fibrosis 
patients (Mougous et al., 2006). Taken together, these investigations suggest that the 
EVP cluster and its homologs encode novel secretion systems, and thus were named as 
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the type VI secretion system (Pukatzki et al., 2006). Although the proteins encoded in 
these clusters are conserved, only few proteins shared low homology with proteins 
encoded by the type III or type IV secretion systems as reported in the EVP-like locus in 
Rhizobium (Bladergroen et al., 2003). Thus, the genes involved in assembling the type VI 
secretion system need to be defined and the mechanism by which proteins were secreted 
by this secretion system is awaited to be understood. 
Here, we identified the whole EVP gene cluster and carried out a systematic mutation of 
genes encoded in this cluster, and investigated their roles in the secretion of EvpC. We 
found that 12 genes were necessary for the secretion of EvpC. The investigation of the 
ECP protein profiles of these mutants led us to identify two other secreted proteins: EssA 
and EvpI. We found that both EvpC and EvpI were required for the secretion of EssA, 
but EssA was not necessary for the secretion of EvpC and EvpI. The yeast two-hybrid 
studies showed that EvpO but not EvpH interacted with three other components of the 
EVP gene cluster, suggesting that the EVP gene cluster encodes a complex secretory 
system and EvpO might be the scaffold of this type VI secretion system. 
V.2 Materials and Methods 
V.2.1 Bacterial strains and plasmids 
The bacterial strains and plasmids used in this study are shown in Table II.1 and Table 
V.1. E. tarda stains were grown in TSB or DMEM at 25°C without shaking, while E. coli 
strains were cultured in LB at 37°C. Cultivation of bacteria in DMEM was carried out at 
5% (v/v) CO2 atmosphere. Antibiotics were applied as described in chapter II when 
necessary. 
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Table V.1. Strains and plasmids used for this study 
 
Strain or plasmid Description Reference or source 
Bacteria     
E. tarda   
PPD130/91 Wild type, Kms, Colr, Amps, LD50=105.0 Ling et al., 2000 
essA essA::pRE112-essA Chlr  This study 
ΔevpA PPD130/91, in frame deletion of evpA This study 
ΔevpB PPD130/91, in frame deletion of evpB Srinivasa Rao et al., 2004 
ΔevpC PPD130/91, in frame deletion of evpC Srinivasa Rao et al., 2004 
ΔevpD PPD130/91, in frame deletion of evpD This study 
ΔevpE PPD130/91, in frame deletion of evpE This study 
ΔevpF PPD130/91, in frame deletion of evpF This study 
ΔevpG PPD130/91, in frame deletion of evpG This study 
ΔevpH PPD130/91, in frame deletion of evpH This study 
ΔevpI PPD130/91, in frame deletion of evpI This study 
ΔevpJ PPD130/91, in frame deletion of evpJ This study 
ΔevpK PPD130/91, in frame deletion of evpK This study 
ΔevpL PPD130/91, in frame deletion of evpL This study 
ΔevpM PPD130/91, in frame deletion of evpM This study 
ΔevpN PPD130/91, in frame deletion of evpN This study 
ΔevpO PPD130/91, in frame deletion of evpO This study 
ΔesrC PPD130/91, in frame deletion of esrC Chapter III 
E. coli   
JM109 Kms, Cols, Cms  Promega 
MC1061 (λpir) thi thr1 leu6 proA2 his4 argE2 lacY1 galK2 ara14 xyl5 supE44 
pir 
Rubirés et al., 1997 
SM10 (λpir) thi thr leu tonA lacY supE recA-RP4-2-Tc-Mu Kmr pir Rubirés et al., 1997 
   
Yeast   
AH109 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4D, 
gal80D, LYS2::GAL1UAS-GAL1TATA-HIS3, GAL2UAS-
GAL2TATA-ADE2, URA3::MEL1UAS-MEL1 TATA-lacZ 
Clontech 
   
Plasmid   
pGEM-T Easy Ampr Promega 
pRE112 pGP704 suicide plasmid, pir dependent, Chlr, oriT, oriV, sacB Edwards et al., 1998 
pACYC184 Tetr, Chlr Amersham 
pRW50 lacZ reporter vector, Tetr Lodge, et al., 1992 
pCX340 pBR322 derivative, cloning vector used to fuse EPEC effectors 
to the mature form of TEM-1 β-lactamase 
Charpentier et al., 2004 
pAS2-1 GAL4 (1–147) DNA-BD, TRP1, ampr, CYHs2, Clontech 
pACT2 GAL4 (768–881) AD, LEU2, ampr, HA epitope tag Clontech 
pTD1-1 SV40 large T-antigen (84–708) in pACT2, LEU2, ampr Clontech 
pVA3  murine p53 (72–390) in pAS2-1 TRP1, ampr Clontech 
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V.2.2 Yeast strain and plasmids 
 The yeast strain used in this study is Saccharomyces cerevisiae AH109 (Table V.1). The 
plasmids used for construction of fusion proteins and controls are listed in Table V.1. The 
yeast strain was grown in YPD medium (BD BioSciences, USA). Transformed AH109 
was maintained in Minimal SD Base with -Leu/-Trp DO supplement (BD BioSicences, 
USA).  
V.2.3 Library construction 
Lambda FIX®II/XhoI partial fill-in vector kit and Gigapack® III Plus-11 packaging 
extract kit were used for the construction of phage library containing E. tarda genome as 
described in chapter II.  
V.2.4 Plaque screening and Lambda DNA isolation 
Plaque screening with DIG (Digoxigenin) DNA labeling and detection kit and phage 
DNA isolation with QIAGEN Lambda Midi kit were performed as described in Chapter 
II. 
V.2.5 DNA sequencing 
BigDye Terminator version 3.1 Cycle Sequencing kit was used for sequencing PCR. 
DNA sequencing was carried out on a PRISMTM3100 automated DNA sequencer using 
the ABI PRISM BigDye terminator cycle sequencing kit as described in Chapter II. 
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V.2.6 Mutant construction 
 Non-polar deletion mutants of the EVP genes were generated by the sacB-based allelic 
exchange (Edwards et al., 1998). Mutants were verified by PCR. A defined insertion 
mutation of essA was constructed with suicide plasmid pRE112 (Edwards et al., 1998). 
Briefly, internal fragment of essA was amplified from E. tarda chromosome with primer 
pair of essA-for: 5’-TGGTACCATATCCTATGGGCTGCC-3’ and essA-rev: 5’- 
TGGTACCTTTAGGACTATCTCAA-3’ containing KpnI restriction enzyme sites (bold). 
Amplified fragment was ligated to pGEM-T Easy vector and transformed into E. coli 
JM109. The internal fragment was then recovered by KpnI and finally ligated to 
corresponding site in pRE112, and transformed into E. coli MC1061 λpir. The 
recombinant plasmid was isolated and transformed into E. coli SM10 λpir. The 
transformant was used to conjugate with the E. tarda wild type to obtain defined mutant 
by selecting Chlr and Colr colonies. The insertion of plasmid on the chromosome of the 
mutant was confirmed by PCR using appropriate primers.  Complementation of the EVP 
mutants was achieved by providing the related genes on the pACYC184-based plasmids.  
V.2.7 Edman N-terminal sequencing 
Proteins were blotted onto polyvinylidene difluoride (PVDF) membranes (Bio-Rad, 
USA). The membrane was then stained with 0.1% Coomassie in 50% (w/v) methanol for 
15 to 30 min, followed by destaining with 50% methanol (v/v) until the bands were 
observed. Protein spots were excised from the PVDF membranes and loaded onto the 
amino acid sequencing cartridge. The N-terminal sequencing was performed with a 
Procise model 494 pulsed-liquid-phase protein sequencer (Applied Biosystems, USA). 
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V.2.8 Generation of Polyclonal Antibodies 
Anti-EssA and anti-EvpC antibodies were raised in rabbits against keyhole limpet 
hemocyanin-conjugated peptides (EssA, KRNITLEQKGRGSNL; EvpC, 
IKLDKVDGESTDDK) by BioGenes (Berlin, Germany). The antibodies were affinity 
purified by using specific peptides as ligands.  
V.2.9 Protein Assay 
ECPs of E. tarda strains grown in DMEM were separated by 12% 1D-PAGE, followed 
by silver staining. Western blot was performed as described early (Chapter II). Both anti-
EssA and anti-EvpC were used at 1:5, 000. Anti-FLAG M2 monoclonal antibody (Sigma, 
USA) was used at 1:1, 000 to detect FLAG tagged proteins. 
V.2.10 Yeast two-hybrid analysis 
 The yeast two-hybrid fusions constructed were made by PCR amplification of target 
genes and cloning of the amplicon into bait (pAS2-1) and prey (pACT2) vectors. All 
fusion constructs were made as full length fusions, except the putative membrane 
proteins of EvpN and EvpO, for which the fusion constructs were made for each of their 
soluble domain (EvpN1-182, and EvpO444-1263). The resulting bait and prey plasmids were 
used to co-transform yeast strains AH109. The transformants were plated onto the 
Minimal SD Agar Base supplied with -Leu/-Trp DO supplement. The yeast colonies from 
these plates were spotted onto Minimal SD Agar Base plates supplied with -Ade/-His/-
Leu/-Trp DO supplement (BD Biosciences, USA) and X-α-Gal (100 μl 4 mg/ml for one 
15 cm plate) (Clontech, USA). 
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Table V.2. Oligonucleotides used in the preparation of probes for Southern blot analysis 
 
  Oligonucleotide used  
Gene  Primer pair Sequence (5' to 3') 
essA essA-probe-for TGGCGCGTTATGTCGATTT 
 essA-probe-rev AGTTGTGGCTACTGATATGC 
evpK evpK-probe-for GGGCTGCTGTTGCTGGAT 
 evpK-probe-rev TAACGTCAGGTAAAAGGC 
evpO evpO-probe-for GGATGCGATTTATTGGCT 
 evpO-probe-rev GGCGTTCTGCTGCTGGAT 
rorf1 rorf1-for TTTGGTAGGTCATCGGCA 
 rorf1-rev ATGTTGTCTCTCCCTCGGT 
rorfB evp-RFP-for CATGACCTGATAGTTCTC 
  evp-RFP-rev CTTCTTCTGTCCCGATGT 
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V.2.11 Virulence in fish 
Healthy naïve blue gourami (T. trichopterus Pallas) of approximately 14 g were obtained 
from a commercial fish farm and infected with E. tarda as described previously (Ling et 
al., 2000). The mortality of the fish was recorded over a period of seven days after 
infection. The LD50s were calculated by the method of Reed and Muench (Reed and 
Muench, 1938). 
V.2.12 β-galactosidase assays 
E. tarda were grown in DMEM overnight at 25°C. β-galactosidase activities were 
determined with cells permeabilized with SDS and chloroform as described by Miller 
(1972) and in chapter III. 
V.2.13 Southern hybridization  
Southern hybridization was performed according to the descriptions in chapter II. PCR 
products were used for the generation of probes with the primers shown in Table V.2. 
V.2.14 Bioinformatic tools 
DNA and protein sequences were analyzed by using databases from NCBI. 
Transmembrane domains and localization were analyzed with TMHMM and PSORT-B 
Prediction programs, respectively. InterProScan were used for the analysis of EvpO and 
its homologs domain architectures. The alignment of EvpO and its holomologs were 
generated by Vector NTI analysis software (InforMax, USA). 
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V.2.15 Nucleotide accession numbers 
The DNA sequences of E. tarda PPD130/91 evpH to evpO, and the flanking sequences of 
EVP gene cluster were deposited in GenBank under accession numbers # . 
V.3 Results 
V.3.1 Sequence analysis of EVP gene cluster 
 In the previous work, the EVP gene cluster was partially sequenced (GenBank accession 
no. AY424360) (Srinivasa Rao et al., 2004). To complete this cluster, a combination of 
genomics walking and phage library screening was carried out, and a fragment of 17.6 kb 
was sequenced including the full length of evpH (2610 bp). Bioinformatics analyses 
identified seven more ORFs encoded in the same direction as evpH, and were named as 
evpI, evpJ, evpK, evpL, evpM, evpN, and evpO, respectively (Fig. V.1). The deduced 
peptide sequence of one of these genes, evpO, displayed similarity to IcmF-associated 
proteins in the IAHP cluster found in many gram-negative proteobacteria (Das et al., 
2003). The results suggest that the EVP cluster is an IAHP cluster in E. tarda. Further 
analysis displayed that most of the EVP proteins were conserved compared to those in the 
IAHP clusters of other bacteria, including S. enterica serovar Typhimurium, P. 
aeruginosa, V. cholerae and R. leguminosarum, in which the IAHP clusters were reported 
to be involved in pathogensis and/or protein secretion (Table V.2) (Mougous et al. 2006). 
Conserved domain analysis revealed that the presence of uncharacterized highly 
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Fig. V.1. Genetics organization of the EVP gene cluster and its flanking ORFs. The corresponding G + C content (%) was analyzed by 
Vector NTI with windows size of 500. 
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Homologs involved in pathogenesis or protein secretion in other bacterial species (Identity/Similarity) 
Protein Name S. Typhimurium (LT2) P. aeruginosa (PAO1) HSI-1 V. cholerae R.. leguminosarum Conserved domain 
Eip19A(EssA) NA NA NA  NA NA 
EvpA SciH (39/65) PA0083 (40/64) VCA0107 (32/47) ImpB (46/63) DUF770 
EvpB SciI (49/65) PA0084 (50/66) VCA0108 (40/57) ImpC (56/71) DUF877 
EvpC SciM (27/45); SciK (35/54) Hcp1/PA0085 (29/48) VCA0017 (14/25) NA DUF796 
EvpD NA NA NA NA NA 
EvpE SciD (32/50) PA0087 (30/45) VCA0109 (22/34) NA DUF1316 
EvpF SciC (31/46) PA0088 (36/53) VCA0110 (30/43) ImpG (37/53) DUF879/COG3519 
EvpG SciB (32/50) PA0089 (34/49) VCA0111 (27/38) ImpH (29/46) DUF1305 
EvpH SciG/ClpB (39/57) ClpV/PA0090 (51/70) VCA0116 (45/59) NA ClpN/AAA//ClpA 




VCA0123 (18/27) NA VgrG/DUF586 
EvpJ NA PA0824 (13/19) NA NA NA 
EvpK SciA (25/41) PA0082 (26/43) VCA0119 (16/24) ImpA (26/45) COG3515 
EvpL SciN (13/25) PA0080 (16/24) VCA0113 (9/20) NA COG3521 
EvpM SicO (24/40) PA0079 (26/44) VCA0114 (22/36) ImpJ (26/45) DUF876 
EvpN SciP (28/40) PA0078 (10/17) VCA0115 (16/29) ImpK (28/43) COG3455 
EvpO SciS (27/41) PA0077 (28/43) VCA0120 (15/24) ImpL (29/47) 
IcmF/AmpE; DUF1215    
(C-terminal); MotB 
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Table V.3. EVP protein homologs in the IAHP clusters involved in protein secretion or virulence 
    NA, Not Available 
 
 
Of the seven new EVP proteins, EvpI and EvpJ are related to recombination hot spot 
elements (Rhs) based on the amino acid sequences similarity. EvpI is similar to many of 
Vrg proteins in other bacteria. EvpJ shows similarity to a series of hypothetical proteins 
and a stretch of its amino acids sequence is similar to Rhs-family proteins.  EvpL is 
similar to some lipoproteins. The blast against NCBI database revealed that the homologs 
of EvpL were present in the IAHP clusters in Burkholderia, Geobacter and Photorhabdus 
species. Although the blast analysis against NCBI databases did not retrieve any homolog 
in the IAHP cluster of Salmonella, Pseudomonas, Vibrio, and Rhizobium species, the 
corresponding proteins were shown to share the same conserved domain (COG3521) 
(Table V.3). 
Directly upstream of evpA, an ORF was predicted and it was separated from evpA by 251 
bp (Fig. V.1). Its derivative proteins is homologous to that encoded by eip19A (71% 
identity and 62% similarity) of E. ictaluri and MED222_19894 (69% identity and 79% 
similarity) of Vibrio sp. MED222. 
Several more ORFs flanking the EVP gene cluster were also sequenced (Fig. V.1), the 
homology search indicated that they were not associated with the IAHP clusters in other 
bacteria. The G + C content analysis did not display any differences between the EVP 
genes and their flanking ORFs (Fig. V.1), suggesting that the EVP gene cluster in E. 
tarda did not have the typical characteristics of a PAI.  However, the G + C content of 
eip19A was significantly lower than other EVP genes and flanking sequences (Fig. V.1), 
suggesting a possible horizontal gene transfer.  
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V.3.2 Systematic mutation of individual genes of the EVP secretion system 
Although the EVP gene cluster has been implicated in protein secretion, the roles of 
individual genes within the region have not been studied. Mutation of the genes in this 
cluster should be useful in defining the mechanism by which the EVP gene cluster affects 
E. tarda protein secretion. EvpC was the only secreted protein identified from the 
previous studies (Srinivasa Rao, et al., 2004). To address whether a dedicated export 
machinery for EvpC exists and to establish which genes are essential for the secretion of 
EvpC, we constructed 13 non-polar deletion (ΔevpA and ΔevpD-ΔevpO) (Table V.4), and 
analyzed the EvpC secretion in all the EVP mutants, including ΔevpB and ΔevpC from 
the previous study (Srinivasa Rao, et al 2004). All the mutants showed no defect in 
growth when cultured in TSB and DMEM media.  Supernatants from all exponentially 
growing E. tarda mutants (ΔevpA-ΔevpO) in DMEM culture were examined with 1D-
PAGE. Consistent with the previous report, the deletion of evpC led to the absence of 
EvpC from the supernatant and no EvpC was visible in ΔevpB culture supernatant (Fig. 
V.2; Srinivasa Rao et al., 2004). We also found that out of another 13 mutants, 11 of 
them (ΔevpA, ΔevpE-ΔEvpI, and ΔevpK-ΔevpO) showed deficiency in secretion of EvpC 
(Fig. V.2), and this secretion deficiency of EvpC in the EVP mutants was not due to a 
general defect in total protein export, because 1D-PAGE analysis of the supernatants 
from both the wild type and the EVP mutants cultures revealed nearly identical protein 
profiles except for EvpC and other two more unknown proteins (Fig. V.2). The secretion 
deficiency of EvpC in most EVP mutants was restored to nearly the wild type level after 
the introduction of a plasmid-borne wild type copy into the respective mutants (Table 









Length (aa) pI@ Codons deleted(aa) LD50† Complementation# 
WT - - - 5.0 - 
ΔevpA 171 5.3 4-156 6.9 N 
ΔevpB* 495 5.2 54-482 6.9 Y 
ΔevpC* 163 5.7 34-139 7.1 Y 
ΔevpD 407 8.4 75-395 5.0 ND 
ΔevpE 158 5.0 9-149 6.8 Y 
ΔevpF 614 6.4 47-565 6.8 Y 
ΔevpG 341 7.8 35-310 6.5 Y 
ΔevpH 861 5.6 10-860 6.9 N 
ΔevpI 661 6.7 15-644 ND Y 
ΔevpJ 119 11.8 19-99 ND ND 
ΔevpK 355 4.8 14-304 ND Y 
ΔevpL 235 7.0 35-228 ND Y 
ΔevpM 462 5.8 15-439 ND Y 
ΔevpN 216 4.9 12-186 ND Y 
ΔevpO 1263 9.5 13-1257 ND ND 
* Srinivasa Rao et al., 2004. 
@ Protein pI was predicted with Vector NTI. 
†  ND, not determined 
# For the complementation, ECP profiles were examined. ‘Y’ denotes complementation restore to the wild 
type ECP profile; ‘N’ denotes complementation did not restore to the wild type ECP profile. “ND” denotes 

















                     
 
 
Fig. V.2. Survey of the ECP profiles of E. tarda PPD130/91 and its EVP mutants.  Proteins from bacterial culture supernatant 
corresponding to the same number of bacteria grown in DMEM were analyzed by 12% 1D-PAGE and stained with silver. 
EseC
EvpI















































ΔevpH mutant. All these results demonstrate that at least 12 proteins (EvpA-EvpB, EvpE-
EvpI, and EvpK-EvpO) encoded in the EVP cluster are essential for the secretion of 
EvpC. However, the mutation of evpD and evpJ did not affect secretion of EvpC as well 
as the other two unknown proteins (Fig. V.2), suggesting that EvpD and EvpJ are not 
necessary for the secretion of EvpC and other secreted proteins of the EVP secretion 
system. The two new secreted proteins were characterized in the next secretion (V.3.3). 
Some of the EVP genes required for EvpC secretion have similar LD50s in a fish model 
infection (Table V.3), suggesting their possible roles as apparatus components.  
V.3.3 Identification of secreted proteins of the EVP secretion system  
Two more proteins besides EvpC were not secreted in the 13 mutants (all the ΔevpA-
ΔevpO mutants except ΔevpD and ΔevpJ) (Fig. V.2), indicating that these two proteins 
are also secreted through EVP secretion system. The two protein bands were excised 
from the gels and were subject to MALDI-TOF MS. They were identified as eip19A 
homolog and EvpI, respectively (Fig. V.3 and 4). We thus named eip19A homolog as 
essA (EVP secretion system secreted protein A) (Fig. V.1, Table V.3). To further confirm 
the MALDI-TOF results, an insertional mutant of essA was constructed. 1D-PAGE 
analysis showed that the secretion of EssA was abolished from the ECPs of essA cultured 
in DMEM (Fig. V.5). The deficiency in secretion was restored with a plasmid-borne wild 
type copy of essA (Fig. V.5). 
V.3.4 Identification of the start codon of essA 
The predicted molecular weight of EssA is higher than the E. tarda TTSS translocon 
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      1 MGLTSDSRLL SLSTPLGKDA LQVVQCRGEE AIADLYRFEL ELFSTDPALA  
    51 WQSLVGQAAA LRLALPNGQT RYWHGVIGRA AYRGAEQHGF AYYAELVPRL  
   101 AWLQHAQECQ IFQEKTVPQI IEAVLKARGI SDFRLSLSQR YAPREYCVQY  
   151 RESDLSFISR LMEEEGIFYW FEHSESRHVL VLADGNAAVQ PCKVRSDIVY  
   201 RPKHRSESGD DIQWWMPSLA VVPANVFLNA YTFEQPTAHL LTSSASVAKQ  
   251 GKLSDVAVYD FTDDYTQTRE GERRAKLKME GLEAMQARIE GGGRCRTLAP  
   301 GYGFSLQKHF RKDCNGDYLL LSVRHEIVNN LPWQEQEVNY QNHFICLPKS  
   351 LPYRTLSQTP RPVMHGVQTA VVTGPQGEEI HTDRHGRVKV HFHWDRLGTQ  
   401 DDKSSCWIRV AQGWAGLGWG GMQLPRVGQE VIVDFVDGNP DAPLITGRVY  
   451 NAHQTPPFKL PDNKTQSGIQ TRSTPNGNPE HFSLLRFEDK MGAEEVFMQA  
   501 ERDFRRRVKH DDELTVEHDR RVTIKNDCAE TVSEGNYLQS ITKGKHTRVI  
   551 EGDALTEVKS GNSTLQVNKG DHATTASAGS LHLKAGTAIT LSVGSNRIVI  
   601 DSGGVLIEGM NITVKGKQSI ALSGLSVAIT GTQSASLSSS AEAEVSSSVM  
   651 TSIKGGIVKI N 
 
 
Fig. V.3.  Identification of EvpI with MALDI-TOF MS. Matched peptides of predicted 






     1 MNRCFLQRSA NSLAYNNALK ATEKGWRVMS ILNSELDWSH VGSISTGPGT  
    51 VVSDAFNISY GLPTKELLPA GTALYKFNGF SSLARPPITD DTPLSPWWSP  
   101 VQPFRHDGGL QQRMLVAKLN GVSMREWGRL TSVIKENWSS LDHLLEIVLK  
   151 VPVYAWFGGF KGMSRIDNGM PSKRNITLEQ KGRGSNLPGG ATQFYIPNLT  
   201 VGHISSHNFS ALK 
 
 
Fig. V.4.  Identification of EssA with MALDI-TOF MS.  Matched peptides of predicted 










Fig. V.5. ECP profile of essA and its complemented strain. Lane 1 to 3 is ECPs isolated 
from E. tarda wild type, essA, and essA complemented strain, respectively. Proteins were 




 components EseB and EseD, (Tan et al., 2005). However, in the 1D-PAGE analysis, its 
molecular weight is lower than EseB and EseD (Fig. V.2 and Fig. V.5). Therefore, we 
considered the possibility that a second initiation condon was the actual start codon. 
Examination of the DNA sequence found another ATG 84 bp downstream of the first one 
(Fig. V.6). To determine the real start codon, EssA was blotted to a PVDF membrane and 
the amino-terminal sequence was determined. Six residues (SILNSE) derived from its 
amino-terminus were identical to those predicted for the EssA protein using the second 
start codon, except for the lack of the first methionine (Fig. V.6 and Table V.5). Western 
blot analysis of EssA in cytoplasm and bacterial culture supernatant showed identical 
molecular weight, confirming that no signal peptide was excised during its secretion as 
those observed in the type II and type IV secretion systems (Hueck, 1998). Amino-
terminus of EvpI and EvpC was also determined, and no peptides were cleaved off except 
for the lack of first methionie in EvpC (Table.V.6). 
V.3.5 Association of the EVP secreted proteins  
Although EvpI and EvpC themselves are secreted proteins, the mutation of evpC and evpI 
also led to the absence of EssA in the supernatant of bacteria culture (Fig. V.2), 
indicating that EvpC and EvpI are also required for the secretion of EssA. In contrast, the 
mutation of EssA did not affect the secretion of EvpC and EvpI (Fig. V.5), suggesting 
that these three secreted proteins may have different functions. To further gain insight of 
their functions, we used yeast two-hybrid to study their associations with EvpC as a bait. 
We found that EvpC could interact with EvpC (Fig. V.7), suggesting EvpC forms homo-
oligomer.  However, we could not identify the interactions of EvpC with EssA or EvpI, 
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                               Table V. 5. N-terminal sequencing results 
 






       1 Atgaataggtgttttttgcaaagatcggcgaattcactcgcctac 
        M  N  R  C  F  L  Q  R  S  A  N  S  L  A  Y  
     46 aataacgcgcttaaagctactgaaaaaggatggcgcgttAtgtcg 
        N  N  A  L  K  A  T  E  K  G  W  R  V  M  S  
     91 attttgaattcggagctggactggtcccatgtcgggagtatttct 
        I  L  N  S  E  L  D  W  S  H  V  G  S  I  S  
    136 acaggcccaggcaccgtcgtcagtgatgcatttaacatatcctat 
        T  G  P  G  T  V  V  S  D  A  F  N  I  S  Y  
    181 gggctgccgacgaaagagctgcttccggcgggaacagccttatac 
        G  L  P  T  K  E  L  L  P  A  G  T  A  L  Y  
    226 aaattcaatggatttagttcattggcaaggcccccgatcactgac 
        K  F  N  G  F  S  S  L  A  R  P  P  I  T  D  
    271 gataccccactgtctccctggtggagcccggtccagccattccgc 
        D  T  P  L  S  P  W  W  S  P  V  Q  P  F  R  
    316 cacgatggcggtctgcagcagcgtatgctggtcgctaagctaaac 
        H  D  G  G  L  Q  Q  R  M  L  V  A  K  L  N  
    361 ggcgtatcaatgagggagtggggacgactcacctctgtcatcaaa 
        G  V  S  M  R  E  W  G  R  L  T  S  V  I  K  
    406 gaaaactggagttctctcgaccatttacttgagatagtcctaaag 
        E  N  W  S  S  L  D  H  L  L  E  I  V  L  K  
    451 gttcccgtctatgcctggtttgggggatttaagggcatgtcgcgt 
        V  P  V  Y  A  W  F  G  G  F  K  G  M  S  R  
    496 attgataatggtatgccctctaaacgaaatatcacgctggaacaa 
        I  D  N  G  M  P  S  K  R  N  I  T  L  E  Q  
    541 aaaggcaggggatcgaacctccccggcggggccacacagttctat 
        K  G  R  G  S  N  L  P  G  G  A  T  Q  F  Y  
    586 attccaaacctgacggttgggcatatcagtagccacaacttttca 
        I  P  N  L  T  V  G  H  I  S  S  H  N  F  S  
    631 gccttgaaataa 642     
        A  L  K  *  
 
Fig. V.6. Illustration of the start codons of essA. The predicted start codon was shown in 
red, and actual start codon was shown in green and highlight with arrow under it. The 
stop codon of essA was indicated with “*”. 
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 respectively (Fig. V.7). 
V.3.6 Mutations of EVP genes led EvpC and EssA accumulation inside the bacteria 
To further investigate the mechanism of this secretion system, we tested whether the EVP 
secreted protein EssA or EvpC was expressed in these EVP mutants. We found that EvpC 
was still detected in the cell pellets of all the 15 mutants excluding ΔevpC (Fig. V.8), 
demonstrating that the synthesis of these proteins was not abrogated by the mutants and 
the absence of EvpC in the supernatant was due to the failure of secretion but not 
expression. The decreased level of EvpC in the pellet of the EVP mutants was not 
observed except in that of ΔevpA when compared to the wild type (Fig. V.8), indicating a 
lack of a feedback inhibitory mechanism seen in the flagellar system and the TTSS 
(Aldridge and Hughes, 2001). In contrast, in the E. tarda wild type, ΔevpD and ΔevpJ 
mutants, the levels of EvpC were lower than other EVP mutants (excluding ΔevpA) (Fig. 
V.8). These decreases could be explained by the fact that the mutation of EVP genes 
blocked the export of EvpC and lead to its accumulation inside the bacteria. The 
decreased expression level of EvpC in the ΔevpA mutant than that in the wild type could 
be due to that the deletion of DNA sequence in evpA affects the DNA structure and thus 
decreases the activities of the promoter upstream of evpA (Chapter II). 
Similar to EvpC, EssA was still detected in cell pellets of the 15 EVP mutants (Fig. V.8), 
demonstrating that the synthesis of EssA was not abrogated by the mutations. The 
decreased levels of EssA in the pellets of the wild type, ΔevpD, and ΔevpJ were also 
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Fig. V.7.  Illustration of the interactions among three EVP secreted proteins with a yeast 
two-hybrid system. Yeast strains harboring the indicated bait and prey yeast two-hybrid 
constructs were plated onto the 5-bromo-4-chloro-3-indolyl-α-D-galactoside indicator 
plates and allowed to develop at 30°C. A posive control (P) yeast harboring pTD1-1 and 
pVA3 plasmids, and a negative control (N) yeast harboring empty plasmida pACT2 and 

















































Fig. V.8. Expression of EssA and EvpC in the E. tarda wild type and its 15 mutants.  
Proteins corresponding to the same number of bacteria grown in DMEM were analyzed 
by 12% 1D-PAGE and Western blot with anti-EssA and anti-EvpC sera. 
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 V.3.7 Characteristics of EvpO and its homologs 
To gain insight on the function of EVP proteins, we analyzed the transmembrane 
domains and the localization of all EVP proteins in the bacterial cells. Of the 13 EVP 
proteins essential for EssA secretion, only EvpN and EvpO had the transmembrane 
domain (Table V.6). The localization prediction of the EVP proteins showed that EvpO 
was on the inner membrane, and EvpH was in the cytoplasm (Table V.3). The 
localization of other EVP protein was not successfully predicted (Table V.3). Since EvpO 
homologs were found in all the IAHP clusters, we speculated it must play an important 
role. To further investigate the function of EvpO in this secretion system, we generated a 
multiple sequence alignment based on the EvpO homologs from 14 bacterial pathogens 
bearing IAHP clusters. We found that a nucleotide triphosphate binding site (Walker A 
motif) (Walker et al., 1982) was conserved in all the EvpO homologs in IAHP clusters 
and IcmF from L. pneumophila (Purcell and Shuman, 1998; Vogel et al., 1998; Segal and 
Shuman, 1999) (Fig. V.9A). Domain architecture analysis also revealed a nucleotide 
triphosphate hydrolase domain in most of EvpO homologs from IAHP clusters, 
suggesting that these proteins may have the ATPase activities. In contrast to IcmF of L. 
pneumophila, the nucleotide triphosphate binding site is flanked by three transmembrane 
segments in most of the EvpO homologs in the IAHP clusters, and this stretch of amino 
acid sequences are predicted to facing the cytoplasm side (Fig. V.9B). The large 
periplasmic C-terminal domain of all the EvpO homologs following the third 
transmembrane domain contains a conserved domain of DUF1215 (Fig. V.9B), 
suggesting that it may be important for EvpO function.  
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         Table V.6. Characteristics of the EVP proteins and their predicted functions 
 
Name TM* Predicted location# Predicted fuction 
EssA - unkown effector? 
EvpA - unkown apparatus 
EvpB - unkown apparatus 
EvpC - unkown apparatus 
EvpD + unkown unknown 
EvpE - unkown apparatus 
EvpF - unkown apparatus 
EvpG - unkown apparatus 
EvpH - cytoplasmic apparatus 
EvpI - unkown apparatus 
EvpJ - unkown unknown 
EvpK - unkown apparatus 
EvpL - unkown apparatus 
EvpM - unkown apparatus 
EvpN + unkown apparatus 
EvpO + inner membrane apparatus 
 
*  Transmembrane was predicted with TMHMM program 
# Protein localization in the bacterial cells was predicted with PSORT-B.
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185 275190 200 210 220 230 240 250 260(185)
--VLPWFMLLGRPGSGKSALLAQSGLAAPLDLPHELNDGK--------ALVDWWYFDKAVILDISGQFVQPEASQE------URSUWNRMLEdwardsiella tarda EvpO (110)
IYDLPWYVIFGAPGSGKTTALTNSGLQFPLGDALGENAVKGIG---GTRNCNWWFADEAILIDTAGRYTTQDDLDGS-----SKAGWEGFLAgrobacterium tumefaciens str. C58 AGR_L_1062 (129)
-------MVIGPAGSGKTTLLREGFPSDIIYAPEGARGTEQR------LYLTPHVGKQAVIFDIDGTLCAPADADILHR-----RLWEHALEscherichia coli O157:H7 str. Sakai ECs0218 (1)
LREMPWYVIVGPPATGKTTALRQSGLNFPIDLTDDLQGVGGT------RNCDWFFSENAVLIDTAGRYVQQESQPDV-----DAAEWLGFLMesorhizobium loti mlr2349 (124)
LWQLPWYMVIGPAGSGKTTLLREGFPSDIIYAPEGARGTEQR------LYLTPHVGKQAVIFDIDGTLCAPADADILHR-----RLWEHALEscherichia coli O157:H7 EDL933 Z0250 (103)
--QLSFVVITGKNAQGKSALLKQSNMEEMPVFSEEHAKLYFN--------------QKGIIVELGENWLTNSKTLL----------LTT-LLegionella pneumophila  IcmF (25)
LYALPWYLVLGLENAGKTSLINRSGQNFVFSSVMRASGQKSEN----PYSFDWWIGDESVLIDPDGELLTQGNRSEENDGALERRLWLHFVVibrio cholerae VCA0120 (125)
LYRLPWYMVIGARNSGKSTLIKEGYKLTEISASERLHAEDAAD-----LRVRCWLGEQAVIIDPAGVLIEQPTTPIAGKASLNSRLWQSLLYersinia pestis YPO3603 (126)
LYELPWFMVVGSPGDGKTTALLNTGLQFPLAEQMEQTSRILTVPGGGTLHCDWWFTNEAVLIDTAGRYARHDDGGEASAAQRNAGEWQGFLSalmonella typhimurium STM0285 (185)
LYELPWYVIIGPPGSGKTTALMNSGLDFPLAAQMGAGAIRGVG---GTRNCDWWFTDEAVLLDTAGRYTTQDSHAQV-----DKAAWLGFLPseudomonas aeruginosa PA0077 (48)
RDALPWYLVIGRAGAGKTTALARARIASPLRRARHDASLAPT------EDCDWWCFDDAVVLDLAGRFAEPDATDD------DRRAWGALLBurkholderia thailandensis BTH_II0855 (110)
LYVLPWYLVIGESGSGKSTSLASARLPSPYTDSRRSADDAGT------RNCDWWFFEESVVLDTAGRYAVPVNGER------DRDEWQKLLGeobacter sulfurreducens GSU3166 (113)
LYTLPWFMIFGETASGKSTAVSHARLTSILSDAGPTKGIAST------RNCDWWFFERAVILDTAGRYAVPLESG-------DGDEWERFLdelta proteobacterium MldDRAFT_1482 (117)
LHVLPWYLLIGAPGSGKSTLLQSSGLEFPLKAHGTHAALEGVG---GTRNCDWWFADQAVFLDSAGRYTTQDSDAIA-----DAGAWHGFLXanthomonas oryzae pv. oryzae XOO3038 (127)
LYELPWYIVIGNPAAGKSTAVLNSGLQFPFADKGGAVIQGIGG----TRNCDWFFTTEGILLDTAGRYSVHEEDRR---------EWLGFLRalstonia solanacearum RRSL_01754 (117)











Fig. V.9. Characteristics of EvpO and its homologs.   (A) Alignment of EvpO with its homologs from the IAHP cluster in different 
bacterial pathogens. IcmF from L. pneumophila was included for comparasion. Underlined region indicates the Walker A motif. (B) 
Comparasion of the predicted domain organization of L. pneumophila IcmF and those of EvpO homologs from the IAHP clusters. Both 
IcmF and EvpO homologs in the IAHP clusters have the Walker A motif and DUF 1215 domain. However, the Walker A motif in EvpO 
homologs is flanked by three transmembrane domains (TM1 to TM3) (EvpO homolog from S. enterica serovar typhimurium has two 
more TMs at the N-terminus, and in P. aeruginosa and E. coli O157:H7 str. Sakai, EvpO homologs have only the TM3 domain). 
Proteins amino acid sequences in EvpO homologs predicted to face cytoplasm side are indicated with blue line, and those face periplasm 
are indicated with pink line. The primers for the yeast two-hybrid bait or prey construction of EvpO are indicated with arrows. 
ATP/GTP binding site (Walk A motif) 
IcmF 
TM1 TM2 TM3Walker A DUF1215




V.3.8 Components of the EVP secretion system interact 
Of the five secretion systems in gram-negative bacteria, three of them form protein 
complex to facilitate their functions. The observation that each of the 13 EVP proteins 
was required for EssA secretion indicates that these proteins work together to form 
apparatus complex. Since EvpO is a potential integral inner membrane ATPase and 
conserved in all the IAHP clusters, we speculate that EvpO may be the scaffold of this 
secretion system, and it may interact with one or several EVP proteins. To test this 
hypothesis, we performed a yeast two-hybrid screening by cloning EvpO444-1263 soluble 
domain into the bait vector to make in-frame fusion with the GAL4 DNA binding domain. 
All the EVP genes essential for EssA secretion including EvpN1-182  and EvpO444-1263 
soluble domains were cloned into the prey vectors to make in-frame fusions with GAL4 
activation domain. As seen in Fig. V.10, three positive interactions were identified 
between the EvpO444-1263 soluble domain and EvpA, EvpL and the EvpN1-182 soluble 
domain,  respectively.  The interaction of EvpO444-1263 with EvpL is stronger than with 
EvpA and EvpN1-182 as the yeast colonies having EvpO444-1263 and EvpL plasmids grew 
faster than those having EvpO444-1263 and EvpA or EvpN1-182, and was comparable to that 
of a positive control (Fig. V.10). These results indicate that EVP proteins interact 
reciprocally to form a secretory complex, and EvpO may be important for the complex 
assembly.  We also investigated the interaction of EvpH with other EVP proteins as ClpV, 
the homolog of EvpH in P. aeruginosa, was proposed to be the core component of the 
type VI secretion system.  In contrast to EvpO, we could not detect any interactions 
between EvpH with other EVP proteins, including EvpH itself, suggesting that EvpH 




















Fig. V.10.  Survey of the interactions of EvpO or EvpH with the other EVP proteins with a yeast two-hybrid system.  
Yeast strains harboring the indicated bait and prey yeast two-hybrid constructs were plated onto the 5-bromo-4-chloro-3-indolyl-α-D-
galactoside indicator plates and allowed to develop at 30°C. The EvpO constructs expressed the C-terminal nontransmembrane 
domain portion of the protein (amino acids 444-1263) and the EvpN constructs expressed the N-terminal nontransmembrane domain 
portion of the protein (amino acids 1-182). The other EVP proteins were expressed as full-length fusion proteins. A posive control (P) 
yeast harboring pTD1-1 and pVA3 plasmid and a negative control (N) yeast harboring the empty plasmid pAS2-1 and pACT2 were 
also shown.  







results support our genetics data that the EVP genes encode for the apparatus component 
of a novel secretion pathway that functions to directly secrete EssA. 
V.3.9 C-terminus is important for the secretion of EvpC and EssA 
To investigate the function of the EVP secretion system, we constructed the fusion 
proteins of EvpC or EssA with the FLAG tag in plasmid pACYC184. Both fusion 
proteins expressed well in E. tarda. However, we found that FLAG tag abolished the 
secretion of EvpC-FLAG in ΔevpC background (Fig. V.11A). EssA-FLAG was 
detectable in both the cell culture and the culture supernatant of essA mutant, and no 
difference was observed in the amount of EssA or EssA-FLAG in the supernatant from 
identical number of bacteria expressing the wild type copy or FLAG-tagged EssA (Fig. 
V.11B). We also took advantage of TEM-1 β-lactamase in plasmid pCX340 (Charpentier 
and Oswald, 2004), which has been successfully used in studying the translocations of 
TTSS effectors (Charpentier and Oswald, 2004; Dahan et al., 2005; Kelly et al., 2006). 
To examine whether the β-lactamase interferes with EssA secretion, we constructed a C-
terminally tagged version of the complete EssA protein. As shown in Fig. V.11C, 
although the EssA-TEM protein was expressed in essA, we could not detect it in the 
ECPs. To further address the roles of C-terminal on their secretion, we constructed 
truncated EvpC and EssA, and expressed them in ΔevpC or essA mutant, respectively. 
We found that both the truncated EvpCΔ20 and EvpCΔ30 could not be secreted in the 
ΔevpC background, but they could be detected in the cell pellet (Fig. V.11D). 
Interestingly, we found that EvpC Δ20 has higher molecular weight than that of the wild 
type copy (Fig. V.11D). In contrast to EvpCΔ20 and EvpCΔ30, EssA 
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Fig. V.11. The role of C-terminus for the secretion of EvpC and EssA.  FLAG-tag 
abolished EvpC secretion (A) but did not affect the secretion of EssA (B). However, 
TEM-1 tagged EssA could not be secreted (C). EvpC could not be secreted after deleted 
the C-terminal sequences (C). The deletion of EssA C-terminal sequences decreased its 
secretion. 
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could still be secreted after deleting 15 amino acid from C-terminus, but the amount 
decrease significantly compared to that of the wild type protein (Fig. V.11C). Further 
deletions of EssA (EssAΔ30) were not successful because their expressions in the cell 
pellet were not detected. 
 V.3.10 EssA is under the regulation of EsrC  
The EVP cluster was regulated by the TTSS regulator, EsrC, and a promoter upstream of 
evpA has been identified (Chapter II). essA is possibly transcripted in separated operon.  
To find out whether EsrC regulates essA, plasmid pRWessA carrying lacZ transcriptional 
fusion to the upstream of essA was constructed with the low-copy plasmid pRW50. The 
constructed plasmid was introduced into the E. tarda wild type and ΔesrC mutant. High 
β-galactosidase activities were detected in the wild type containing pRWessA, confirming 
the presence of a promoter in front of essA (Fig. V.12). In contrast, the β-galactosidase 
activities decrease significantly in the ΔesrC mutant, indicating the regulation of essA by 
EsrC (Fig. V.12). 
V.3.11 essA contributes to the virulence of E. tarda 
The disruption of essA in E. tarda did not affect the secretion of other EVP secreted 
proteins such as EvpC and EvpI, suggesting that they may have different function in the 
infection process. To test whether essA is involved in the pathogenesis of E. tarda, we 
infected fish with the same dosage (4.5 × 106 CFU) of the E. tarda wild type and essA 
mutant. We found that essA had severely decreased the virulence in blue gourami fish. 





























Fig. V.12. Effect of ΔesrC on the expression of essA. 
The transcriptional levels of the reporter gene fusion in the E. tarda wild type and ΔesrC 
mutant were measured by assaying β-galactosidase activities in bacterial cell lysates. The 
values represent the mean ± SD from one representative experiment performed with 




























Fig. V.13. Survival of the blue gourami fish after intramuscularly injection of the E. 
tarda wild type, essA mutant and its complemented strain (essA + essA), respectively. 
Groups of ten fish were injected separately with different strains at a dosage of 4.5×106 
CFU. Surviving fish were recorded in a period of seven days. Identical results were 
obtained in two separate experiments. 
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(Fig. V.13). However, the essA exhibited lower virulence and 90% fish injected with the 
insertional mutant of essA survived (Fig. V.13). The introduction of a wild type copy of 
essA complemented the virulence of a essA mutant to the same magnitude as that of the 
wild type (Fig. V.13). Taken together, these results suggest that essA contributes to the 
pathogenesis of E. tarda. 
V.3.12 Distribution of EVP genes in E. tarda strains 
To determine the prevalence of these genes in other E. tarda strains, Southern analyses 
were performed by using probes from essA, evpK and evpO, and from their flanking 
genes of rorf1 and rorfB. Six virulent strains and 6 avirulent strains were used for this 
study. Positive hybridization was observed in all the strains for the probes of rorfB and 
rorf1, but the restriction patterns of hybridization were different between virulent and 
avirulent strains (Table V.7; Fig. V.14D and E). These results suggest that the flanking 
genes of the EVP gene cluster are prevalent in all the E. tarda strains including the 
virulent and avirulent strains. In contrast to these results, positive hybridizations were 
only observed in the virulent strains for the probes of essA, evpK, and evpO, and the 
restriction pattern of the hybridizing bands was the same in all the positive strains, 
respectively, suggesting that the genes from the EVP gene cluster are distributed in all the 
E. tarda virulent strains and the sequences of the EVP genes in different strains are very 
conserved (Table V.7; Fig. V.14A, B and C). Therefore, we conclude that the EVP genes 
identified in E. tarda PPD130/91 are broadly distributed among various virulent strains. 
V.4 Discussion 
The EVP gene cluster was implicated in protein secretion and contributed to the 
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Table V.7. Distribution of the EVP genes and it flanking ORFs in different E. tarda 
strains 
 
EVP ORFs  Flanking ORFs Strain virulence/avirulence
essA evpK evpO  rorfB rorf1 
Resources 
PPD130/91 Virulence  +  +  +   +  + AVA, Singapore 
AL 93/79 Virulence  +  +  +   +  + AVA, Singapore 
E381 Virulence  +  +  +   +  + Niigata, Japan 
NE8003 Virulence  +  +  +   +  + Nagasaki, Japan 
NUF251 Virulence  +  +  +   +  + Nagasaki, Japan 
SU226 Virulence  +  +  +   +  + Shizuoka, Japan 
PPD76/87 Avirulence  -  -  -   +  ± AVA, Singapore 
PPD125/87 Avirulence  -  -  -   +  ± AVA, Singapore 
PPD129/87 Avirulence  -  -  -   +  ± AVA, Singapore 
PPD453/86 Avirulence  -  -  -   +  ± AVA, Singapore 
PPD499/84 Avirulence  -  -  -   +  ± AVA, Singapore 
ATCC15947T Avirulence  -  -  -   +  ± AVA, Singapore 
 





































Fig. V.14. Distribution of the EVP genes and their flanking ORFs among the 12 virulent 
and avirulent E. tarda strains. Southern hybridization was performed with different genes 
as probes. Lane 1 to 12 are genomic DNA from PPD130/91; AL 93/79; E381; NE8003; 
NUF251; SU226; PPD76/87; PPD125/87; PPD129/87; PPD453/86; PPD499/84; and 
ATCC15947T, respectively. A. Probe from essA; B, Probe from evpK; C, Probe from 




pathogenesis of E. tarda (Srinivasa Rao et al., 2004). However, only partial sequence of 
the whole gene cluster has been revealed in the previous study. Here, we have completed 
the sequence of the EVP cluster. Our results revealed that the EvpO protein was highly 
similar to a number of IcmF related proteins, and further analysis showed that the EVP 
gene cluster was a member of the IAHP clusters defined by Das and Chaudhuri (2003). 
The previously study showed that IAHP clusters encoded a novel secretion machinery 
(Srinivasa Rao, et al., 2004; Pukatzki et al., 2006; Mougous et al., 2006). However, the 
functions of individual genes within these clusters remain unclear. To gain a 
comprehensive understanding on the functions of IAHP clusters, we undertook a 
systematic approach by generating a full set of deletion mutants for all the 15 EVP genes 
in E. tarda, and characterized the roles of these mutants in protein secretion and 
expression. Our results showed that the deletion of 12 conserved genes in the EVP gene 
cluster led to the absence of EvpC in the culture supernatant, but EvpC were detected in 
all cell pellets (Fig. V.2 and Fig. V.8). The inability to secrete EvpC in these mutants 
suggests that they may function as apparatus component for the secretion of EvpC. 
Furthermore, most of the 12 proteins are conserved in the IAHP clusters among different 
bacteria, demonstrating the essential role of these proteins for the type VI secretion 
system.  
In addition, our analyses of ECPs profile led us to identify two more secreted proteins, 
namely EvpI and EssA. EvpI is homologous to VrgG which is presented in a variety of 
bacteria. The vgrG gene is a component of multicopy rearrangement hot-spot elements 
described in E. coli (Lin et al., 1984) and other gram-negative bacteria (Wilderman et al., 
2001). The predicted features of VgrG are associated with ligand-binding proteins found 
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either on the cell surface or extracellularly (Wang et al., 1998). Here, our results 
indicated that EvpI was not only a secreted protein but also a protein essential for the 
secretion of other proteins such as EssA and EvpC. The roles of EvpC and EvpI for EssA 
secretion suggest that they are essential secretion apparatus element of this novel 
secretion system. EvpC and EvpI may form a secreted “translocon” (Goure et al., 2005) 
that is assembled in the targeting cells membranes to secrete or to translocate EssA. 
Indeed, Hcp1, the homolog of EvpC in P. aeruginosa, forms hexamer complex after 
secretion (Mougous et al., 2006). In accordance with these results, we observed that 
EvpC formed oligmer in a yeast two-hybrid system. However, we could not observe the 
interaction between EvpC and EvpI. These could be because that there is some other 
intermediate protein(s) which has not been identified yet. Taken together, our results 
showed that at least 13 genes encoded in the EVP gene cluster were essential for the 
secretion function of this secretion system, and thus we predict that these proteins and 
their homologs in other IHAP clusters function as apparatus of the type VI secretion 
system (Table V.6). 
Currently, there are five general types of transporters used by gram-negative bacteria for 
protein secretion (Hueck, 1998). These transporter components of the secretion apparatus, 
to a certain extent, shared functional properties. To drive protein transfer, all these 
systems have at least one integral inner membrane component that can be energized by 
ATP hydrolysis. Although EvpH is a possible ATPase as the homologs in Salmonella and 
EPEC displayed ATP hydrolysis activities (Schlieker et al., 2005), bioinformatics 
analysis did not show any transmemberane domain (Table V.6). Another important 
protein encoded in the EVP gene cluster was EvpO, which may also have ATPase 
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activity as a Walker A motif was observed in EvpO and its homologs in the other IAHP 
clusters (Fig. V.9). Protein families with such motif in gram-negative bacteria include the 
ABC transporters (Higgins, et al., 1990) and the bacterial type II secretion system protein 
E (Hobbs and Mattick, 1999) which provide energy for the protein secretion. Furthermore, 
most of EvpO homologs from IAHP clusters shared at least three strong transmembrane 
domains and were predicted to be located on the inner membrane (Fig. V.9 and Table 
V.6). Therefore, it is possible that EvpO serve as an inner membrane scaffold upon which 
other components of the EVP secretion system are assembled. To support this idea, three 
EVP proteins were observed to interact with EvpO (Fig. V.10). These specific yeast two-
hybrid interactions and the operon organization of the EVP gene cluster strongly suggest 
that the EVP proteins interact to form a secretory complex. It is possible that the bacterial 
pathogens use this complex to translocate effector protein(s) into the host cells. EssA may 
be such an effector protein for this secretion system as it contributed to the virulence of E. 
tarda, and the essA mutant did not affect any other proteins secretion as those observed 
for ΔevpI and ΔevpC. Furthermore, EssA is not conserved in different bacterial pathogens 
which characteristics were observed in the TTSS effectors (Hueck, 1998).  Thus, this 
secretion system could be energized via EvpO and translocates EssA all the way through 
the complex to the extracellular milieu or the host cells.  
The AAA+ family protein EvpH may be another ATPase to provide energy during the 
secretion process. Multiple ATPases were observed in other secretion systems. In A. 
tumefaciens type IV secretion system, at least three ATPases (VirD4, VirB11 and VirB4) 
energize the substrate translocation (Atmakuri et al., 2004). Similarly, EvpH and EvpO 
may act in concert to provide energy for the secretion of substrate(s). The requirement of 
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EvpH for substrate secretion suggests it is a core component as that observed for ClpV in 
P. aeruginosa (Mougous et al., 2006). However, different from ClpV in Salmonella and 
EPEC (Schlieker et al., 2005), the oligomerization of EvpH was not observed in E. tarda 
(Fig. V.10). This could be because the oligomerization required a strict environment 
(Schlieker et al., 2005) which the yeast cells could not provide. 
The mechanisms by which proteins destined to travel through the type VI secretion 
systems are not understood. The N-terminal sequencing confirmed that there was no 
excise of peptides from EssA, EvpC and EvpI during their secretion (Table V.5), 
suggesting that it has a different secretion mechanism from those of type II and Type V 
secretion systems, whose substrates will be cleaved off the N-terminal secretion signal 
sequences (Henderson et al., 1998; Hueck, 1998; Henderson et al., 2004). The mature 
forms of EssA, and EvpC lack the first methionine (Table V.5), much like Tir of EPEC 
TTSS (Kenny et al., 1997) and SopE (Wood et al., 1996) of Salmonella TTSS. In 
Salmonella, the cleavage of N-formyl-methionine is a common modification (Miller et al., 
1987). In EPEC, the cleavage of the first methionine of Tir was not essential for both the 
secretion and translocation of Tir (Kenny et al., 1997). A similar N-terminal methionine-
specific peptidase may be involved in the cleavage of the first methionine of the EVP 
secreted proteins.  Accordingly, EssA, EvpC as well as EvpI, are secreted without the 
processing of a typical N-terminal signal peptide.  Interestingly, we found that the FLAG 
tag affected the secretion of EvpC but not EssA (Fig. V.11A and B). The secretion of 
EssA was abolished when a TEM-1 fused to the C-teminal of EssA (Fig. V.11C). Further 
investigation showed that the deletion of C-terminal peptides of both EvpC and EssA 
affected their secretions (Fig. V.11D and E). Taken together, these results suggest the 
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secretion signals of the EVP secreted proteins may be different from those of the TTSSs.  
The different effects of the FLAG tags on the secretion of EvpC and EssA suggest that 
the secretion signal is probably not included in the sequences of C-terminus. The possible 
explanation is that FLAG tags may differently affect the folding of EvpC and EssA, and 
the EVP secretion system might recognize the corrected folding of their secretion 
proteins rather than the amino acid sequences. However, the truncation experiment could 
not give the explanation. Further site-directed mutagenesis experiments are needed to test 
whether the corrected folding of the secreted proteins is important for their secretion. 
In conclusion, we have characterized the essential components of a novel secretion 
system, and our data clearly showed that the EVP cluster formed a secretory complex to 
secrete virulence factors. Since many gram-negative bacterial pathogens carry EVP gene 
clusters, we predict that the homologs of EVP proteins in other bacterial pathogens may 
also function as secretion apparatus. The characterization of this novel secretion system 






Chapter VI. General conclusions and future directions 
VI.1 General conclusions 
E. tarda is a ubiquitous organism with a broad host range and can cause diseases in both 
humans and animals. Pathogenesis of E. tarda is multi-factorial. Previous investigation 
identified two gene clusters, namely TTSS and EVP, which were found to contribute to its 
pathogenesis (Tan et al., 2005; Srinivasa Rao et al., 2004). With comparative proteomics, 
a two-component system EsrA-EsrB was shown to control the expression of these two 
gene clusters. 
In the present study, we initially aimed to further characterize the regulation of the TTSS. 
The analysis of genes encoded in E. tarda TTSS found an AraC family protein, EsrC, 
which showed similarity to a large number of transcriptional regulators of the TTSS in 
other bacteria. A deletion of esrC was constructed and the deletion mutant increased the 
LD50s in blue gourami fish, reduced ECPs production and failed to aggregate. 
Complementation of ΔesrC restored these three phenotypes. 2D-PAGE showed that EsrC 
regulated the expression of secreted proteins encoded by the TTSS (such as EseB and 
EseD) and the EVP (EvpC) gene clusters. The regulation of EsrC on EseD was shown on 
the transcription level using RT-PCR anlysis. Using a promoterless plasmid, we found 
that the expression of esrC required a functional two-component system of EsrA-EsrB. 
EsrC in turn regulated the expression of selected genes encoded in the TTSS, such as the 
transcriptional unit of orf29and orf30, but not esaC, while esaC was directly controlled by 
EsrA-EsrB. Interestingly, orf29 and orf30 were also directly regulated by EsrA-EsrB two-
component secretion system. Genes in the EVP gene cluster were regulated at the 
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transcriptional level by EsrC, and a promoter was identified upstream of evpA. The 
regulation of EsrC on the EVP cluster was probable directly as recombinant EsrC can 
drive evpA-lacZ expression in E. coli. Thus, our conclusion is that EsrC is a 
transcriptional regulator which controls the expression of the TTSS selected proteins and 
the EVP gene cluster. 
To further study the regulation of E. tarda TTSS, we investigated the function of Orf2, a 
hypothetical protein encoded upstream of eseB. Orf2 has the typical characteristics of a 
TTSS chaperone. It is a 13 KDa small protein, located next to the tranlocators, and has a 
coiled-coil structure at the N-terminal region. An in-frame deletion of orf2 abolished the 
secretion of EseB and EseD but not EseC. Complementation of Δorf2 restored the export 
of EseB and EseD into the culture supernatant. Further studies showed that Orf2 was not a 
secreted protein and it was located both on the membrane and within the cytoplasm. 
Mutation of orf2 did not affect the transcription of eseB but reduced the amount of 
translational fusion protein EseB-LacZ in E. tarda, suggesting that Orf2 is not a regulator 
but a chaperone for the E. tarda TTSS translocon components EseB and EseD, and thus 
was named as EscBD. Co-purification studies demonstrated that EscBD formed 
complexes with EseB and EseD, respectively. EscBD could not properly bind to EseB and 
EseD concurrently. Collectively, these results demonstrate that EscBD functions as a 
TTSS chaperone for the translocon components EseB and EseD in E. tarda. 
The finding that EsrC regulated the EVP gene cluster led us to investigate the function of 
the EVP gene cluster. First, we constructed a phage library and the Lambda DNA 
containing the EVP gene cluster was isolated. The whole EVP gene cluster and its 
flanking genes were sequenced. We found 16 genes in the completed EVP gene cluster. 
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Bioinformatics analysis showed that proteins encoded in this cluster are homologous to 
proteins in the IAHP clusters in other bacterial pathogens.  
Many virulence factors are secreted through secretion systems. The IAHP cluster in 
several bacterial pathogens has been implicated in the proteins secretion and was named 
as a type VI secretion system in V. cholerae (Pukatzki et al., 2006). However, the 
individual genes for this novel secretion system have not been defined. In this study, we 
systematically mutagenized all the 16 genes in the EVP gene cluster and analyzed the 
ECP protein profiles of these mutants. We identified one potential effector (EssA) and one 
secreted secretion apparatus protein (EvpI) inside the EVP cluster which were absent from 
some of the EVP mutants. Our characterization showed that the secretion of EssA 
depended on 13 EVP genes including evpC and evpI. In contrast, mutation of essA did not 
affect the secretion of EvpC and EvpI. Thus, we successfully identified 13 proteins 
encoded by the EVP gene cluster that were required for the secretion of EssA. We 
predicted their functions as apparatus components of the type VI secretion system of E. 
tarda. Of these 13 apparatus components, we found two possible ATPases, namely EvpO 
and EvpH, and we demonstrated that EvpO, but not EvpH, interacted with three EVP 
proteins. Different from IcmF of L. pneunophila, we showed that most of the EvpO 
homologs in the IAHP clusters of the 14 bacterial pathogens possessed at least three 
transmembrane domains. Since only EvpO is predicted to be localized on the inner 
membrane, we propose that EvpO is the scaffold protein for the type VI secretion system. 
EssA was under the regulation of EsrC and a promoter was identified upstream of essA. 
EssA was not found in most bacteria carrying the IAHP clusters when comparing other 
known proteins in NCBI database, and it was shown to contribute to the pathogenesis of E. 
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tarda, suggesting that it may be a virulent “effector” of the type VI secretion system 
which needs further study.   
This research study has yielded significant insights into the understanding of E. tarda 
pathogenesis. The characterization of type III or type VI secretion systems will help in 
developing suitable diagnostics for the prevention and treatment of infection diseases in 
both E. tarda and the other gram-negative bacterial pathogens. 
VI.2 Future directions 
E. tarda is a relatively new emerging pathogen, and its virulence factors are less 
understood. Previous studies identified two important virulence mechanisms that were 
related to protein secretion, namely the TTSS and the EVP gene clusters. In the present 
study, we characterized many virulence factors in these two secretion systems. Our 
finding demonstrated that a novel secretion system was encoded by the EVP gene cluster 
and there was a cross-talk between the EVP secretion system and the TTSS in E. tarda. 
There are more works needed to be done to understand these two secretion systems. 
Therefore, our future work will focus on the followings: 
1. To investigate the translocation of Orf29 and Orf30 into the EPC cells or fish 
macrophage cells by fusing the N-terminal sequences to a reporter gene (such as β-
lactamase or CyaA). 
2. To characterize the gene(s) in mutant 306 by the combination of genomic walking 
and phage library screening, and examine how this gene regulates the TTSS and 
EVP secretion system. 
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3. To identify protein encoded in the PST operon that controls the TTSS and EVP by 
systematical deletion of individual gene in this operon. phoB and phoR genes are 
needed to be identified using degenerate primers, and examine whether the 
identified PST protein regulates the TTSS and EVP through PhoB. 
4. To map the binding domains of EseB and EseD that interact EscBD for 
comparisons with other defined chaperone families. 
5. To confirm the translocation of EssA with Western blot and examine the location 
and the binding partner of EssA after translocation. 
6. To investigate the secretion or translocation signal of EssA using site-directed 
mutagenesis. 
7. To confirm the ATPase activities of EvpO and determine whether ATPase 
activities are involved in the protein secretion. 
8. To map the binding domains of EvpO interacting with its partners of EvpA, EvpL 
and EvpN.  
9. To identify the binding partner(s) of EvpI by using co-immunoprecipitation or 
using a yeast two-hybrid system, and examine their roles in the EssA translocation. 
10. To investigate the secretion mechanism of the type VI secretion system in E. tarda 
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